The anaesthetic management of patients undergoing caesarean section surgery and its impact on post-operative analgesia by Chetty, Sean
  
 
 
 
 
 
 
 
THE ANAESTHETIC MANAGEMENT OF PATIENTS UNDERGOING 
CAESAREAN SECTION SURGERY AND 
ITS IMPACT ON POST-OPERATIVE ANALGESIA 
 
 
 
 
 
Sean Chetty 
 
A Thesis submitted to the Faculty of Health Sciences, University of the 
Witwatersrand, Johannesburg, in fulfilment of the requirements for the degree 
of Doctor of Philosophy 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Signed on the 14th October 2016 in Johannesburg 
 ii
DECLARATION 
 
 
 
I Sean Chetty, declare that this thesis is my own, unaided work. It is being 
submitted for the Degree of Doctor of Philosophy at the University of the 
Witwatersrand, Johannesburg. It has not been previously submitted for any 
degree or examination at any other University 
 
This thesis is submitted in the divided block format, which is approved by the 
Faculty of Health Sciences. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
_________________ 
Sean Chetty 
 
 
14th day of October 2016 in Johannesburg 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iii
DEDICATION 
 
 
To my wife Trusha, for her constant support and encouragement during this 
journey to complete my PhD 
 
To my children, Keyuri and Tanika, for inspiring me each day to strive to be a 
better person 
 
To my parents, and my sister, for always supporting my academic goals and 
applauding my achievements 
 
To my paternal grandmother, for establishing a level of self-confidence in me 
that has driven my ambitions and goals throughout my life 
 
To my patients, for humbling me and reminding me every day why I chose to 
become a doctor  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 iv
PRESENTATIONS ARISING FROM THIS STUDY 
 
Poster Presentations 
 
 
1. European Society of Anaesthesia Congress 2015 
 The recommended Anaesthetic Technique for Caesarean Section 
 surgery in South Africa  
 S Chetty, P Kamerman, F Paruk 
 
2. European Pain Congress 2015  
  Post-operative Analgesia Practices after Caesarean Section surgery in 
 South  Africa: Results of a national survey 
 S Chetty, P Kamerman, F Paruk 
 
3. World Congress of Anaesthesiologists 2016 
  Low Dose Intrathecal Morphine Reduces Post-Operative Opioid 
 Requirements after Caesarean Section 
 S Chetty, P Kamerman, F Paruk 
 
 
Oral Presentations 
 
 
1. SASA National Congress 2015 
 Obstetric Anaesthetic Practices in South Africa: Results of a national 
 survey  
 S Chetty, F Paruk, P Kamerman 
 
 
Invited Speaker Presentations 
 
 
1. Indoanaesthesia Congress 2016 
 Post-op Caesarean Section pain – How bad can it be?  
 S Chetty 
 
2. European Society of Anaesthesia Congress 2016 
 Pain after C-section: what does really work and how do you get benefit 
 from participating in PAIN OUT? 
 S Chetty 
 
3. IASP World Pain Congress 2016 
 Improving management of post-operative pain – Can it be done in low 
 and middle-resource countries? 
 S Chetty 
 
 
 
 
 v
ABSTRACT 
 
 
Poorly controlled pain following caesarean section surgery can have a 
debilitating effect on the physical and emotional well being of a woman during 
the post-operative period.  Good intra-operative anaesthetic management 
during caesarean section surgery is requisite to improve post-operative 
analgesia, and thereby contribute to the well being of the patient. 
 
In South Africa (SA) there are currently no national obstetric anaesthesia 
practice guidelines.  Anaesthetic service providers therefore rely on 
knowledge acquired during their anaesthetic training and recommendations 
from international guidelines (which may not be applicable in SA). In order to 
establish a reference standard of anaesthetic care for obstetric patients in SA, 
a semi-structured interview was conducted with the heads of department 
and/or their representatives from the eight anaesthesiology academic 
departments in SA in 2012.  The experts provided recommendations on the 
intra-operative anaesthetic management of patients for elective and 
emergency caesarean sections, as well as the post-operative monitoring and 
analgesic management of these patients.  The recommendations were based 
on the experts’ understanding of the uniquely local healthcare environment in 
SA. 
 
Following the establishment of the SA reference standard, a national survey 
of anaesthetic service providers was conducted in 2014 to establish what the 
practises are in South Africa for caesarean section anaesthetics.  Nine-
hundred-and-thirty-three survey responses were analysed, which equated to a 
58% response rate.  The majority of anaesthesia providers (97.8%) perform 
single shot spinal anaesthesia for caesarean sections.  Thirty percent of 
respondents chose to use Quincke spinal needles, despite the increased risk 
of this needle causing post-dural puncture headaches (PDPH).  The preferred 
local anaesthetic drug was 0.5% bupivacaine with dextrose, and fentanyl was 
the most commonly used additive agent, as opposed to common international 
practice, which advocates morphine.  The survey also revealed that 58% of 
doctors work in hospitals that do not have a post-operative monitoring 
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protocol for patients following caesarean section surgery.  This contrasts to 
recommendations suggested by the national experts regarding patient 
monitoring requirements. 
 
A clinical trial was then conducted to compare the analgesic efficacy of two 
different doses of intrathecal morphine (50μg and 100μg) with 25μg fentanyl.  
Patients in both morphine treatment groups had significantly lower post-
operative opioid requirements than patients in the fentanyl group.  The pain 
numerical rating scale (NRS) scores were however not statistically different 
and there was also no difference in the side effects profile or emotional 
parameters measured, between the groups. 
 
This study highlights the differences in the recommended practise of obstetric 
anaesthesia in SA compared to other countries and demonstrates how 
obstetric anaesthesia is practised in SA.  The final component of this study 
has demonstrated how international best practices can be easily implemented 
in SA to improve the anaesthetic care of the obstetric patient. 
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CHAPTER ONE: INTRODUCTION 
 
Caesarean section rates vary globally.  In South Africa this rate exceeds the 
World Health Organisation (WHO) recommended rate of 10 – 15%, ranging 
between 16.1% and 20.3% in the public sector district hospitals and 
metropolitan hospitals, respectively (Moodley, 2010).  In the private sector, 
the caesarean section rate is reported to be as high as 70% (CMS, 2015).  
The high rate of caesarean sections in South Africa may be due to a more 
defensive practice of obstetrics by South African doctors and the high rate of 
maternal requests, but there are no definitive data on the cause.  This trend 
towards high caesarean section rates is not unique to South Africa.  The 
caesarean section rate in the United States of America (USA) in 2013 was 
32.7% (Martin et al., 2015).  European figures range from 14.8% in Iceland to 
52.2% in Cyprus, with a median European rate of 25.2% (Macfarlane et al., 
2015).  The authors of this European study highlighted that there is evidence 
that the rising prevalence of caesarean sections across Europe may be due to 
non-medical reasons, such as maternal request, health system organization 
and reimbursement policies. However further research is required to make a 
definitive determination of the rising rate of caesarean sections in Europe 
(Macfarlane et al., 2015). 
 
The increasing number of caesarean sections being performed means that 
there is an increasing number of women who require anaesthesia for the 
procedure and, analgesia for post-surgical pain following the birth of their 
children. Inadequately treated post-operative pain is associated with its own 
complications (Stephens et al., 2003), which lead to increased morbidity 
following delivery.  Consequently, the anaesthetic management of the 
obstetric patient in South Africa, and internationally, has become an 
increasingly important component in the care of these women.   
 
In South Africa there are no accepted guidelines or protocols for the 
anaesthetic management of the caesarean section patient.  Furthermore, 
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there are no data available regarding who should take responsibility for the 
management of the post-operative pain in these patients (eg. obstetrician or 
anaesthesiologist), or how the pain is being managed.  Indeed, even if pain 
management protocols are used and are correctly implemented, yet they do 
not result in higher patient satisfaction, then the analgesic regimen has failed. 
 
Good anaesthetic management of the caesarean section patient has the 
potential to improve patients’ birth experiences (Karlstrom, 2007) and 
decrease the risk of post-operative morbidity (Stephens et al., 2003).  The 
period of childbirth can make a woman extremely vulnerable. Women 
delivering their babies by caesarean section are particularly vulnerable and 
may feel disempowered during this process.  As healthcare providers we have 
an ethical responsibility to provide high quality pain management to these 
vulnerable patients.  Failure to do this may be considered as a violation of the 
ethical principles of medicine.  
 
The lack of information surrounding anaesthetic practice and post-operative 
pain management for South African caesarean section procedures served as 
the impetus for this study.  The ultimate goal of the research described in this 
thesis is to lay the foundational information required to improve pain 
management for women having caesarean sections in South Africa. That is, 
we need basic information on current analgesic practices used for caesarean 
sections in South Africa, which can inform the establishment of safe, effective, 
and cost effective pain management protocols, which can be implemented 
within the resource constraints of the local public healthcare system.  
 
1.1 Study Aims 
 
a) To describe the post-operative pain management practices of doctors 
managing caesarean section patients in South Africa. 
 
b) To evaluate the safety and efficacy of different intrathecal opioids in 
women who have undergone caesarean section surgery. 
 3
1.2 Specific Objectives 
1.2.1 Aim (a) 
• To determine what is considered the reference standard in South Africa 
(as determined by the anaesthesiology academic heads of department) 
with regards to caesarean section relating to: 
 Preferred method of anaesthesia  
 Use of adjuvant drugs for neuraxial anaesthesia 
 Post-operative monitoring practices 
 Post-operative pain management 
 
• To determine what the preferences are amongst specialist 
anaesthesiologists working in the public and private sector with regards 
to anaesthesia for caesarean section relating to: 
 Preferred method of anaesthesia  
 Use of adjuvant drugs for neuraxial anaesthesia 
 Post-operative monitoring practices 
 Post-operative pain management 
 
• To determine what the preferences are amongst non-specialist medical 
practitioners (registrars, medical officers and general practitioners) with 
regards to anaesthesia for caesarean section relating to: 
 Preferred method of anaesthesia  
 Use of adjuvant drugs for neuraxial anaesthesia 
 Post-operative monitoring practices 
 Post-operative pain management 
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1.2.2 Aim (b)  
• To evaluate the analgesic effect of three different intrathecal opioid 
mixtures (100μg morphine, 50μg morphine and 25μg fentanyl) in 
women who had undergone caesarean section surgery, relating 
specifically to: 
i. Post-operative analgesic requirements at two time points (12 
hours and 24 hours) post surgery 
ii. Pain scores at two time points (12 hours and 24 hours) post 
surgery 
iii. Sedation scores at two time points (12 hours and 24 hours) post 
surgery 
iv. Post-operative nausea scores at two time points (12 hours and 
24 hours) post surgery 
v. Post-operative pruritus scores at two time points (12 hours and 
24 hours) post surgery 
 
• To determine the impact that the patients’ post-operative pain has on 
their activities in the first 24 hours after surgery 
 
1.3 References 
 
CMS 2015. The Council for Medical Schemes Annual Report 2014/15. South 
Africa: The Council of Medical Schemes. 
KARLSTROM, A. 2007. Postoperative Pain After Cesarean Birth Affects 
Breastfeeding and Infant Care. JOGNN, 36, 430-440. 
MACFARLANE, A. J., BLONDEL, B., MOHANGOO, A. D., CUTTINI, M., 
NIJHUIS, J., NOVAK, Z., ÓLAFSDÓTTIR, H. S., ZEITLIN, J. & THE 
EURO-PERISTAT SCIENTIFIC COMMITTEE. 2015. Wide differences 
in mode of delivery within Europe: Risk-stratified analyses of 
aggregated routine data from the Euro-Peristat study. BJOG: An 
International Journal of Obstetrics & Gynaecology. 
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MARTIN, J. A., HAMILTON, B. E., OSTERMAN, M. J. K., CURTIN, S. C. & 
MATHEWS, T. J. 2015. Births: Final data for 2013. National Vital 
Statistics Reports. 1 ed. 
MOODLEY, J. 2010. National Committee on Confidential Enquiries into 
Maternal Deaths  Report 2005 to 2009. 
STEPHENS, J., LASKIN, B., PASHOS, C., PEÑA, B. & WONG, J. 2003. The 
burden of acute postoperative pain and the potential role of the COX-2-
specific inhibitors. Rheumatology, 42, iii40-iii52. 
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CHAPTER TWO: LITERATURE REVIEW 
 
In this chapter a review of the literature is presented and includes a 
discussion of the anaesthetic techniques of the caesarean section procedure, 
evaluation of pain after surgery and the management of pain after caesarean 
section surgery. 
 
2.1 History of the caesarean section 
 
The first documented successful caesarean section was performed in the 
Netherlands in 1792 on a woman who had a very small pelvis.  In Africa, army 
surgeon, Dr. James Barry, performed the first documented caesarean section 
in Cape Town, South Africa, in 1826.  (Van Dongen, 2009) 
 
Prior to the advent of anaesthesia, caesarean section surgery was considered 
to be brutal and the associated mortality was extremely high.  In 1846, William 
T.G. Morton initiated the revolution of modern surgery with the demonstration 
of the anaesthetic effects of diethyl ether.  The discovery of anaesthesia 
permitted surgeons to take more time during surgery and to refine their 
methods and therefore improve their techniques.  This ultimately resulted in 
an improvement in surgical outcomes.  These purported benefits 
subsequently also influenced the surgical care of the pregnant patient, 
culminating in improved survival of women following the abdominal delivery of 
the foetus.  The development of silver wire sutures by J. Marion Simms, to 
suture the uterine incision, lead to a reduction in women dying from 
unnecessary blood loss post caesarean sections.  These changes together 
with an improvement in the understanding of sepsis, as well as the 
introduction of antibiotics, resulted in the caesarean section procedure 
developing into the relatively safe procedure that it is today. (Sewell, 1998) 
 
The advent of anaesthesia has thus played a vital role in the outcome 
improvement of surgical procedures.  This positive influence has also 
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extended to the improvement of caesarean section surgery, permitting more 
women access to this form of delivery.  Anaesthesia currently has a very well 
defined role to play in improving the analgesic outcomes of women following 
their caesarean sections. 
 
2.2 The caesarean section surgical procedure 
 
A caesarean section constitutes a modern obstetric surgical procedure that is 
classically defined as “the delivery of a foetus through a surgical incision in 
the anterior abdominal wall” (Landon, 2007).   
 
The indications for a caesarean section are numerous and may be divided 
into maternal, foetal or maternal-foetal indications, as depicted in Table 2.1. 
 
TABLE 2.1: Indications for caesarean section  
 
Maternal   
  
Specific cardiac disease (Marfan’s syndrome, unstable coronary artery 
disease) 
  Specific respiratory disease (Guillian-Barré syndrome) 
  Conditions associated with increased intracranial pressure 
  Mechanical obstruction of the lower uterine segment (tumors, fibroids) 
  Mechanical vulvar obstruction (condylomata) 
    
Foetal   
  Non-reassuring foetal status 
  Breech or transverse lie 
  Maternal herpes 
  Congenital anomalies 
    
Maternal- 
 foetal Cephalopelvic disproportion 
  Placental abruption 
  Placenta previa 
  
Elective caesarean delivery 
 
Adapted from (Landon, 2007) 
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Irrespective of the indication for the procedure, the surgery always involves an 
incision through the maternal abdominal wall and anterior uterine wall in order 
to extract the baby.  Thereafter the surgeon needs to ensure that haemostasis 
is effected before surgical closure of the abdominal wound in multiple layers. 
 
The surgical procedure stimulates multiple nociceptors in the skin, muscle and 
visceral organs. Nociceptors are free nerve endings in the skin, muscle and 
the viscera that respond to different potentially tissue-damaging stimuli in 
multiple ways.  The tissue trauma leads to the release of a number of 
nociceptive mediators, such as bradykinin, hydrogen ions and substance P. 
These substances lead to the development of a pro-inflammatory milieu that 
sensitizes the nociceptor membranes, increasing their excitability.  All these 
nociceptor stimuli (mechanical, thermal and chemical) are then transduced 
into electrical signals by membrane depolarization.  If these electrical signals 
are of sufficient magnitude, or distribution across nociceptors, then this 
electrical potential is transformed into an action potential. (Vadivelu et al., 
2009, Gold and Gebhart, 2010) 
 
Figure 2.1 illustrates how the different mechanisms (thermal, mechanical or 
chemical) lead to the release of mediators that act on the nociceptors.  The 
illustration demonstrates how these mediators will ultimately converge on 
transducers, such as TRPV1, leading to the transduction of the initial 
stimulation into an electrical signal.  The figure also demonstrates how the 
transduction of noxious stimuli involves several cell types and may require 
multiple specific proteins, which are uniquely positioned within the nociceptor 
membrane, for the process of conversion of nociceptor stimulation into 
electrical signals that will travel to the central nervous system.  The electrical 
signal is then interpreted in the brain as pain. (Gold and Gebhart, 2010) 
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FIGURE 2.1: Transduction of stimuli into electrical signals (Gold and Gebhart, 
2010) 
 
The pain that patients experience has at least two components, somatic and 
visceral. Somatic pain is initiated from the nociceptors in the abdominal 
wound.  These have both deep and cutaneous locations.  The signal from 
these nociceptors is transmitted to the spinal cord through the anterior 
divisions of the spinal segment nerves from thoracic nerve 10 (T10) to lumbar 
nerve 1(L1). These nerves run laterally in the abdominal wall between layers 
of the internal oblique and transversus abdominis muscles.  The visceral 
component of the pain is transmitted from the nociceptors in the uterus 
through the afferent nerve fibres that pass through the inferior hypogastric 
plexus.  These nerves then enter the spinal cord through the T10 to L1 spinal 
nerves (McDonnell et al, 2009). 
 
The signals travel through the peripheral nerve fibres to the dorsal horn of the 
spinal cord and then ascend to the brain via the ascending spinal tracts, 
where they are finally perceived in the sensory cortex as pain.  These nerve 
fibres in the spinal cord have receptors that are responsive to opioid 
stimulation.  Stimulation of these receptors results in the inhibition of the 
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transmission of nociceptive stimuli to the brain.  This endogenous pain 
modulation system forms an important component of the innate pain control 
mechanisms.  These receptors also provide a useful point of intervention for 
the management of pain after caesarean section surgery. (Helms and Barone, 
2008) 
 
2.3 Anaesthesia for caesarean section surgery 
 
The anaesthesia indicated for caesarean section surgery can be in the form of 
general anaesthesia or neuraxial anaesthesia. Taking into account the unique 
anatomical and physiological changes that accompany pregnancy such as a 
reduced functional residual capacity and profound haemodymanic alterations, 
the pregnant patient at term (37 completed weeks gestation) poses a greater 
anaesthetic risk than a non-pregnant female (Birnbach and Browne, 2005).  
Consequently, neuraxial anaesthesia, which has lower risks associated with 
its use compared to general anaesthesia, predominates as the preferred 
anaesthetic method for caesarean section surgery (Tagaloa et al., 2009).  
Amongst the neuraxial anaesthesia techniques, spinal anaesthesia is reported 
to be more cost effective, less technically challenging and has been reported 
to achieve adequate surgical anaesthesia in a shorter timeframe as compared 
with epidural anaesthesia (Riley et al., 1995).  Both spinal and epidural 
neuraxial anaesthesia techniques however, allow the mother to be conscious 
for the birth of her baby, and facilitate bonding to occur sooner with the 
neonate (within the theatre) as opposed to general anaesthesia (Stevens et 
al., 2014).  In addition, there have been reports of a higher prevalence of 
chronic pain in patients who have had a caesarean section under general 
anaesthesia as compared to regional anaesthesia (Nikolajsen et al., 2004).   
 
Based on the analysis of data from a large registry, Butwick et al (2016) 
demonstrated that there appears to be racial and ethnic disparities between 
the mode of anaesthesia for caesarean section surgery amongst women in 
the USA.  After analyzing the records of the cohort comprising of 50974 
women who had caesarean sections, the authors reported that the rates of 
general anaesthesia for caesarean section surgery f
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women, in this study, was 11.3%, compared with rates of 5.2% for 
Caucasians and 5.8% for Hispanics.  Even after correcting for obstetric and 
non-obstetric covariates, the odds of African American women having general 
anaesthesia for their caesarean section remained high (OR=1.7, 95%CI = 1.5 
– 1.8) compared to other race groups in the USA. (Butwick et al., 2016) 
 
Neuraxial anaesthesia involves the administration of a local anaesthetic 
solution into either the spinal or epidural space through a percutaneous 
puncture along the vertebral column.  The onset of anaesthesia is 
approximately five minutes with spinal anaesthesia and 15 – 30 minutes with 
epidural anaesthesia (Kleinman, 2002).  The duration, extent and intensity of 
the neural blockade largely depend on the type, volume and concentration of 
the local anaesthetic used (Kleinman, 2002), and any additive agents co-
administered with the local anaesthetic. Indeed, the addition of non-
anaesthetic agents to enhance the intensity and duration of the anaesthesia 
and analgesia is now commonly practiced (Gadsden, 2005).  Additive agents 
commonly cited in the literature include neostigmine, clonidine, and opioids 
(Dahlgren et al., 1997, Krukowski et al., 1997, Benhamou et al., 1998). Of 
these agents, opioids are by far the most commonly used additive (Tagaloa et 
al., 2009).  It has been suggested that intrathecal administration of opioid 
agents allows direct stimulation of the mu opioid receptors in the substantia 
gelatinosa of the dorsal horn of the spinal cord by suppressing excitatory 
neuropeptide release from C-fibres (Cousins, 1984). This allows for a more 
intense neuraxial block with a lower risk of transfer to the foetus (due to the 
low dose of opioid used). 
 
Irrespective of the mode of anaesthesia provided to a woman for her surgery, 
the goal remains the same in that the patient should not experience any 
undue negative physiological response to the surgical incision, including 
undue pain.   
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2.4 Consequences of inadequately treated caesarean section pain 
 
The childbirth experience is multidimensional and therefore complex to 
interrogate and explain (Waldenström et al., 1996); there are multiple factors 
that can influence the patient’s emotional experience, and all of these can 
influence how she will perceive her birthing experience.  Waldenström et al 
(1996) identified pain as one of six factors that contributed to explaining the 
overall birthing experiences of women.   Post-operative pain can result in a 
number of unwanted physical and psychological sequelae for the patient 
(Breivik, 1998).  These sequelae can have a negative impact on the mother 
as well as the mother-baby relationship if they are not detected or managed 
appropriately.  Karlstrom (2007) reported that women in their study, who 
experienced more pain than expected after their caesarean section, were 
more likely to have a negative birth experience.  Sixty two percent of women 
in their study reported that their ability to take care of their babies was 
adversely affected by their post-operative pain to a large or very large extent 
in the first 24 hours after delivery. 
 
The physiological response to surgery is an important component of the 
healing process.  The purpose of this response is to promote the development 
of a catabolic state, which is required for the healing process to occur.  
However, uncontrolled pain can exacerbate this normal response and this can 
lead to increased morbidity.  Inadequately treated acute post-operative pain 
can adversely affect a number of different organ systems, but in the post-
caesarean section patient, the most significant organ system affected is the 
central nervous system. 
 
Prolonged activation of peripheral nociceptors can cause central sensitization 
and may lead to the development of chronic pain syndromes (Woolf, 1983).  
Therefore, inadequately treated acute post-operative pain increases the risk 
of development of chronic pain.  Cogan et al (2002) reported that 19% of 
patients in the Quebec Post-operative Pain Management study experienced 
pain beyond three months following surgery.   
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In 2004, Nikolajsen et al (2004) found that 18.6% of post-caesarean section 
patients experienced persistent scar pain for more than three months after 
their surgery. The authors sent a postal survey to 244 patients who had 
caesarean section surgery over a one-year period at their hospital in 
Denmark, asking questions about chronic pain. Two hundred and twenty 
patients responded. Of the 41 patients who reported chronic pain following 
their surgery, 27 still had pain at the time of the survey; and 13 (5.9%) 
patients reported this to be constant.  In addition to the physical burden to the 
individual patient and her family, chronic pain also incurs an economic cost to 
the community at large. Gaskin and Richards (2011) estimated that the total 
cost of pain to the American economy ranged between 560 and 635 billion 
United States dollars (USD) in 2010.  This estimation was based on both the 
direct cost of care and the indirect costs related to the loss of productivity in 
the economy.  The authors demonstrated that the annual cost of treating pain 
was greater than the costs related to heart disease, cancer and diabetes in 
2010 (Gaskin and Richard, 2011).   
 
Unrelieved post-operative pain can also have a negative psychological effect 
on the patient.  Patients whose pain is inadequately controlled may 
experience sleep deprivation, anxiety, helplessness and fatigue (Stephens et 
al., 2003).  All these physiological disturbances can prevent rapid recovery 
and rehabilitation of the patient in the post-operative recovery period (Pavlin, 
2002). 
 
In patients who have had caesarean section surgery, inadequately treated 
pain in the post-operative period can also adversely affect the bonding 
between mother and baby.  Poor post-operative pain control has been shown 
to have a significant negative impact on breastfeeding and infant care 
(Karlstrom, 2007).  The interference with this important nurturing process can 
lead to impaired bonding between mother and baby during this vital period.  
 
Other organ systems that may be adversely affected by inadequate post-
operative pain management include the respiratory system (Stephens et al., 
2003, Breivik, 1998), the cardiovascular system (Stephens et al., 2003), 
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endocrine and metabolic systems (Stephens et al., 2003, Breivik, 1998), 
haematologic system (Stephens et al., 2003), gastrointestinal system (Breivik, 
1998, Stephens et al., 2003), genitourinary system (Stephens et al., 2003) 
and the immune system (Page, 2000). 
 
The multitude of problems that can develop in post-operative patients whose 
pain is poorly controlled demonstrates that this important aspect of patient 
care must be prioritized when planning maternal health care services. 
 
2.5 Patients perception of post-caesarean section surgery pain 
 
Surgery and the associated anaesthesia have the potential to become a 
frightening experience for many patients. Shafer et al (1996) demonstrated 
that many patients fear anaesthesia more than surgical complications (Shafer 
et al., 1996).   Furthermore obstetric patients tend to experience additional 
anxieties about their surgery, which are related to fears about the baby’s 
exposure to the anaesthetic agents and other drug exposures.  In addition to 
these concerns, expectant mothers are often concerned about their ability to 
take care of their babies in the post-operative period.  Pain, both during and 
after the caesarean section procedure, has been documented as the most 
important factor that obstetric patients are concerned about in relation to the 
entire surgical procedure for a caesarean section.  Side effects, such as 
nausea and vomiting, pruritus and shivering, rank lower on the list of concerns 
that these patients have (Carvalho et al., 2005a). 
 
Pain in the post-operative period is influenced by many different factors, 
including pre-existing psychological stressors (Keogh et al., 2006), intra-
operative experiences (Keogh et al., 2006) and even the methods used to 
evaluate the patient’s pain (Chooi et al., 2013).  Pre-operative psychosocial 
factors have been hypothesized to influence the post-operative experience.  
Since most women deliver their babies vaginally, the majority of the research 
done in this field has investigated patients who experience this mode of 
delivery (Keogh et al., 2006).  Keogh et al (2006) examined the influence of 
pre-operative psychosocial factors on the post-operative experiences of 
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women who delivered their babies by caesarean section.  The authors 
evaluated women and their birth partners during the pre-, intra- and post-
operative period following caesarean section surgery.  Using regression 
analyses, they concluded that factors that predict the mother’s post-operative 
pain are the patient’s pre-operative negative expectations, her level of fear 
and her level of pain during the surgery and also her partner’s level of fear 
during the surgery.  In fact, the birth partner’s level of fear during the surgery 
was the most significant predictor of the patient’s post-operative pain in their 
study. 
 
Based on the results of the Keogh et al (2006) study, experiencing pain during 
surgery has the potential to influence the pain perception that the patient will 
experience in the post-operative period.  As such, a dense regional 
anaesthetic block will then probably not only provide good intra-operative 
analgesia but may also positively impact post-operative pain experiences.  
Keogh and colleagues (2006) also suggested that the anaesthesiologist may 
play a pivotal role in alleviating the patients’ fears during surgery and this may 
also have a positive impact on the woman’s post-operative pain experience as 
well.  These results are supported by findings of a similar study (Jamison et 
al., 1993) investigating the psychosocial influences of women, undergoing 
abdominal hysterectomy surgery, on their post-operative intravenous 
analgesic use.  Pre-operative emotional distress in this group of patients was 
significantly associated with the dose of analgesia used in the post-operative 
period (Jamison et al., 1993).  Both these studies were however small single 
centre prospective studies. 
 
In addition to pre-operative anxiety, prenatal depression may also influence 
post-operative pain experiences.  Many studies have shown that depression 
and pain are comorbid but the interaction between these two conditions is not 
fully understood. Lou and Kong (2012) investigated the influence that pre-
operative depression has on post-operative pain.  The authors performed the 
Self Rating Depression Scale (SRDS) on 764 pregnant women before their 
surgery and then also evaluated their pain at 24, 48 and 72 hours post-
operatively.  They found that 29.7% of the women evaluated had positive 
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depressive symptoms prior to surgery.  The authors demonstrated a 
statistically significant association (p<0.05) between pre-natal depression and 
pain scores in the post-operative period for all three periods evaluated.  This 
study showed that pre-natal depression had a profound negative effect on the 
pain perception of women in the post-operative period.  Considering that close 
to 30% of the study population had positive symptoms, this implies that this 
may have a significant impact on pain management in the post-operative 
period for this population group. It is therefore important that women should 
be screened and managed for depressive symptoms prenatally.  This can 
have a positive impact on pain perception after surgery (Lou and Kong, 2012).  
Despite the statistically significant results reported by Lou and Kong, not all 
research in this field of study has yielded a positive correlation between the 
presence of psychological factors and post-operative pain. Hansson et al 
(1989) also investigated the influence of pre-operative psychological factors 
on pain in a different patient population, but could not link levels of pre-
operative stress and tension with the post-operative pain experienced in 
patients undergoing third molar dental surgery (Hansson et al., 1989).   
 
In addition to psychosocial factors, there is also evidence to suggest that 
psychophysical assessment of somatosensory function by quantitative 
sensory testing can have a predictive value in identifying women who will 
experience higher levels of pain after their caesarean section.  Granot et al 
(2003) conducted pre-operative physical thermal quantitative sensory testing 
on fifty-eight pregnant women who were scheduled for elective caesarean 
section surgery.  The post-operative pain of these patients was then 
evaluated on the first day after their surgery. The authors found that the pre-
operative quantitative sensory thermal testing at 48oC provided the most 
statistically relevant correlation (r-0.527, p<0.003) with the post-operative pain 
experienced by these patients, suggesting that this could be used as a 
predictive model for post-operative pain in this patient population.  Pan and 
colleagues (2006) attempted to increase the predictive value of pre-operative 
testing further by combining physical and psychological testing.  They 
evaluated thirty-four patients between one and ten days prior to their 
scheduled elective caesarean section surgery.  Multiple five-second heat 
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stimuli were applied to the patients and their levels of perceived pain intensity 
and unpleasantness to the stimuli were recorded.  In addition, all patients also 
completed the State Trait and Anxiety Inventory (STAI), which is a tool used 
to assess anxiety levels.  The authors were able to identify risk factors for rest 
pain, movement pain and analgesic drug use in the post-operative period.  
The results of this study suggests that the severity of pain and opioid use in 
the post-operative period can be determined by a combination of factors that 
can be tested pre-operatively.  The multiple regression analyses from the 
study suggest the ability to obtain a high probability of the occurrence of 
severe pain post-caesarean section surgery using these physical and 
psychological pre-operative tests. 
 
The patient’s perception of the post-operative pain may also be influenced by 
the method used to evaluate their pain.  Chooi et al (2013) used the verbal 
numerical rating scale (VRNS) to assess standard pain scores and compared 
this with comfort scores post caesarean section.  Three-hundred patients 
were randomized into two groups.  Patients was asked to either rate their pain 
after surgery or alternatively to rate their comfort level after surgery.  The 
group of patients who were asked to rate their pain (as opposed to their 
comfort) had significantly higher scores at rest (p=0.001) and with movement 
(p<0.001).  The implication was that using words like “pain” when evaluating 
patients in the post-operative period may actually have a negative connotation 
for the patient and they may perceive the sensations they have after surgery 
to be unpleasant.  This was in contrast to using neutral words that may not 
create a negative perception in the patient.  In this study, more than half of the 
women in the group who were questioned directly about pain, reported that 
they had pain (74%) but also stated they were comfortable (79%), when this 
was asked directly.  This implies that it may actually be more helpful to ask a 
patient as a direct question if they are comfortable, or if they are bothered by 
the pain or if they want treatment – in order to assess the patient after 
surgery, rather than just asking about their pain score.  These findings may be 
explained by the fact that negative suggestions have been shown to influence 
changes in the anterior cingulate cortex.  This area of the brain links the limbic 
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system to the sensory cortex.  Changes in this area of the brain can therefore 
influence the clinical experience of the patient (Rainville P. et al., 1997). 
 
The patient’s perception of their post-operative pain is influenced by a 
multitude of different factors.  Many of these are related to the patient’s pre-
operative physical and mental state however the method of assessment used 
to evaluate their pain may also have an important influence on how the patient 
experiences their pain. 
 
2.6 Pain Assessment Tools 
 
Pain is a subjective experience (Merskey et al., 1979), which makes the 
assessment of pain for clinical or research purposes very challenging.  Its 
measurement requires patient compliance and the physical and mental ability 
to provide a response. This response involves converting the subjective 
experience of the patient into an objective measurement that can be analyzed 
and interpreted (Revill et al., 1976). 
 
There are a number of different validated tools that have been developed for 
this purpose.  Each of them has advantages and disadvantages depending on 
the purpose for which they are being used.  The most popular pain 
measurement tools are unidimensional instruments.  These pain assessment 
tools only assess one dimension of the patient’s pain such as the intensity of 
the pain, or the frequency of pain attacks or quality of the pain.  To only 
evaluate one dimension of the patient’s pain experience may not adequately 
uncover the true nature of the pain. Unidimensional pain evaluation 
instruments are however easier to administer and easier for the patients to 
understand.  The reproducibility and validity of the results obtained with these 
tests in research studies is a factor that has resulted in these instruments 
being very popular (Flaherty, 1996). 
 
There are multidimensional pain evaluation instruments available, however 
these tools are much more complicated and tend to be more difficult for 
patients to complete.  These tools assess the different facets of the patient’s 
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life that may be affected by the pain and addresses important issues like 
quality of life. 
 
2.6.1. Numerical Rating Scale 
 
The Numerical Rating Scale (NRS) is an eleven-point rating instrument.  The 
scale is made up of numbers from zero to ten, orientated either vertically or 
horizontally.  Zero implies no pain and ten implies maximum pain for the 
individual patient. This is a unidimensional pain evaluation tool. 
 
 
FIGURE 2.2: Format of the Numerical Rating Scale (Downie et al., 1978) 
 
The NRS was described by Downie et al in 1978 and has been shown to 
exhibit good correlation with the less complicated ‘simple descriptive scale’ 
(SDS) (correlation factor 0.680).  It also offers an advantage over the SDS 
with respect to measurement error (Downie et al., 1978).  The original NRS 
was developed as an eleven point scale (0 to 10) however multiple versions 
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have been developed since in an effort to improve the sensitivity of the scale 
and the rates of correct response (Flaherty, 1996).   
 
When evaluating a patient using the NRS, the patient is asked to rate their 
pain (most often the intensity of the pain) on the scale.  The instrument allows 
for the conversion of a subjective experience into an objective value, which 
can be analysed and interpreted. 
 
The NRS is a popular pain evaluation instrument for both clinical practice and 
pain research because it offers the clinician and patient a number of practical 
advantages.  The scale is simple to administer and score, and is easy for 
patients to understand irrespective of the primary language of the patient.  In 
addition to pain intensity, the scale can also be used to evaluate the effect of 
analgesic therapy (Flaherty, 1996).  The main disadvantage associated with 
the NRS is that it has been found to be less reliable in very young and very 
old patients (Flaherty, 1996). There are, however, other pain evaluation tools 
that can be ultilised in these subsets of patients.  
 
2.6.2 The Visual Analogue Scale 
 
The Visual Analogue Scale (VAS) constitutes a simple straight line (either 
horizontal or vertical) with anchors at each end representing the extreme 
boundaries of the entity being measured.  This is a unidimensional pain 
evaluation tool. The patient is asked to rate his/her experience of the 
measured entity by placing a mark on the line at the point on the line that 
represents their preference.   
 
 
 
FIGURE 2.3: The Visual Analogue Scale (Wewers and Lowe, 1990) 
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The VAS has been used as a tool of measure in science for a very long time.  
The pain VAS originated from the scales used in the field of psychology to 
measure patient well-being (Pagare et al., 2015).  Bond and Pilowsky (1966) 
modified the VAS for the assessment of pain in cancer patients using the 
anchors of “I have no pain at all” on the left and “My pain is as bad as it could 
possibly be” on the right sides of the horizontal line.  This was followed by 
Woodford and Merskey (1972), who published one of the earliest uses of the 
VAS in pain research in the Journal of Psychosomatic Research.  These 
authors correlated the VAS method of pain assessment with a descriptive 
method used to assess pain in forty-three patients referred to a psychiatrist for 
pain management. 
 
Many different variations of the VAS exist.  Investigators are free to decide if 
the line should be vertical or horizontal, and the investigator can also 
determine the length of the line used in a study.  However, the 100 millimeter 
(mm) horizontal line is the most common variation used (Wewers and Lowe, 
1990).  The use of the horizontal line has been shown to produce a more 
accurate and uniform distribution of scores than is obtained when the VAS is 
orientated in vertical format (Scott and Huskisson, 1976).  In addition, lines 
shorter than 100mm are less accurate at determining variations in pain 
experience than the 10, 15 or 20 centimeter lines (Revill et al., 1976).   
 
The score of the VAS scale is calculated by measuring the distance in 
millimeters from the left sided anchor point to the patient’s mark on the line.  
The VAS scale is therefore able to produce a sensitive measurement of the 
patient’s perception of their pain and avoids categorization of the result, which 
is generally associated with visual descriptors.  The simplicity of the VAS pain 
scoring system has made this a very popular tool for both clinical practice and 
research.  It can be used in patients with poor eyesight and also in patients 
where vocabulary level is a concern. Disadvantages of the VAS include the 
fact that the tool can only be used when the patient is physically present and 
is able to make a mark on the line.  It is therefore not suitable for telephonic 
follow-up with patients.  Some patients also have difficulty in converting their 
subjective experience of pain into a meaningful mark on a straight line.  This 
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can result in patients recording inaccurate responses on the scale.  
Researchers have attempted to overcome some of the disadvantages of the 
VAS by modifying the tool to accommodate for its disadvantages.  The 
Graphic Rating Scale (GRS) is a modification of the VAS where verbal 
descriptors are placed on the straight line, giving the patient a reference point 
for their answer (Scott and Huskisson, 1976).  
 
 
FIGURE 2.4: The Graphical Rating Scale (Scott and Huskisson, 1976) 
 
The NRS, as described in detail in 2.6.1, is also a modified form of the VAS.  
It includes numbers at set points on the line, which assists the patients in 
orientating themselves to the scale. 
 
2.6.3 Verbal Descriptor Scale 
 
The Verbal Descriptor Scale (VDS) was first developed and validated by 
Professor Kenneth Keele in 1948.  The chart was developed for evaluating 
patients’ responses to analgesics.  Professor Keele commented in his 
publication:  “Pain charts are of value in defining the action of analgesics” 
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(Keele, 1948).  While the VDS and other pain scales have matured into more 
robust assessment tools, these words were profound at a time when pain 
assessment was not being appropriately carried out by the medical 
profession. 
The VDS consists of numerically ranked words describing the intensity of the 
patients’ pain at the time of the assessment.  This is a unidimensional pain 
evaluation tool.  
 
 
FIGURE 2.4: The Verbal Descriptor Scale (Iowa, 2016) 
 
The patient has a more direct descriptor of the pain that they can identify with.  
However, a disadvantage of the VDS is that the scale artificially organizes the 
descriptors into categories by forcing the patient to choose one of the 
provided descriptors, and this may not actually reflect the true sensation of the 
patient. 
 
2.6.4 McGill Pain Questionnaire 
 
The McGill Pain Questionnaire (MPQ) is a multidimensional pain assessment 
instrument.  The questionnaire assesses multiple factors that are influenced 
by or may influence the patient’s pain.  These include factors such as the 
pattern of the pain over a period of time, the sensory and affective 
components of the pain and also the location of the pain.  These factors are 
evaluated in addition to the intensity of the pain.  The MPQ was developed by 
Ronald Melzack, who is considered to be one of the founding fathers of the 
discipline of pain medicine.  In the original publication of the MPQ the author 
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commented that: “ The questionnaire was designed to provide quantitative 
measures of clinical pain that can be treated statistically” (Melzack, 1975). 
 
The most important advantage of the MPQ is that the instrument addresses 
the multidimensionality of pain taking into account the psychological and 
behavioral components of the pain.  Despite being a very useful tool, the MPQ 
is not popular in general clinical practice, especially for acute pain, because it 
is a complex document and requires a long period of time to complete 
correctly.  In 1987 a short version of the MPQ was published (Melzack, 1987).  
This abbreviated form of the tool increased the clinical applicability of the 
MPQ while maintaining most of the advantages of the multidimensional 
assessment tool. 
 
The screening tools discussed above are only four of many examples of pain 
assessment tools available for both clinical and research practice.  
Irrespective of the type of pain assessment tool that is used to evaluate a 
patient’s pain, all these tools require that the relevant patient population is 
able to understand how to use these tools so that they can convert their 
subjective experience into an objective quantifiable value on the pain scale.  
South Africa has a literacy rate of 94.3% (Barrientos and Soria, 2016).  
Despite this high rate of literacy, there is still a portion of the population who 
are not able to easily understand pain assessment tools and we need to be 
cogniscient of the fact that pain assessment tools may not be clinically useful 
in this population.   
 
Mudgalkar and colleagues (2012) investigated the impact of literacy on the 
ability to use two different pain assessment tools in a rural community in India.  
These authors concluded that illiterate patients could easily and reliably use 
both pain assessment tools that they evaluated (Visual Analogue scale and 
Numeric Analogue Scale).  No studies investigating the validity of pain 
assessment tools in illiterate South Africans could be identified.  However, 
extrapolating the results of the Indian study (Mudgalkar et al, 2012) to South 
Africa, it is reasonable to conclude that illiterate South Africans can also 
reliably use simple pain assessment tools.   
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Another criticism of pain assessment tools is that they only assess the 
patient’s pain once it has already started. Considering the potential severe 
consequences of poorly treated post-operative pain in the obstetric patient, as 
discussed previously, it is imperative that we attempt to identify patients who 
may be at risk for developing severe pain following caesarean section 
surgery. 
 
Pan and colleagues (2013) have developed a predictive model to identify 
patients at high risk of developing severe pain following caesarean section 
surgery.  The tool consists of a simple three-item questionnaire assessing the 
patient’s expectation of their pain and their analgesic requirements following 
surgery, as well as their level of anxiety towards the surgery.  The responses 
to each of the three questions correlated with the pain experienced by the 
patient at 24 hours after surgery (r=0.24 – 0.33, p<0.001). The authors 
concluded that this predicative model could be used to identify high-risk 
women, who could then have their post-operative analgesia tailored to their 
specific requirements following surgery.  
 
Identification of high-risk patients, as well as frequent and regular assessment 
of the patient’s pain in the post-operative period will certainly assist the 
medical staff to manage the patients’ pain more effectively. 
 
2.7 Treatment of post-caesarean section surgery pain 
 
Adequate analgesia for the post-operative caesarean section patient is 
extremely important in order to reduce the risk of side effects associated with 
poor post-operative pain control (as discussed in 2.4).  These new mothers 
need to have good analgesia so that they can mobilise and take care of their 
babies.  The ideal analgesic regimen should have maximum analgesic effect 
with minimal side effects and negligible infant exposure through the breast 
milk (Kwok et al., 2014).  This is not easy to achieve, especially in developing 
countries, where many therapeutic options may not be accessible or 
affordable.   
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The approach to post-caesarean section pain management has evolved over 
time, as different drugs and administration techniques have developed.  There 
are many factors that influence the regimen that is used by the 
anaesthesiologist, to manage a patient’s post-operative pain.  These factors 
include patient preferences and expectations, the expected level of difficulty 
and the duration of the surgery, as well as the preference and level of 
experience of the anaesthesiologist (McDonnell et al, 2009).  The current 
practice in managing the post-operative pain in these patients is to utilize 
balanced, multimodal analgesic techniques (Kwok et al., 2014).  This type of 
therapy involves the use of different analgesic agents such as opioids, non-
steroidal anti-inflammatory drugs (NSAIDs), paracetamol and adjuvant 
agents; as well as administering these agents using different, synergistic 
methods.  Each of these will be discussed below: 
 
2.7.1 Regional anaesthetic techniques 
 
Regional anaesthetic techniques allow the anaesthesiologist to focus the 
patient’s anaesthetic or analgesic therapy to the specific areas being treated.  
This decreases the systemic effects and side effects of any agents that are 
used.  Three regional anaesthetic techniques that can be used in the 
management of post-caesarean section pain are discussed below: 
 
2.7.1.1 Neuraxial Techniques 
 
Neuraxial anaesthetic techniques refer to spinal and epidural anaesthetic 
techniques.  The post-operative analgesic benefits of these techniques are 
dependent on the adjuvant agents that are used in the neuraxial blocks or on 
the duration of the infusion of local anaesthetic agents.  The administration of 
intrathecal opioids has proven to be extremely effective in managing the post-
operative pain of women following caesarean section surgery (Palmer et al., 
1999, Salmah and Choy, 2009, Hunt et al., 1989, Dahlgren et al., 1997, 
Terajima et al., 2003).  Intrathecal fentanyl and sufentanil have been 
demonstrated to be superior to placebo in prolonging the period of effective 
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analgesia following caesarean section surgery (Dahlgren et al., 1997).  
Dahlgren et al (1997) randomized eighty women to receive different doses of 
intrathecal opioids or placebo, and compared the effects on their post-
operative pain VAS scores, and their opioid analgesic requirements in the first 
24 hours after surgery.  The duration of complete analgesia increased from 
ninety minutes in the placebo group to up to four hours in the opioid treated 
groups.  This significant increase in the duration of complete analgesia, in the 
opioid treated patients in this study, was noted by the authors to be similar to 
other earlier studies using these lipophilic opioid drugs.  Despite the improved 
analgesic effects of these intrathecal opioids, these drugs are also associated 
with a higher incidence of side effects such as pruritus (Dahlgren et al., 1997).  
This higher side effects association may result in lower patient satisfaction 
levels after surgery despite improved pain control. 
 
While both these lipophilic opioids  (fentanyl and sufentanil) certainly increase 
the duration of analgesia compared to placebo, the duration of their effect is 
much shorter when compared to the analgesic effect of intrathecal morphine 
(Dahl et al., 1999).  This is because morphine is less lipophilic than fentanyl 
and sufentanil (Fukuda, 2005), and takes longer to penetrate the nerves, 
resulting in a longer onset of action and a prolonged duration of action. 
Palmer et al (1999) compared the analgesic effects of eight different doses of 
intrathecal morphine and placebo, in one-hundred-and-eight women having 
spinal anaesthesia for elective caesarean section surgery.  The post-operative 
opioid analgesic requirements were significantly higher in the placebo group 
compared to five of the eight morphine groups.  The patient controlled 
analgesia (PCA) morphine use was 45.7mg lower in the 75μg morphine group 
compared to the placebo group (95% CI = 4.8mg – 86.6mg).  There was 
however no significant difference in the PCA morphine use between the 
different intrathecal morphine dose groups.  
 
Palmer et al (1999) also found an association in the severity of pruritus 
experienced by the patients following surgery, with the dose of intrathecal 
morphine used.  The authors noted that the 24-hour pruritus score increased 
by 0.6 for each 100μg increase in the dose of intrathecal morphine.  
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Surprisingly, there was no difference in the incidence of nausea and vomiting 
between the treatment groups and the placebo group in this study (Palmer et 
al., 1999).  These results were replicated by a similar study conducted in 
Turkey.  Girgin et al (2008) compared the effect of different doses of 
intrathecal morphine combined with low dose (7.5mg) bupivacaine in women 
undergoing caesarean section surgery.  The authors found no statistical 
difference in the post-operative opioid requirements between the four doses of 
intrathecal morphine evaluated.  However, there was a significant difference 
in opioid requirements between the opioid groups and the control group 
(Mann-Whitney U test, P<0.001).  In addition, these authors also noted that 
there was no difference, between all the groups, for the occurrence of nausea 
and vomiting.   Similar to the Palmer et al (1999) study, there was a significant 
increase in pruritus as the dose of intrathecal morphine increased (linear 
regression, P=0.0001).  None of the patients in the Girgin et al (2008) study 
developed clinical evidence of severe respiratory depression at any point in 
this study.  Both Palmer et al (1999) and Girgin et al (2008) agree that the 
dose response curve for the use of intrathecal morphine for post-operative 
analgesia, for caesarean section patients, follows a sigmoidal pattern.  The 
minimal effective dose of intrathecal morphine is proposed to be 25μg.  There 
appears to be no significant analgesic advantage to using more than 100μg of 
intrathecal morphine in these patients, however there is a significant 
worsening of pruritus as the dose of morphine increases.  
 
Carvalho and Tenorio (2013) conducted a similar comparative study in a 
developing country setting (Brazil), similar to South Africa.  The authors 
randomized 123 pregnant women scheduled for caesarean section surgery to 
receive either 50μg or 100μg of intrathecal morphine with the spinal 
anaesthetic.  There was no significant difference in the analgesic effect 
between the two groups of patients. Pruritus occurred in both groups of 
patients but this side effect was statistically higher in the 100μg morphine 
group.  There were no cases of sedation or respiratory depression in the 
entire study population.  Nausea occurred in both groups of patients but there 
was no statistical difference in the occurrence of this side effect (p=0.512).  
The results of this study imply that the lower dose of intrathecal morphine may 
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provide the same quality of analgesia as the 100μg group but with a lower risk 
of pruritus.   
 
Most authors agree that the optimal dose of intrathecal morphine is 100μg.  
However this dosage does not guarantee that 100% of patients will be 
adequately treated.  Swart et al (1997) compared 100μg intrathecal morphine 
with placebo and found that 4/30(13%) patients in the morphine group used 
more that 40mg of intravenous PCA morphine in the 24 hour period after their 
surgery.  This result implies that not all women will have adequate post-
operative pain relief from 100μg intrathecal morphine.  The use of rectal 
diclofenac, as an adjunctive therapy, can increase the effect of intrathecal 
morphine (Dennis et al., 1995), and this may be used, as a treatment option, 
in patients where intrathecal morphine is not optimally addressing the 
analgesic needs of the patient. 
 
The most common side effects associated with the use of intrathecal 
morphine are pruritus [Number needed to harm (NNH) = 2.6 (95% CI=2.1-
3.3)], nausea [NNH=6.3 (95% CI=4.2-12.5)] and vomiting [NNH=10.1 (95% 
CI=5.7-41.0)].  Based on an intrathecal dose of 100μg morphine, it is 
estimated that 43% of patients will experience pruritus, 12% will experience 
vomiting and 10% will have nausea as a result of this treatment (Dahl et al., 
1999).  Another important side effect that has been noted with intrathecal 
morphine is delayed onset of respiratory depression.  This is a serious, but 
fortunately, a rare side effect. The proposed mechanism of this side effect is 
related to the fact that morphine is highly ionized and does not penetrate the 
lipid-rich neural tissue easily (Fukuda, 2005).  This results in the drug having a 
long duration of action in the cerebrospinal fluid (CSF).  Due to the flow of 
CSF in the spinal canal, the drug can spread in a cephalad direction and 
reach the respiratory centre.  In pooled data from a meta-analysis that 
included 485 patients, only one patient developed respiratory depression. The 
combined NNH for intrathecal opioids (all opioids and different doses) was 
therefore 476 (95% CI=164 - ∞) and was not statistically different from the 
control populations (Dahl et al., 1999).  Kato et al (2008) published a 
retrospective review of 1915 women who received 150μg intrathecal 
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morphine in their spinal anaesthetics for their caesarean section surgeries.  
The incidence of bradypnoea occurring in their cohort was 0.26% while the 
incidence of severe bradypnoea requiring naloxone therapy was only 1/1915 
(0.052%).  In doses of up to 250μg of intrathecal morphine, Abboud et al 
(1988) could not demonstrate any depression of the ventilatory response to 
CO2 that could be attributed to the administration of intrathecal morphine.  
This finding was in stark contrast to the significant ventilatory depression to 
rising CO2 levels observed in response to the administration of subcutaneous 
morphine (Abboud et al., 1988).  Based on the results of these studies, it is 
reasonable to conclude that delayed respiratory depression due to intrathecal 
morphine (especially low dose intrathecal morphine) is an uncommon side 
effect.  In addition, the higher respiratory rate associated with increased 
progesterone levels during pregnancy, may offer a wider margin of safety for 
this side effect, when compared with other patient populations (McDonnell et 
al, 2009). 
 
Reactivation of oral herpes simplex has also been associated with the use of 
intrathecal morphine. Davies et al (2005) found that 38% of patients in their 
intrathecal morphine group experienced a reactivation of oral herpes simplex 
within 30 days of their spinal anaesthetic for their caesarean section surgery.  
This is compared with only 16.6% of patients in the control group.  The use of 
morphine, irrespective of the route of administration (intrathecal or 
intravenous), appears to be associated with a reactivation of the virus. In 
South Africa, where there is a high prevalence of the Human 
Immunodeficiency virus (HIV) infection (Lehohla, 2015), the reactivation of 
oral herpes simplex may pose a greater problem than in the population 
investigated in the Davies et al study. I am, however, unaware of published or 
anecdotal evidence to support or detract from this hypothesis. 
 
Urinary retention is another side effect associated with the use of intrathecal 
opioids.  However this is unlikely to pose a problem in women after caesarean 
section surgery in South Africa, as the use of a urinary catheter after 
caesarean section surgery is a common global practice (Abdel-Aleem et al, 
2014). 
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Intrathecal diamorphine has also been used an alternative to intrathecal 
morphine.  Diamorphine is a more lipophilic derivative of morphine and thus 
has a faster onset of action than intrathecal morphine (Hindle, 2008).  Despite 
having a short half-life in the CSF, its metabolism into active compounds 
ensures that its duration of action is comparable to that of morphine.  This 
drug has the advantage of providing both intra-operative and prolonged post-
operative analgesia (McDonnell et al, 2009).   Diamorphine is not registered 
for use in South Africa and therefore this drug cannot currently be considered 
for therapeutic use in caesarean section surgery patients in South Africa. 
 
Epidural analgesic techniques can also be used to provide post-operative 
analgesia for women after caesarean section surgery.  The options include 
administering a continuous infusion of drugs via an epidural catheter, 
intermittent bolus administration of drugs via an epidural catheter, or a once 
off bolus of a long acting drug into the epidural space.  However, in my 
experience, using an epidural infusion for analgesia after surgery is not an 
attractive option for post-operative caesarean section surgery patients, as this 
form of analgesia will generally require admission to a high-care unit, and will 
also limit the mobilization of the patient as well as her ability to care for the 
baby.  This will therefore defeat the purpose of good analgesia to increase 
mobilization and bonding after surgery. 
 
Epidural opioids administration provides the anaesthesiologist with an 
opportunity to use an epidural without limiting the mobility of the patient that 
can occur with an epidural local anaesthetic infusion. The choice of technique 
used will depend on the type of drug that is being used.  Morphine has low 
lipid solubility and therefore can be administered as a single bolus into the 
epidural space to provide a relatively long duration of therapy.  More lipid 
soluble opioids, like fentanyl and pethidine, have a shorter duration of action 
and therefore will need to be administered more regularly.  These drugs are 
more suited to patient controlled epidural analgesia techniques or continuous 
infusions.  Palmer et al (2000) conducted a dose-response study in sixty 
patients undergoing elective caesarean section surgery to determine the 
 32
effect of different epidural morphine doses in this patient population.  The 
authors concluded that the post-operative analgesic requirements of these 
patients decreased with increasing doses of epidural morphine.  However the 
ceiling analgesic effect appeared to occur at an epidural morphine dose of 
3.75mg.  Above this dose there was no significant improvement in analgesia 
and there was an unacceptable increase in side effects. 
 
When compared with the intrathecal administration of morphine (100μg and 
200μg), 3mg of epidural morphine provided the same quality of analgesia to 
women having elective caesarean section surgery.  However the authors of 
this study noted that the patients in the 100μg intrathecal morphine group 
required more rescue analgesia in the post-operative period (Sarvela et al., 
2002).  In comparison, Lim et al (2005) found that there was no significant 
difference in the quality of analgesia between patients who received 100μg 
intrathecal morphine or epidural morphine at the time of their caesarean 
section.   Both methods of analgesia provided adequate analgesia for 12 – 24 
hours after surgery, but due to standard hospital procedures the number of 
patients in the intrathecal morphine study population was much higher than 
the epidural morphine population (850 vs. 52) in this study and therefore the 
results need to be interpreted with caution.  
 
Extended release epidural morphine (DepoDurTM) is a novel formulation of 
morphine developed specifically for epidural use.  The drug is a liposome-
based morphine delivery system that provides a long duration of analgesia 
(up to 48 hours) following a single dose.  Carvalho et al (2005b) demonstrated 
that the 5mg and 10mg doses of extended release epidural morphine 
provided comparative analgesia to standard 5mg epidural morphine but the 
duration of analgesia extended up to 48hours following a single intraoperative 
dose. (Carvalho et al., 2005b) Atkinson Ralls et al (2011) however found that 
patients who received 20 - 35 ml of epidural lignocaine one hour before the 
administration of the extended release epidural morphine had an increased 
maximal plasma morphine concentration.  This was associated with an 
increased incidence of side effects.  The authors therefore advised extreme 
caution in the use of the drug in caesarean section patients where the surgery 
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is performed under epidural top up. (Atkinson Ralls et al., 2011) The extended 
release morphine formulation is currently not registered for use in South Africa 
and therefore this form of treatment is not accessible for post-operative 
caesarean section pain relief in South Africa. 
 
Epidural fentanyl is commonly used in combination with low dose local 
anaesthetics for labour analgesia.  There is however a paucity of data 
regarding the use of epidural fentanyl for post-operative caesarean section 
analgesia.  Cohen et al (2002) demonstrated that the mechanism of action of 
epidural fentanyl following caesarean section surgery is at a spinal level.  In 
this study, the authors compared the effect of epidural fentanyl and 
intravenous fentanyl; both of which were administered by PCA devices.  The 
groups using intravenous fentanyl required higher total doses of the opioid 
analgesic (p<0.0001), reported greater pain levels (p<0.001) and also 
experienced more side effects, than the epidural groups. (Cohen et al., 2002) 
Indeed, when compared to PCA intravenous morphine, epidural fentanyl, 
administered by a patient controlled epidural analgesia (PCEA) pump, has 
been shown to provide improved analgesia with lower rates of nausea and 
sedation (Cooper et al., 1999).  This study showed that for caesarean section 
surgery patients, PCEA fentanyl is probably a better option to use than 
intravenous morphine.  The addition of low dose bupivacaine to a fentanyl 
epidural infusion has also been shown to improve patient analgesia and 
reduce the total fentanyl consumption while reducing side effects (Cohen et 
al., 1998).  This method of continuous infusion analgesia is however 
prohibitive in its widespread application because of the increased nursing 
requirements needed for patients with indwelling epidural catheters, in 
addition to the risks associated with prolonged indwelling catheter use 
(Wheatley et al., 2001). 
 
Epidural sufentanil has very similar clinical effects to epidural fentanyl 
(Connelly et al., 2000).  There is very little published data available on the use 
of this drug for patients after caesarean section surgery. 
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Pethidine is an opioid of intermediate lipophilicity, which can be administered 
epidurally, intravenously or intramuscularly.  PCEA pethidine has been used 
for post-caesarean section analgesia.  When compared to intrathecal 
morphine, epidural pethidine is associated with lower side effects such as 
pruritus (p<0.001), nausea (p<0.001) and drowsiness (p<0.05) (Paech et al., 
2000).  Paech et al (1994) compared epidural pethidine to intravenous 
pethidine in a double-blind, crossover trial, and demonstrated that epidural 
pethidine resulted in lower pain scores at rest and with cough (p=0.0001), 
higher patient satisfaction ratings (p=0.0001) and lower sedation scores 
(p=0.0001).  The authors of this study highly recommended this form of 
analgesia for the post-caesarean section patient, with the proviso that the 
neonatal effects of pethidine transfer in breast milk had to be investigated 
further.  Ngan Kee et al (1997) also found that patients were more satisfied 
with PCEA pethidine compared to PCIA pethidine. 
 
In addition to opioids, there are also other drugs that can potentially be 
administered neuraxially as part of a post-operative analgesic regimen.  
Neostigmine is an anticholinesterase agent, which results in increased levels 
of intrathecal acetylcholine (ACh) when administered neuraxially.  These 
increased ACh levels lead to analgesia in both animals and humans, without 
associated motor or sensory blockade and also without the side effects of 
respiratory depression and sedation. (Krukowski et al., 1997) 
 
Chung et al (1998) demonstrated that 25µg of intrathecal neostigmine 
significantly increased the time to the first analgesic PCA request (p<0.001) 
and resulted in a lower 24 hour analgesic consumption (p<0.001) when 
compared to the placebo group.  However, the administration of intrathecal 
neostigmine led to an increase in the incidence of nausea and vomiting 
(73.7%) compared to the placebo group (20%, p<0.005) and the morphine 
group (40%, p<0.01).  This high side effect risk currently limits the clinical 
effectiveness of using intrathecal neostigmine for post-operative analgesia.  In 
contrast to the effects of intrathecal neostigmine, Kaya et al (2004) found that 
epidural neostigmine administration in pregnant women having caesarean 
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section surgeries, is not associated with an increased risk of post-operative 
nausea and vomiting.  In addition, these authors also noted that epidural 
neostigmine results in modest analgesia in this population.  The epidural 
administration of neostigmine was however shown to increase the incidence 
of post-operative sweating and sedation.  
 
Clonidine is an alpha-2 (α2) receptor agonist and its neuraxial use has been 
well studied in the peri-operative period.  The mechanism of action of 
neuraxial clonidine is proposed to be due to the fact that α2 adrenergic 
receptors are found in the dorsal horn of the spinal cord, and it appears likely 
that α2 agonists act by both pre- and postsynaptic mechanisms to produce 
antinociception (Chan et al., 2010).  In experimental studies, the lumbar 
injection of clonidine led to pain relief in the lower extremities, but not in the 
upper extremities of healthy volunteers, and the CSF levels of clonidine also 
corresponded to the degree of antinociception experienced (Eisenach et al., 
1996).  Paech et al (2004) conducted a randomized double-blind trial in 240 
women having caesarean sections, with the aim of investigating the analgesic 
efficacy of different formulations of intrathecal drug combinations, which 
included clonidine at different doses.  The authors concluded that a 
combination of intrathecal morphine (100μg) and clonidine significantly 
improved post-operative pain relief.  However this combination also increased 
intra-operative sedation.  The authors recommended that clonidine in doses of 
between 30 – 60μg, in combination with intrathecal opioids was the most 
effective therapeutic combination to use.  The use of intrathecal clonidine 
without intrathecal morphine did not provide any analgesic advantage for 
these patients.  
 
The combination of intrathecal clonidine (75μg) with fentanyl (12.5μg) and 
hyperbaric bupivacaine was also demonstrated by Benhamou et al (1998) to 
significantly increase the duration of post-operative analgesia after caesarean 
section to 215 (± 79) minutes (p<0.05) when compared with other groups in 
the study.  This combination of intrathecal drugs was however also associated 
with increased sedation, but the authors commented that the level of sedation 
never exceeded grade 2 (moderate).  Capogna et al (1995) demonstrated that 
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the administration of clonidine into the epidural space, in combination with 
2mg morphine, also significantly increased the duration of analgesia up to 
13.25 hours with the 75μg dose and 21.55 hours with the 150μg dose, when 
compared with the placebo dose, which only provided adequate analgesia for 
6.27 hours (p<0.0001).  The epidural clonidine also reduced the mean total 
dose of post-operative morphine required from 9.40 mg in the placebo group 
to 5.0mg in the 75μg group down to 3.60mg in the 150μg group (p<0.0001).  
The authors found no significant difference in side effects between the three 
groups.  
 
Dexmedetomidine, like clonidine, is also an α2 receptor agonist.  This drug is 
however a more highly selective alpha-2 adrenergic receptor agonist with an 
α2 to α1 receptor ratio of 1620:1 (Virtanen et al., 1988).  This is approximately 
eight times more specific than clonidine for the α2 receptors, and has been 
reported to have significant analgesic and opioid sparing effects post-
operatively when administered via the intravenous route (Unlugenc et al., 
2005).  Based on experimental studies using clonidine, the analgesic 
properties of dexmedetomidine are suggested to involve both peripheral and 
central mechanisms. There is however, currently no published work on the 
neuraxial use of dexmedetomidine in humans for post-operative analgesia.  
The paucity of data in human trials is most likely due to the suggestion from a 
2008 animal study, that dexmedetomidine may have a neurotoxic effect on 
the myelin sheath when administered via the epidural route (Konakci et al., 
2008). This was however a single centre animal study in rabbits, and more 
animal studies need to be conducted before a verdict can be rendered on this 
issue.  
 
2.7.1.2 Peripheral Nerve Blocks 
Blocking peripheral nerves using local anaesthetic agents are popular 
methods of providing intra- and post-operative analgesia for a variety of 
different surgical procedures.  A major part of the pain experienced after 
abdominal surgery is related to nociceptive input from the anterior abdominal 
wall (McDonnell et al, 2009).  Peripheral nerve blocks have been investigated 
 37
for their efficacy in ameliorating the input from these nociceptors and reducing 
the pain experienced by the patients in the post-operative period.    
 
Ilioinguinal and iliohypogastric nerve blocks have shown that they can be 
used to decrease the post-operative opioid requirements of patients after 
caesarean section surgery.  Bell et al (2002) found that post-operative PCA 
morphine consumption significantly decreased from 67±28mg in the placebo 
group to 48±27mg in the experimental group.  The investigators in this study 
used a blind landmark-based technique to perform the blocks.  Due to the 
double-blinded nature of the trial, block success was not assessed following 
the procedure and the investigators assumed a 95% success rate in the block 
procedures (based on a previous study in their institution).  Despite the 
decreased opioid requirements in the patients who received the peripheral 
nerve blocks, there was however no statistical difference in the opioid related 
side effects (pruritus, p=0.25 and nausea, p=0.79) between the two groups.  
The results of the study by Bell et al (2002) are in conflict with results 
published earlier by Huffnagle et al (1996).  In this study the investigators 
performed bilateral ilioinguinal and iliohypogastric nerve blocks also using a 
blind landmark-based technique.  The results of the study were negative, 
finding no additional benefit to using these blocks for post-operative pain relief 
in caesarean section patients (Huffnagle et al., 1996).  Interestingly, the 
investigators in this study did evaluate for block success and had a high 
incidence of block failure in the group where the blocks were performed 
before surgery.  This is also in contrast to the Bell et al study, which assumed 
a 95% block success rate. The success of peripheral nerve blocks is an 
extremely important requirement in order to make a definitive evaluation of the 
role of these blocks for post-operative analgesia.  The use of ultrasound 
technology to perform these blocks has been shown to result in positive 
analgesic effects after surgery (Gucev et al., 2008).  This publication is 
however only a case series of three patients, and further randomized studies 
evaluating this ultrasound technique are needed before a firm 
recommendation can be made on the usefulness of these blocks for post-
caesarean section analgesia. 
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The transversus abdominus plane (TAP) block involves injecting local 
anaesthetics into the tranversus abdominus plane in the abdominal wall, 
blocking the sensory nerves as they pass through this tissue plane, before 
they pass into the musculature to innervate the anterior abdominal wall.  In 
patients undergoing non-obstetric abdominal surgery, the TAP block has 
demonstrated a clear reduction in post-operative opioid requirements in the 
first 24 hours after surgery.  In addition, the patients in the TAP block group in 
this study also reported lower pain scores at three different evaluation points 
after surgery. (McDonnell et al., 2007) However, the use of the TAP block for 
post-operative analgesia after caesarean section surgery has been mired in 
controversy with conflicting results being published.  The first post-caesarean 
section surgery TAP block study was published in 2008 by McDonnell et al.  
The authors of this study randomized fifty women undergoing elective 
caesarean section surgery to receive bilateral TAP blocks with either 0.75% 
ropivacaine or placebo.  The patients in the TAP block group had a 30% 
reduction in visual analogue pain scores and also had a 70% reduction in their 
mean post-operative morphine dose requirements in the first 48 hours after 
surgery (McDonnell et al., 2008).  In 2009, Belavy et al evaluated the effect of 
the ultrasound guided TAP block technique on post-operative pain in 
caesarean section surgery patients.  The investigators also found that the 
patients in the TAP block group had lower pain scores and had a 40% 
reduction in post-operative morphine requirements.  While the treatment effect 
was not as dramatic as the original McDonnell et al study, this study also 
showed benefit in using the TAP block as part of the analgesic regimen in this 
group of patients (Belavy et al., 2009).  McMorrow et al (2011) compared the 
efficacy of 100μg intrathecal morphine with bilateral TAP blocks for the effect 
on post-operative analgesia in a randomized double-blind placebo controlled 
trial.  The investigators concluded that the “single shot” TAP block was not 
superior to spinal morphine for post-operative caesarean section analgesia 
and also that the use of bilateral “single shot” TAP blocks in patients who 
receive 100μg intrathecal morphine during their spinal anaesthetic, offers no 
additional analgesic benefit for the patients.   
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Bollag et al (2012) have proposed the concept of pain relief from repeated 
local anaesthetic injections through bilateral TAP catheters, in a case series 
published in 2012.  The authors of this paper have proposed that repeated 
local anaesthetic dosing through bilateral TAP catheters might be a viable 
therapeutic alternative in patients in whom the administration of intrathecal 
long acting opioids is not possible.  Further randomized trials are needed to 
evaluate if this is a reasonable treatment option for post-caesarean analgesia. 
 
2.7.1.3 Wound infiltration 
 
Wound infiltration can be performed using a “single shot” approach at the end 
of surgery or by continuous infusion of drugs via wound infusion catheters.  
The efficiency of this treatment option is dependent on the type of 
administration method used and also on the drugs that are used.  Results 
from trials evaluating wound infusion catheter systems have been mixed and 
this is most probably due to the different implantation techniques applied 
(subcutaneous, subfascial or sub-rectus), drug dosing regimens employed 
(continuous or bolus) and types of drugs used (Kwok et al., 2014, Tan, 2012) 
 
In a prospective, randomized, double-blind placebo controlled trial comparing 
epidural analgesia and subfascial wound catheters using an intermittent local 
anaesthetic (0.25% levobupivacaine) bolus technique, Ranta et al (2006) 
found that both techniques had similar outcomes in terms of pain scores (3 or 
less) after the initial four hour period.  O’Neill et al (2012) conducted a similar 
study comparing a continuous infusion of 0.2% ropivacaine, via a subfascial 
wound catheter, with epidural morphine boluses, and found that the pain 
scores at rest were lower in the wound catheter group for up to 48 hours after 
surgery, and that these patients experienced lower side effects as well.  
Fredman et al (2000) compared the effect of a subcutaneous catheter 
connected to a patient controlled elastomeric pump containing either 0.2% 
ropivacaine or placebo (saline), and found decreased movement-associated 
pain and decreased post-operative opioid requirements in the ropivacaine 
group.  Chandon et al (2014) found no difference in the analgesic effect 
between ultrasound guided bilateral TAP blocks and continuous wound 
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infusion with levobupivacaine.  This study was however stopped prematurely 
due to an adverse reaction in one of the patients in the TAP block group.  This 
patient experienced generalized seizures shortly after the administration of 
the TAP block, which was attributed to the partial systemic absorption of the 
local anaesthetic.  The results of this trial therefore need to be interpreted with 
caution. 
 
While most trials utilize local anaesthetics in the wound infiltration catheters, 
Lavand’homme et al (2007) assessed the post-operative analgesic effects of 
continuous wound infiltration with diclofenac in elective caesarean section 
patients and found that the infusion of 300mg diclofenac over 48 hours 
decreased the 48 hour post-operative morphine requirements compared with 
a 0.2% ropivacaine infusion and with intravenous diclofenac.  The results of 
this study not only opened up a previously unknown area of use for 
diclofenac, but it also raises the possibility that NSAIDs may have peripheral 
analgesic effects directly at the site of injury. 
 
The multiple regional anaesthetic techniques that anaesthetic service 
providers can use to manage post-operative pain in caesarean section 
patients can lead to confusion and under-use of these valuable techniques.  
Neuraxial regional anaesthetic techniques have been shown to be extremely 
effective in managing post-operative pain in this patient population.  The 
proviso is that these techniques should be used to administer opioids into the 
neuraxial spaces (intrathecal or epidural).  Opioids (morphine in particular) 
have a longer duration of effect than using local anaesthetic drugs alone.  
This longer analgesic effect can also be prolonged with the addition of other 
neuraxial adjuvant drugs such as neostigmine or clonidine, but this also raises 
the side effects experienced by patients.  Other regional anaesthetic options 
such as peripheral nerve blocks and wound infiltration techniques have 
therapeutic benefits when compared with placebo, however these techniques 
do not seem to have any therapeutic superiority when compared to neuraxial 
opioids. 
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2.7.2 Systemic Analgesia 
 
The systemic administration of analgesics following surgery is a commonly 
used modality of care.  The advantage of this method of drug administration is 
that it is more cost effective, easier for nursing staff to administer and has a 
long history of successful use in post-partum women.  However, the pain relief 
attained by this method of administration is generally considered less effective 
than that achieved following the neuraxial administration of medication. 
(Gadsden, 2005) 
 
2.7.2.1 Intravenous (IV) and intramuscular analgesia (IM) 
 
Patient controlled intravenously administered opioids are a popular method of 
administering medication to patients after caesarean section surgery, 
especially when neuraxial techniques are not possible or after a general 
anaesthetic.   
 
Based on my clinical experience, the IM administration of opioids is very 
popular in South Africa because of the lower cost and reduced level of 
monitoring required when compared to IV or neuraxial administration of these 
analgesics.  In a blinded, randomized comparison between epidural opioids, 
PCA opioids and IM opioids following caesarean section surgery, Harrison et 
al (1988) demonstrated that neuraxial drug administration provided superior 
analgesia to the other two techniques; however this was overshadowed by the 
higher side effect profile in this group.  When comparing PCA administration 
to IM administration, the patients had comparable pain relief and post-
operative opioid use.  Despite the relatively higher pain scores in the PCA 
group (compared to the epidural group), the patient satisfaction levels with 
this method of analgesia was comparable with that of the neuraxial group.  
The authors postulated that this might be due to the more stable level of 
analgesia, lower side effects and knowledge that analgesia was more 
accessible to the patients in the PCA group.  This higher level of patient 
satisfaction for PCA opioids compared with IM opioids following caesarean 
section was also reported in another similarly designed study (Eisenach et al., 
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1988).  The authors in this study found that the number of instances where 
patients reported being uncomfortable was highest in the IM group and lowest 
in the epidural group.  The lower satisfaction levels seen with IM opioids is 
most likely due to the fact that plasma concentrations of opioids are 
unpredictable following IM injections, the injections are painful to receive and 
the patients are probably reluctant to request the injections from the nurses. 
 
In most publications reviewed, morphine is the most common opioid used in 
IV PCA regimens for the management of post-caesarean section pain.  It is 
generally also the standard against which most other analgesic interventions 
are evaluated.  Fentanyl is a synthetic, more potent opioid that is a popular 
drug administered intraoperatively, but has not been shown to provide 
superior analgesia for post-operative caesarean section surgery patients 
when administered via PCA pump (Howell et al., 1995).  Woodhouse et al 
(1996) published similar results of non-inferiority with regards to analgesic 
efficacy, when fentanyl PCA was compared to morphine and pethidine PCA’s.  
Based on the results of both these studies and the higher cost of fentanyl 
compared to morphine, this drug does not appear to be a suitable alternative 
to morphine for post-operative analgesia. 
 
From my own clinical experience, I have noted that pethidine is a popular 
opioid in South Africa for post-operative pain management in both general 
surgical patients and for obstetric post-surgical patients.  The drug can be 
administered intramuscularly and with a long time period between 
administrations so that it does not impact too greatly on nursing workload.  In 
studies comparing the use of this drug to other opioids for post-operative 
analgesia after caesarean section surgery, PCA pethidine has been found to 
provide the same quality of analgesia to PCA fentanyl (Ngan Kee et al., 1997) 
and to both PCA morphine and PCA fentanyl (Woodhouse et al., 1996).  
However there have been serious concerns raised about the secretion of 
pethidine’s active metabolite, nor-pethidine, into breast milk (Shnider and 
Moya, 1964) and its effect on the neurological function of the neonate (Wittels 
et al., 1997).  Based on the risk to the neonate, pethidine should be avoided in 
post-caesarean section patients who are breastfeeding their babies. 
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Tramadol is a weak opioid and is readily available in South Africa, even in the 
public health sector.  In a randomized, double-blinded study conducted in a 
South African academic hospital, Wilder-Smith et al (2003) showed that a 
single combined dose of intramuscular tramadol (100mg) and diclofenac 
(75mg) provided superior analgesia to either drug alone and to placebo.  
Unfortunately this study did not include neuraxial opioids or PCA morphine in 
the comparator groups.  
 
NSAIDs are commonly used analgesic agents globally and they are known to 
be effective against the visceral pain associated with uterine incision and 
involution after caesarean section surgery (Tan, 2012).  Cardoso et al (1998) 
combined intrathecal morphine (at three different doses) with 75mg IM 
diclofenac and found that the addition of IM diclofenac enhanced the 
analgesic effect of the intrathecal morphine, to such an extent that the authors 
recommended that there was no advantage to using intrathecal doses of 
morphine larger than 25μg if this is used in combination with systemic 
diclofenac.  This combination proved to be as effective as higher intrathecal 
morphine doses with and without NSAIDS. 
 
Methadone has also been proposed as an analgesic option in patients having 
caesarean section surgery under general anaesthesia.  In a retrospective 
case-control study, Russell et al (2013) demonstrated that a single bolus dose 
of intravenous methadone intraoperatively, improved the quality of analgesia 
and significantly reduced the post-operative opioid requirements for up to 48 
hours after surgery.  This novel analgesic option needs to be investigated 
further especially for use in patients undergoing neuraxial anaesthesia.  There 
is limited data available on the transfer of methadone across the human 
placenta.  Laboratory investigations conducted by Nekhayeva and colleagues 
(2005) indicated that the transfer of methadone across the placenta favours 
movement of the drug in the direction towards the maternal circulation, and is 
probably affected by enzymatic transport mechanisms in the placenta.  There 
are however no clinical reports available on the effects of methadone on the 
foetus.   In South Africa, methadone is registered as a schedule 6 drug and is 
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not readily available for use in the public health sector (Division of Clinical 
Pharmacology, 2012). 
 
Ketamine is a N-methyl D-aspartate (NMDA) receptor antagonist. It is an old 
IV anaesthetic agent that produces a state of dissociative anaesthesia when 
used at higher doses.  The drug however leads to a number of unwanted side 
effects (such as hypertension and hallucinations) that limits its widespread 
clinical use (Aroni et al., 2009).  At sub-anaesthetic doses, this drug has been 
shown to have analgesic effects and therefore it has the potential to contribute 
to the post-operative analgesia of women after caesarean section surgery.  
Menkiti et al (2012) investigated the effect of an intra-operative bolus dose of 
ketamine on the post-operative analgesia of women having a caesarean 
section in a developing country, where access to intrathecal opioids is limited.  
The authors demonstrated lower pain scores in the ketamine group (p=0.022) 
and also reduced post-operative analgesic requirements (p<0.001) when 
compared to the control group. This drug should therefore be considered for 
post-operative analgesia for caesarean section surgery, especially in 
developing countries. 
 
Paracetamol is well known analgesic drug that is believed to act at both 
central and peripheral levels of the nociceptive pathways (Tan, 2012).  It has 
a significant opioid sparing effect when used in combination with PCA 
morphine (Remy et al., 2005) and therefore offers an attractive option to be 
used as part of a post-caesarean section pain management regimen.  
However results of studies investigating the effect of paracetamol in obstetric 
patients have been conflicting.  Siddik et al (2001) compared the analgesic 
effect of intravenous paracetamol and rectal diclofenac and found that while 
diclofenac had a significant opioid sparing effect for post-caesarean section 
surgery patients, paracetamol offered no such benefit.  Inal et al (2006) 
however, compared the analgesic effects of a single dose of IV paracetamol 
with a single dose of IV pethidine at the end of surgery and demonstrated 
lower VAS scores and a longer time to first supplementary analgesic request 
in the paracetamol group.  Abu Omar et al (2011) also showed positive results 
demonstrating that the addition of regular intravenous paracetamol to the 
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treatment of patients who received intrathecal morphine during their spinal 
anaesthetic decreased the need for rescue analgesia in the 24hours after 
their caesarean section.  There appears to be a trend that IV paracetamol can 
offer a viable alternative to reduce supplementary opioid requirements for 
post-caesarean section patients. 
 
While there are many effective IV and IM alternatives for pain management 
after caesarean section surgery, alternative routes of administration of drugs 
have also been evaluated and proven to be effective in many cases. 
 
2.7.2.2 Oral analgesia 
 
Administering medication via the oral route is simple, cost-effective and 
generally more convenient for nursing staff and patients (Tan, 2012).  Almost 
all classes of drugs that are available in IV and IM formulations are available 
as oral medications.  In South Africa, caesarean section surgery patients 
generally have their IV lines removed 24 hours after surgery in order to 
facilitate mobilization and promote interaction with the newborn baby.  At this 
point of treatment, oral analgesia (usually a combination of opioids, 
paracetamol and NSAIDs) becomes a necessity. There are however studies 
which have also evaluated the efficacy of oral analgesia in the early post-
operative period following caesarean section. 
 
Jakobi et al (2000) assessed patient satisfaction levels towards two oral 
analgesic regimens for pain management following caesarean section surgery 
under epidural analgesia.  Group 1 (109 patients) were given one-gram (g) of 
oral dipyrone at regular intervals, on request, also and allowed access to 
30mg immediate release oral morphine for rescue analgesia. Group 2 (90 
patients) were given immediate release oral morphine (30mg) at regular 
intervals, on request, and then given access to 1g oral dipyrone if they 
requested additional analgesia. The patient satisfaction scores were high in 
both groups (90±9.6 in group 1 and 83.7±8.9 in group 2).  The patients in 
group 1 had an average effective analgesic time of 6.5±0.6 hours compared 
to 5.05±0.5 hours in group 2.  The authors concluded that oral analgesics 
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provided satisfactory and cost effective analgesia for this group of patients.  
These authors did not however do a direct comparison with neuraxial, IV or IM 
analgesic options in this study.  In South Africa, dipyrone is not registered for 
use.  However, there are a number of oral NSAIDs available for post-
operative use and paracetamol is also easily accessible.  Valentine et al 
(2015), demonstrated that regular doses of paracetamol after surgery 
decreased the opioid use, without compromising the quality of analgesia after 
caesarean section surgery. 
 
When comparing an oral opioid regimen with PCA morphine in 93 women 
having caesarean section surgery, Davis et al (2006) demonstrated that 
patients using regular doses of oral oxycodone-acetaminophen experienced 
less pain at six and twenty-four hours after surgery than those using PCA 
morphine.  The patients using the oral regimen also had less side effects than 
the IV group.  Based on the results of this study the authors recommended 
that consideration should be given to expanding the use of oral analgesia for 
pain relief following caesarean section surgery.  McDonnell et al (2010) did a 
direct comparison between regular oral oxycodone and intrathecal morphine, 
comparing the quality of post-operative pain relief afforded by each analgesic 
regimen.  One hundred and twenty women scheduled for elective caesarean 
section surgery were randomized into two groups.  The authors concluded 
that while the oral oxycodone regimen provide comparable pain relief to the 
intrathecal morphine regimen, with a lower incidence of pruritus, the patient 
satisfaction score was significantly lower in the oral oxycodone group 
(p=0.010).  
 
A recent Cochrane Collaboration review on “Oral analgesia for relieving post-
caesarean pain” assessed data from eight trials with 962 patients to 
determine the effectiveness, safety and cost-effectiveness of oral analgesia 
for post-caesarean pain relief. The authors found that due to the limited data 
available, “no conclusions can be made regarding the safest and the most 
effective form of oral analgesia for post-caesarean pain” (Mkontwana and 
Novikova, 2015).  Further studies are needed in this field.  
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Gabapentin is an oral alpha-2 delta ligand calcium channel blocking agent.  
The analgesic effect of the drug is due to its inhibition of the release of 
excitatory neurotransmitters in the dorsal horn of the spinal cord.  A 
preoperative dose of 600mg gabapentin was demonstrated by Moore et al 
(2011) to reduce the 24 hour VAS pain scores from 41mm in the placebo 
group to 21mm in the gabapentin group (p=0.001).  These authors have 
proposed that 600mg gabapentin, when used as part of a multimodal 
analgesic regimen, will improve post-operative caesarean pain and improve 
patient satisfaction.  In 2012, Short et al compared two different preoperative 
doses of gabapentin (300mg and 600mg) with placebo to investigate their 
analgesic effects following caesarean section surgery.  The authors did not 
find any difference in the analgesic effects of either of the gabapentin doses 
compared to placebo (p=0.61).  They did however conclude that the study 
was underpowered and a larger study is required to confirm these results.  In 
light of these conflicting results, it is not possible to determine if gabapentin 
can offer any analgesic benefit for patients after caesarean section surgery. 
 
2.7.2.3 Rectal analgesia 
 
Medication can be absorbed from the rectum with the same mechanism of 
absorption as medication is absorbed from the upper gastrointestinal tract.  
This route of administration is advantageous especially when the patient does 
not have IV access, and severe nausea and vomiting precludes oral drug 
administration.  The negative factors associated with rectal administration of 
drugs are that absorption may be interrupted by defecation and patients may 
also not be fond of the technique. (de Boer et al., 1982) 
 
Based on my clinical experience, it appears that the rectal route of 
administering post-operative analgesia is very popular in South Africa.  
Paracetamol suppositories are commonly used for post-operative pain relief in 
paediatric patients and NSAIDs suppositories are routinely inserted into the 
rectum at the end of surgery during caesarean sections.  The use of NSAIDs 
after caesarean section surgery is however controversial.  There are valid 
concerns about the risk of increased bleeding after surgery, together with the 
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concerns about bronchospasm, gastrointestinal bleeding and renal 
dysfunction due to NSAIDs use (Dahl and Raeder, 2000).  Dahl et al (2002) 
conducted a randomized, double-blind placebo controlled trial to evaluate the 
opioid sparing effect of diclofenac suppositories in patients following 
caesarean section surgery.  Eighty-two women were randomized to receive 
100mg diclofenac suppositories or placebo suppositories every twelve hours 
after surgery.  The NSAIDs group used significantly less morphine during the 
32 hour evaluation period (14 ± 1.5mg) as compared to the placebo group 
(21.5 ± 1.6mg, p<0.05).  The VAS pain scores were however not significantly 
different between the groups.  In addition, there was no difference in bleeding 
or any other NSAIDs associated side effects between the two groups during 
the evaluation period. 
  
2.7.2.4 Transdermal analgesia 
 
At present only fentanyl and buprenorphine transdermal patches are 
registered for use in South Africa.  Both these patches are indicated for 
moderate to severe chronic pain.   
 
There is no published literature on the use of transdermal opioid analgesics 
for pain relief following caesarean section surgery.  Lehmann et al (1997) 
studied the safety and effectiveness of transdermal fentanyl patch 
administration on the post-operative pain relief following abdominal surgery.  
The authors found that similar post-operative analgesia was achieved with 
less IV analgesics in the fentanyl group compared to the placebo group.  In 
addition, there was no difference in the respiratory rate or heamoglobin 
oxygen saturation between the two groups. 
 
Transdermal analgesia may provide a novel way of providing analgesia to 
women following caesarean section surgery, however more research is 
needed in this area before any recommendations can be made. 
 
Irrespective of the method of anaesthesia used or the choice of post-operative 
analgesia techniques or medication, every caesarean section patient should 
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be monitored in the post-operative period.  The Obstetric Anaesthesia 
Guidelines (Wee et al., 2005) in the United Kingdom state that the post-
operative care of the caesarean section patient should meet the same 
standard of care as that required for any post-operative patient.  The 
American Practice Guidelines (Horlocker et al., 2009) state that patients who 
receive neuraxial opioids should be monitored for up to 24 hours following 
intrathecal administration of hydrophilic opioids and for at least 2 hours 
following the administration of a single dose of a lipophilic opioid.  The current 
South African Society of Anaesthesiologists Practice Guidelines (Bettings et 
al., 2013) make no specific recommendations on the post-operative 
management of caesarean section patients or of patients who have received 
neuraxial opioids. 
 
2.8 Guidelines for the management of post-caesarean section pain 
  
In 2003, John R Hampton, the Emeritus Professor of Cardiology at the 
University of Notingham, wrote “A fool – loosely defined as someone who 
does not know much about a particular area of medicine – will do well to 
follow guidelines when treating patients, but a wise man (again, loosely 
defined as someone who does know about the disease in question) might do 
better not to follow them slavishly” (Hampton, 2003).  These words succinctly 
explain the usefulness of practice guidelines for clinicians.  
 
Practice guidelines should be considered as being basic recommendations for 
the safe and efficient management of patients with particular clinical 
conditions.  Guidelines are generally based on a synthesis of current scientific 
evidence, expert opinion, open forum commentary and clinical feasibility data 
(Apfelbaum et al., 2016).  These documents should be used to supplement, 
strengthen and validate institutional policies rather than be used as a blanket 
set of rules that may not be feasible in every clinical environment.  It is the 
obligation of every health care practitioner to ensure that their patients are 
provided with the best care possible within the constraints of the environment 
in which they are working.  Practice guidelines can be used to advocate for an 
improvement in these environments.  This is especially true in developing 
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countries where practitioners are often faced with a shortage of drugs, 
consumables and equipment that may be considered essential in the 
developed world. 
 
Practice guidelines for obstetric anaesthesia are generally very 
comprehensive and include recommendations on a wide variety of obstetric 
anaesthesiology topics ranging from management during labour, pre-
operative management, operative delivery and post-operative care.  For the 
purposes of this literature review, I will limit the review to aspects of 
anaesthesiology practice guidelines that relate only to the pain management 
of the obstetric patient. 
 
The American Society of Anesthesiologists (ASA) Task Force on Obstetric 
Anesthesia published Practice Guidelines for Obstetric Anesthesia in 2016 
(Apfelbaum et al., 2016).  These comprehensive guidelines addressed the 
pre-, intra- and post-operative anaesthetic management of the obstetric 
patient in detail, basing recommendations on scientific evidence and expert 
opinion.  These guidelines state that the choice of a particular anaesthetic 
technique for a caesarean section must be individualized and based on the 
circumstances of each patient.  However, the document does indicate that 
neuraxial techniques are preferred over general anaesthesia in most cases.  
Moreover, the ASA guidelines advise that for patients who have a neuraxial 
anaesthetic for their caesarean section surgery, neuraxial opioids should be 
used preferentially over intermittent injections of parenteral opioids to manage 
post-operative pain. The guidelines are clear that there is evidence for better 
analgesia with epidural opioids as opposed to intermittent IV or IM opioids 
(Apfelbaum et al., 2016).  While the ASA guideline is very comprehensive and 
well researched, it falls short in that it does not make any recommendations 
on the type of opioids that should be used in the neuraxial anaesthetic 
techniques.  The authors fail to discuss the implications of using hydrophilic 
opioids vs. lipophilic opioids in the neuraxial techniques.  The use of different 
types of opioids will result in different durations of effective analgesia and side 
effects.  In addition, there was no discussion about the benefit of multimodal 
analgesic techniques in this patient group. 
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In 2009, the ASA Task force on Neuraxial Opioids did however publish 
practice guidelines for the prevention, detection, and management of 
respiratory depression associated with neuraxial opioid administration 
(Horlocker et al., 2009).  Following detailed analyses of the literature, these 
guidelines recommend that the “lowest efficacious dose of neuraxial opioids 
should be administered to minimize the risk of respiratory depression”.  
Caution is also advised in using neuraxial opioids together with parenteral 
opioids, sedatives, hypnotics or magnesium as this practice increases the risk 
of respiratory depression.  The techniques that are currently available for the 
detection of respiratory depression (pulse oximetry, end-tidal carbon dioxide 
monitoring, respiratory rate count, depth of respiration assessment and 
sedation level) are discussed in the guidelines, however there is insufficient 
evidence available to be able to make a firm recommendation on the 
preferred techniques that should be used.  (Horlocker et al., 2009) 
 
The 2009 guideline (Horlocker et al., 2009) does discuss the consequences of 
using lipophilic versus hydrophilic opioids with regards to the duration of risk.  
In addition, the different administration techniques are discussed and the 
duration of risk of the single injection techniques vs. the continuous infusion 
techniques is explained.  The recommendation from the guidelines committee 
is that all patients receiving neuraxial opioids should be monitored for 
adequacy of ventilation, oxygenation and level of consciousness. The duration 
of this monitoring ranges from two hours for lipophilic opioids (eg. Fentanyl) 
up to twenty-four hours for hydrophilic opioids (eg. Morphine).  
 
The National Institute of Clinical Excellence (NICE) in the United Kingdom of 
Great Britain and Northern Ireland (UK) updated its 2004 guidelines on 
Caesarean section in November 2011(Griffiths et al., 2011). This is a very 
comprehensive document addressing many aspects of a caesarean section 
including surgical and anaesthetic management.  The guidelines recommend 
that women should be offered intrathecal or epidural diamorphine for intra- 
and post-operative analgesia as this reduces the need for supplemental 
analgesia after caesarean section surgery.  In the absence of the neuraxial 
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option, PCA opioids are recommended.  In addition, NSAIDs should be used 
as an adjunctive analgesic agent because of their opioid sparing effects.  The 
guideline also indicates that wound infiltration or ilioinguinal nerve blocks have 
also been found to be effective alternatives to systemic analgesics following 
caesarean section surgery. 
 
The Australian and New Zealand College of Anaesthetists (ANZCA) and 
Faculty of Pain Medicine (FPM) updated their Acute Pain Management 
Guidelines in 2015 (Schug et al., 2015).  These guidelines include a section 
on the management of pain after caesarean section surgery.  Analysis of the 
literature evaluating oral analgesia after caesarean sections did not allow the 
guidelines committee to make any conclusions regarding their use.  The 
document states that they were only able to identify small trials and these had 
contradictory results.  The studies on parenteral analgesics were also deemed 
to be inadequate. Trials assessing synthetic IV opioids were not remarkable.  
The guidelines do mention that there are trials that show some benefit in 
using IV dexamethasone, ketamine or dexmedetomidine, however none of 
these studies were overwhelmingly encouraging (Schug et al., 2015). 
 
Neuraxial analgesia (intrathecal and epidural) was also discussed in the 
ANZCA guideline, in addition to peripheral regional anaesthetic blocks.  The 
ANZCA and FPM guideline (Schug et al., 2015), unlike the NICE guidelines 
(Griffiths et al., 2011), do not however advise the reader to use any particular 
drug regimen or analgesic technique.  Users of the ANZCA guideline are 
expected to interpret the data provided and to make their own decisions about 
the analgesia that should be used. 
 
The Procedure Specific Post-operative Pain Management (PROSPECT)  
Working group is dedicated to providing recommendations on pain 
management interventions that are related to specific surgical procedures 
(Neugebauer et al., 2007).  These recommendations are available online so 
that they are freely accessible and easily available for use.  The PROSPECT 
recommendations for caesarean section surgery are very specific and are 
categorized into pre-operative, intra-operative (pre-delivery), intra-operative 
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(post-delivery), surgical techniques and post-operative recommendations.  
Recommended analgesic options include the use of intrathecal morphine 
intraoperatively, together with IV paracetamol and IV NSAIDS after the 
delivery of the baby.  In addition, regional anaesthetic techniques are also 
recommended as adjunctive analgesic techniques for these patients 
(PROSPECT Working Group, 2015). 
 
The South African Acute Pain Management Guidelines were originally 
published in 2009 as an official publication of the South African Society of 
Anaesthesiologists. The guideline has been updated in 2016 (Lundgren et al., 
2016) to reflect changes in practice and drugs that have become available in 
South Africa during the seven-year period since the guidelines were first 
published.  The South African guideline (Lundgren et al., 2016) recommends 
a neuraxial anaesthetic technique for all women having caesarean sections 
unless there is a contraindication to this technique.  The rationale behind this 
bold recommendation is that this anaesthetic technique will provide analgesia 
for the surgery and for a period of time after surgery as well.  The guideline 
provides details on the use of intrathecal bupivacaine with or without the 
addition of fentanyl (12.5 – 20µg).  The guideline specifically does not 
recommend intrathecal morphine for these patients, despite overwhelming 
evidence in the international literature regarding the superior efficacy of this 
mode of analgesia for patients having caesarean sections.  For those 
patients, where general anaesthesia is necessary, the guideline provides 
recommendations on the use of drugs to blunt the intubation response and 
also on the use of opioids during the procedure.  There is no recommendation 
pertaining to the requirements for monitoring of patients for the side effects of 
analgesics in the post-operative period; however this may be beyond the 
mandate of the guidelines committee.  
 
Despite the widespread availability of practice guidelines for the management 
of pain after caesarean section surgery, it is the implementation of these 
guidelines that will ultimately influence the experience of women after their 
caesarean sections.   Unfortunately, evidence exists (from other specialities) 
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that there are often multiple barriers to the implementation of clinical practice 
guidelines at the grass roots level of care.  Organisational limitations are often 
cited as important factors to the poor uptake (Ebben et al., 2013).  Cabana et 
al (1999) also discussed the barriers to implementing guidelines by medical 
practitioners.  They identified a number of factors such as knowledge, attitude 
and behavior, which act as barriers.  Based on their assessment of 
implementation barriers, Cabana and colleagues (1999) proposed a rational 
approach towards improving the implementation of clinical guidelines. These 
suggestions included addressing doctors’ lack of knowledge and lack of 
awareness of guidelines, as well as teaching the medical practitioners to deal 
with external barriers that will influence guideline implementation.   
 
2.9 Anaesthetic practices for the management of pain after caesarean 
section surgery 
 
Anaesthetic practices tend to differ across different regions of the world 
depending on local practices, drug availability, equipment standards and staff 
availability.  Surveys of obstetric anaesthetic and analgesic practices have 
been conducted in a number of regions around the world to document 
practices in different regions. 
 
Tagaloa et al (2009) conducted an online survey investigating obstetric 
anaesthesia practices amongst the members of the Society of Obstetric 
Anesthesia and Perinatology (SOAP), in the USA.  The majority of 
respondents in this survey (85%) indicated that single shot spinal anaesthesia 
was their preferred regional anaesthetic technique for elective caesarean 
sections.  The popularity of this technique was anticipated considering that 
spinal anaesthesia has been shown to be more cost effective, easier to 
perform and faster in onset compared to epidural anaesthesia (Riley et al., 
1995).  In a study performed in the UK, Jenkins and Khan (2003) published 
data on caesarean section anaesthesia for the South-west Thames (SWT) 
region of England from 1992 to 2002 using a regional database.  During this 
period the caesarean section rate in the SWT region rose from 13.9% in 1992 
to 24.2% in 2002.  The rate of general anaesthesia for caesarean section 
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surgery decreased in the SWT region of the UK from 43.1% in 1992 to only 
9.8% in 2002. There was a subsequent increase in the use of regional 
anaesthesia during this period from 69.4% to 94.9% for elective caesarean 
sections, and 49.3% to 86.7% for emergency caesarean sections.  The 
authors commented that the rise in regional anaesthesic techniques for 
obstetric patients might have contributed to the decline in the maternal 
mortality rate during this period.  This study did not discuss the types of drugs 
used in the regional anaesthetics nor the monitoring of patients after their 
surgeries. A survey of obstetric anaesthesia practices in Belgium (Van Houwe 
et al., 2006), published in 2006, reported that 80% of respondents used a 
spinal anaesthetic technique for caesarean sections; either alone (34%) or as 
part of a combine spinal-epidural technique (46%).  General anaesthesia was 
not a common modality used for obstetric patients.  These results differed 
from other European countries where practice surveys have been done.   
Reports from a German study (Stamer et al., 2005) exploring obstetric 
anaesthetic practice for the period 2000 to 2002 (3 years), revealed that a 
spinal anaesthesia technique was only used in 50% of scheduled caesarean 
sections.  For urgent and emergency cases the spinal anaesthesia rate 
decreased to 34.6% and 4.8% respectively during the evaluation period.  This 
spinal anaesthetic rate is much lower than has been reported in the surveys 
from the USA, the UK and Belgium. Chan and Ng (2000) conducted a survey 
in 1996 to determine the obstetric anaesthesia and analgesia practices in 
Malaysia during this period. Malaysia is a middle income Asian country with 
maternal mortality rate of 40 per 100000 live births in 2015.  Data submitted 
from 35 hospitals were analysed in this survey.  These hospitals comprised of 
17 government hospitals and 18 private hospitals.  The authors reported that 
the regional anaesthesia rate for caesarean sections in their sample was 
41.9%.  Spinal anaesthesia was the most popular form of regional 
anaesthesia used for these procedures (84.6%).  Epidurals were performed in 
only 12.2% of cases. 
 
Practices related to post-operative pain control for patients also vary widely 
across the world.  Most respondents in the Tagaloa et al (2009) survey used 
intrathecal opioids in their spinal anaesthetic to improve the post-operative 
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pain relief for their patients.  The median dose of morphine reported in this 
survey was 200μg.  This is higher than doses that have been shown to 
provide effective analgesia in the obstetric population (Abboud et al., 1988).  
Systemic analgesic therapy was not popular with only 12% of respondents 
using IV PCA therapy but NSAIDs were used by 81% of the respondents as 
part of their analgesic regimen.  In 2003, Faboya and Uncles (2006) 
conducted a study in the SWT region of England investigating the practice of 
post-operative analgesia after elective caesarean section surgery.  Only 33% 
of the hospitals surveyed had a written protocol for post-operative analgesia.  
Sixty-seven percent of respondents routinely used intrathecal diamorphine 
(200-500µg) for post-operative analgesia for caesarean section surgery 
patients.  The remaining 33% used fentanyl in a dose range of 10-25µg.  
Morphine PCA was used in 33% of the hospitals when fentanyl was used 
intrathecally.  All hospitals used diclofenac after surgery, with 90% of the 
respondents initiating this therapy at the end of surgery by using a rectal 
suppository for patients.  This survey confirmed that hospitals in the SWT 
region of the UK practiced multimodal analgesic techniques during the period 
reviewed (Faboya and Uncles, 2006).  In Belgium, Van Houwe et al (2006) 
reported that intrathecal opioids were not used in the spinal anaesthetics for 
caesarean sections. There appeared to be an even distribution of hospitals 
using epidural analgesia vs. IV/IM analgesia for post-operative pain 
management.  The majority of epidural analgesia (81%) was provided using 
patient controlled epidural analgesia (PCEA).  When IV/IM regimens were 
used, the respondents preferred a multimodal analgesic technique, which 
included NSAIDs (Van Houwe et al., 2006).  Data from the 2005 German 
survey (Stamer et al., 2005) indicated that one third of the hospitals (143/397) 
who responded to the survey reported combining opioids with local 
anaesthetics for the spinal anaesthesia.  Sufentanil was the most commonly 
used agent (77%) followed by fentanyl (15%) and morphine (13%).  CSE was 
performed by a minority of the respondents (10.6%), where sufentanil was 
also the most popular opioid additive used.  In Israel, only 12% of obstetric 
anaesthesia units surveyed reported routinely using intrathecal morphine for 
post-operative pain control for patients after a caesarean section.  Most units 
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(68%) removed the epidural catheter after surgery and did not use it for post-
operative analgesia.  Only two units (9%) reported using TAP blocks 
occasionally for post-operative analgesia but the majority did not utilize this 
form of analgesia.  NSAIDs were only used in 47% of the units surveyed 
(Orbach-Zinger et al., 2014). 
 
The practices related to post-operative monitoring are also different in the 
various countries.  Sixty-three percent of the respondents in the SOAP study 
reported that they monitor patients who received neuraxial opioids for up to 
24-hours, and 93% of the respondents indicated that their hospital had a 
protocol for monitoring of these patients (Tagaloa et al., 2009).  No details 
regarding the post-operative monitoring practices of patients after caesarean 
section were reported by Faboya and Uncles (2006) in their study of practices 
in the SWT region of England. Similarly, no details regarding post-operative 
monitoring practices were reported by Stamer et al (2005) or Chan and Ng 
(2000) in their respective surveys.  In Israel, there were 72% of hospitals 
where anaesthesiologists did not monitor patients’ post-operative pain control.  
However, in the few units where intrathecal morphine is used for caesarean 
section patients, patients are monitored for respiratory depression every two 
hours for 24 hours after surgery (Orbach-Zinger et al., 2014).  
 
There is a paucity of data from Africa regarding anaesthetic practices for 
obstetric patients.  No studies on obstetric anaesthesia practices in Central 
Africa have been found in the medical literature.  A letter published in the 
International Journal of Obstetric Anesthesia in 2006, discussing the evolution 
of obstetric anaesthesia in West Africa made reference to obstetric 
anaesthesia practices in Nigeria.  The author reported that the mainstay of 
obstetric anaesthesia in West Africa was general anaesthesia, despite 
regional anaesthesia being available, safer and cheaper in this region.  
Ketamine anaesthesia was very common, and this resulted in a high number 
of maternal deaths due to aspiration and cerebrovascular accidents (Okafor, 
2006) 
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In 1978, Buley et al (1978) published the results of a survey they conducted in 
the Republic of South Africa and South West Africa (now called Namibia) on 
the obstetric anaesthesia practices in these countries.  The authors reported 
that the majority of obstetric anaesthetics (90%) were performed by non-
specialist practitioners.  General anaesthesia was the preferred method of 
anaesthesia in an overwhelming majority of the hospitals surveyed (125/131, 
95%).  Only 7 hospital in Natal and KwaZulu (now called KwaZulu Natal) and 
1 in the Transvaal (this former province is now divided into Gauteng, Limpopo 
and Mpumulanga provinces), used regional anaesthetic techniques for 
caesarean section surgery.  This data from South Africa is very outdated and 
the anaesthetic practice reported in this study, while acceptable during the 
1970’s, is considered inappropriate care in 2016.  There are unfortunately no 
other reports in the medical literature regarding obstetric anaesthetic practices 
in South Africa since this 1978 publication. 
 
A worrying factor in the delivery of obstetric anaesthesia in South Africa is the 
level of training of the service providers. Lamacraft et al (2008) conducted a 
study investigating the experience and training of doctors performing obstetric 
anaesthesia in the Free State province in South Africa and found most 
obstetric anaesthetics in this province were administered by junior doctors, 
who had very little prior anaesthetic training.  And, in a 2012 editorial in the 
Continuing Medical Education journal, Diedericks commented that the 
majority of anaesthetics in South Africa are provided by non-specialists, and 
in most cases this is for caesarean sections (Diedericks, 2012). If this is the 
case, it brings us back to first part of the statement made by John R Hampton, 
“A fool – loosely defined as someone who does not know much about a 
particular area of medicine – will do well to follow guidelines when treating 
patients…”, highlighting the need for clear, succinct guidelines on anaesthesia 
for caesarean sections in South Africa.  
 
There is a significant paucity of information in the medical literature pertaining 
to the current obstetric anaesthesia practices in South Africa.  Without this 
knowledge it is impossible for the country to develop an effective plan to 
improve the anaesthetic care of women having caesarean section surgery in 
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South Africa.  Hence, I undertook a series of studies to describe the post-
operative pain management practices of doctors managing caesarean section 
patients in South Africa and to evaluate the safety and efficacy of different 
intrathecal opioids on post-operative pain experiences in women who have 
undergone caesarean section surgery.  The results of these studies will be 
presented in the forthcoming chapters. 
 
2.10 Summary 
 
In this chapter the literature review was presented.  In the following chapter 
the study titled “Developing a reference standard for anaesthesia for 
caesarean sections in South Africa” will be presented. 
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CHAPTER THREE: Expert opinion on anaesthesia for 
caesarean sections in South Africa 
 
3.1 Introduction 
 
South Africa has a high caesarean section rate (Moodley, 2010, CMS, 2015), 
and the anaesthetics for these procedures can be performed by many 
different categories of doctors ranging from junior medical officers to 
experienced specialists (Bettings et al., 2013).  These procedures are 
performed in many different types of hospitals ranging from rural district 
hospitals to tertiary academic hospitals. Moreover, there are currently no 
national guidelines for the anaesthetic management of caesarean sections in 
South Africa. 
 
A number of international caesarean section anaesthesia guidelines exist 
(Apfelbaum et al., 2016, Griffiths et al., 2011), however resource limitations 
mean that these guidelines may not be locally applicable.  Compared to the 
public healthcare sector, the private health sector in South Africa is relatively 
well-provisioned in terms of doctor: patient ratio, equipment, and access to 
medicines. The high financial and resource availability in private healthcare 
means that international guidelines may be followed, but this sector services 
only a minority of the South African population. The bulk of the population is 
serviced by the public healthcare sector, which faces severe financial and 
other resource restrictions. For example, in 2013/4 the private sector spent 
146 million rands on 8 million people (17% of the population), while during the 
same period the total public health expenditure on health was 141 million 
rands, to service the health needs of the remaining 83% of the population 
(Blecher et al., 2011).  The resource constraints faced by the public sector 
means that they are less able to match the resources international guidelines 
call for to implement an effective caesarean section anaesthesia and post-
operative analgesia service. Thus, a bespoke service, which takes into 
account local resource constraints, needs to be established. 
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Before locally appropriate guidelines can be developed it is essential to 
ascertain the current status quo in South Africa so that we have a reference 
point from which the country can gauge improvements in its obstetric 
anaesthetic services when aspiring towards a benchmark. 
 
3.2 Aim 
 
To describe the current reference standards for obstetric anaesthesia 
practices in South Africa 
 
3.3 Objectives 
 
To describe the reference standard in South Africa (as determined by the 
anaesthesiology academic heads of department at the eight medical schools) 
for anaesthesia for caesarean section surgery relating specifically to: 
a. Preferred method of anaesthesia  
b. Use of adjuvant drugs for neuraxial anaesthesia 
c. Post-operative monitoring practices 
d. Post-operative pain management 
 
3.4  Ethical considerations 
 
This was a prospective study involving an interview with the academic heads 
of the eight university anaesthesiology departments in South Africa.  All 
anaesthesiology specialist training in South Africa takes place in these eight 
university departments. 
 
Participants voluntarily participated in the study and provided written informed 
consent. 
 
The protocol was reviewed and approved by the Human Research Ethics 
Committee – Medical (HREC) of the University of the Witwatersrand -
Approval number M111124   (APPENDIX A). 
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3.5  Research Methodology 
 
A semi-structured interview was conducted with the academic heads of 
departments of anaesthesiology at the eight South African medical schools in 
2012.  A semi-structured interview method was chosen in order to ensure that 
all pre-determined areas of discussion points are covered, while also allowing 
the interviewees to freely discuss points which they deemed to be appropriate 
for the topic of caesarean section anaesthesia. 
 
The interview questionnaire was formulated to determine what the 
interviewees considered to be the reference standard for caesarean section 
anaesthesia in South Africa, with specific reference to: 
 
i. Method of anaesthesia  
ii. Use of adjuvant drugs for neuraxial anaesthesia 
iii. Post-operative monitoring practices 
iv. Post-operative pain management practice 
The questions used in the interview were based on the questionnaire 
developed by Tagaloa et al (2009) and used in a 2011 survey conducted in 
the USA (APPENDIX B).  The questionnaire was modified to take the local 
South African healthcare environment into account, and also to include 
questions related to the post-operative practices applicable to caesarean 
section patients.  These changes related to the following points: 
 
• Questions related to demographics and the experts’ experience were 
omitted 
• Some questions were rephrased to take into account that the 
questionnaire was directed at an expert for their opinion rather than what 
their personal practice was 
• Drugs used for spinal anaesthesia were adjusted to include only drugs 
available in South Africa and also allowed for volume used to be indicated 
(Questions 4, 5 and 6) 
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• Drugs used for epidural anaesthesia were adjusted to include only drugs 
available in South Africa (Question 11) 
• The experts were given more alternatives regarding their choice of 
management of a labouring patient requiring a caesarean section 
(Question 13) 
• The experts were asked if they thought that maternity units should have a 
monitoring protocol, as opposed to whether their hospital had a protocol 
(Question 18) 
• The options for NSAIDs were adjusted to include more drugs available in 
South Africa (Question 27) 
• Route of administration of NSAIDs was included (Question 29) 
• Use of IV paracetamol was included (Question 30) 
• Oral analgesic options were adjusted to include drugs available in South 
Africa (Question 31) 
• The experts were asked for comments or questions they thought may be 
relevant to obstetric anaesthesia in South Africa (Question 33) 
To ensure face validity of the questionnaire, the modified questionnaire was 
reviewed by 12 senior members of staff of the Department of Anaesthesiology 
at the University of the Witwatersrand. Feedback was used to refine the 
survey questionnaire further. Following the validation process, changes were 
made to the punctuation of certain questions.  The modifications made to the 
original questionnaire are indicated in APPENDIX C. 
 
The interviews were recorded using an electronic voice recorder (Philips 
Digital Voice Tracer LFH0862). 
 
The interview questions, participant information sheet and consent forms are 
referenced in the appendix. 
 
APPENDIX D: Semi-structured Interview Questionnaire 
APPENDIX E: Participant Information Sheet 
APPENDIX F: Participant Consent Form 
APPENDIX G: Participant Consent for Electronic recording  
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3.5.1 Data Analysis 
 
Recordings were transcribed within one week of the interview being 
completed and the data analysed using qualitative data analysis methods 
including content analysis (Mayring, 2000).  The responses to each of the 
questions were categorized into themes based on the options given to the 
interviewees.  The categories were then quantified and interpreted in 
conjunction with any supporting statements made by the interviewees while 
answering the questions. 
 
Data Description: 
Continuous parametric data are described using mean and standard 
deviation.  Continuous non-parametric data is described using median and 
interquartile ranges.  Categorical data is presented using frequencies and 
percentages. 
 
In order to maintain confidentiality of the respondents, responses are not 
linked to specific institutions in the reporting of the data. 
 
3.6  Results and Discussion 
All eight medical faculties in South Africa in 2012 participated in this study.  
During the interviews, the departments were represented by the head of 
department, or the head of department and the departmental obstetric 
anaesthesia expert or only the departmental obstetric anaesthesia expert (at 
the behest of the head of department) (Table 3.1).  
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TABLE 3.1: Participating universities and interviewees 
Head of Department 
only 
Head of Department and 
Departmental Obstetric 
Anaesthesia Expert 
Departmental 
Obstetric Anaesthesia 
Expert 
University of Limpopo 
(MEDUNSA Campus) 
 
University of the 
Witwatersrand 
University of Cape Town 
 
University of KwaZulu Natal 
 
University of Pretoria 
 
University of the Free State 
University of Stellenbosch 
 
Walter Sisulu University 
 
At the four universities that were represented by both the head of department 
and the obstetric anaesthesia expert, the representatives came to a 
consensus and provided an ‘institutional response’ to the questions. Thus the 
denominator used to calculate proportions was eight (the number of 
institutions), and not the total number of participants. 
 
3.6.1 Preferred method of anaesthesia 
3.6.1.1 The use of spinal anaesthesia for caesarean sections 
 
There was unanimous agreement at all the institutions, that the preferred 
anaesthetic technique for the majority of patients having an elective 
caesarean section should be a single shot spinal anaesthetic.   Epidural 
anaesthesia, combined spinal-epidural anaesthetic technique and general 
anaesthesia were not recommended as the preferred technique by any of the 
institutions. 
 
The agreement amongst all the institutions (n=8) was that the single shot 
spinal anaesthetic offers the quickest, most reliable and safest anaesthetic 
option for patients having an elective caesarean section.  These claims are 
consistent with findings that spinal anaesthetic techniques are easier and 
more cost effective to perform than other neuraxial anaesthetic techniques 
(Riley et al., 1995).  In addition, these recommendations are also in alignment 
with international guideline recommendations from the USA (Apfelbaum et al., 
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2016) and the United Kingdom of Great Britain and Northern Ireland (UK) 
(Griffiths et al., 2011), which advocate regional anaesthetic techniques for 
caesarean section surgery. 
 
Type of needle for spinal anaesthesia 
 
The needle design and size can influence the effects and side-effects 
experienced by patients from the spinal anaesthetic procedure (O'Connor et 
al., 2007), and thus selection of needle is an important consideration when 
delivering spinal anaesthesia.  There was agreement from all the institutions 
that a pencil point needle should preferentially be used when performing a 
spinal anaesthetic for a caesarean section.  The pencil point needle seperates 
the fibres of the dura rather than cutting through them (Calthorpe, 2004).  This 
atraumatic entrance into the subarachnoid space reduces the risk of a dural 
flap developing, thereby decreasing the risk of a post-dural puncture 
headache (PDPH) occuring. 
 
The suggested pencil point needle types included: (multiple options were 
possible) 
o Whittacre© (5/8) 
o Sprott© (3/8)               
o Pencan© (1/8) 
 
These recommendations are in line with those of the ASA, which state that 
“pencil-point spinal needles should be used instead of cutting-bevel spinal 
needles” (Apfelbaum et al., 2016). 
 
All institutions agreed that the Quincke© needle should never be used to 
perform a spinal anaesthetic for obstetric patients.  The Quincke© needle is a 
cutting spinal anaesthetic needle that is associated with a greater risk of 
developing PDPH (O'Connor et al., 2007). Respondents at all institutions 
however, conceded that the reality was that this cutting needle is sometimes 
all that is available in the public sector hospitals, and therefore doctors often 
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may not have any choice but to use this needle.  The frequency of this 
problem was not quantified. 
 
Gauge of needle for spinal anaesthesia 
 
The gauge of the spinal anaesthestic needle refers to the external diameter of 
the needle and is based on the Standard Wire Gauge system (Poll, 1999).  
The higher the gauge number, the smaller is the outer diameter of the needle.  
Using a wide diameter needle to perform a spinal anaesthetic is associated 
with an increased risk of the patient developing a PDPH (O'Connor et al., 
2007).   
 
All institutions recommended that smaller gauge needles should be used to 
perform spinal anaesthetics for patients having caesarean section surgery.  
Half (4/8) of the institutions recommended that a 26G needle be used.  About 
one third (3/8) of the institutions recommended that the 25G needle was 
preferable, citing easier needle control as the reason for using the slightly 
larger diameter needle.  Only one institution recommended that the 27G 
needle was appropriate. (Figure 3.1) 
 
 
FIGURE 3.1: Choice of gauge of spinal anaesthetic needle 
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The 27G needle is the smallest gauge needle that is currently available for 
clinical use in South Africa.  Most institutions (7/8) were of the opinion that this 
size of needle should be reserved for use by experienced practitioners 
because the needle is very small and is more difficult to manoeuvre when 
performing a spinal anaesthetic.  The risk associated with its use therefore 
outweighs the benefit of a lower PDPH risk.  
 
The 22G needle is a relatively large bore needle that has a higher association 
with PDPH (O'Connor et al., 2007).  There was unanimous agreement that 
this needle should not be routinely used to perform a spinal anaesthetic in 
pregnant patients.  However, three institutions highlighted that the caveat is 
that, in certain cases (eg. morbidly obese patients) this needle may be more 
appropriate to use as it easier to manoeuvre and can decrease the tissue 
trauma.  This is an important point as 42% of South African women are 
reported to be overweight (Ng et al., 2014). 
 
Local anaesthetic choice for spinal anaesthesia 
 
Current international guidelines (Apfelbaum et al., 2016, Griffiths et al., 2011) 
do not recommend any specific local anaesthetic for use in obstetric spinal 
anaesthetics, but there was unanimous agreement across the institutions that 
the local anaesthetic of choice for obstetric spinal anaesthetics is 0.5% 
bupivacaine with dextrose.  None of the institutions recommended using any 
of the other available local anaesthetics (bupivacaine 0.5%, lignocaine 2%, 
ropivacaine 0.75% or levobupivacaine 0.5%).  Bupivacaine 0.5% with 
dextrose is a hyperbaric local anaesthetic solution that spreads towards the 
thoracic kyphosis when the patient is in the supine position (Kleinman, 2002).  
This cephalad spread results in an attenuation of the nerve impulses from 
approximately the T4 level of the spinal cord.  
 
Bupivacaine with dextrose is available as a pre-mixed solution for intrathecal 
use in South Africa.  One expert commented that in their center, the 
availability of the pre-mixed solution is often erratic, and they advocate that 
 anaesthetic service providers mix their own hyperbaric solution of bup
by adding dextrose to plain 0.5% bupivacaine.  This practice is potentially 
dangerous if strict attention to detail is not maintained with regards to dilutions 
and aseptic techniques.
 
Dose of local anaesthetic for spinal anaesthesia
 
The dose of local anaesthetic administered for a spinal anaesthetic has an 
impact on the quality of the anaesthesia and the incidence of hypotension 
(Kleinman, 2002).  The experts interviewed in this study had varied responses 
regarding the appropriate dos
used.  Four of the institutions recommended a range of doses while the other 
four were very specific in what dose they felt was the most appropriate.  
These results are illustrated in 
 
FIGURE 3.2: Recommended doses of 0.5% bupivacaine with dextrose for 
single shot spinal anaesthetic
 
The range of recommended doses of 0.5% bupivacaine with dextrose, ranged 
between 1.8ml and 2.1ml (9mg 
of 0.5% bupivacaine with dextrose was 1.9ml (9.5mg).  Yet, using 
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≤10mg bupivacaine (2ml of a 0.5% solution) for obstetric spinal anaesthesia 
has been demonstrated to be associated with a higher incidence of visceral 
pain during the surgical procedure (Kiran and Singal, 2002). 
 
One expert was highly critical about using doses lower than 2ml of 0.5% 
bupivacaine with dextrose, correctly indicating that this increases the risk of a 
failed spinal anaesthetic.  Therefore the minimum dose recommended by this 
expert was 2ml.  Nevertheless, the lowest dose recommended across the 
institutions was above the 8mg bupivacaine dose Arzola and Wieczorek 
(2011) identified as being associated with severely compromised anaesthetic 
efficacy. 
 
The use of adjuvant drugs for elective spinal anaesthesia 
 
All the experts recommended the use of an opioid additive with the intrathecal 
local anaesthetic to improve the efficacy of the spinal block.  One expert 
stated:  
 
“It is wrong not to use an opioid”  
 
Neuraxial opioid administration allows for a more direct stimulation of the 
opioid receptors in the spinal cord, which improves the intensity of the 
anaesthetic and, depending on the opioid used, will also prolong the analgesic 
efficacy of the block (Cousins, 1984).  This theory also applies to lipophilic 
opioids such as fentanyl. 
 
This institutional recommendation is in line with the 2016 American Pain 
Society (APS) Guidelines (Chou et al., 2016), which recommend intrathecal 
opioids as one of the therapeutic analgesic options for caesarean section 
patients.   Fentanyl was universally recommended as the opioid that should 
be used as an additive agent for the spinal anaesthetic in order to improve the 
efficacy of the block and to provide better intraoperative analgesia.  This 
recommendation is certainly justified, as intrathecal fentanyl has been 
 demonstrated to increase the effectiveness and duration of analgesia when 
compared to control groups 
 
The recommended fentanyl dosage ranged between 10 
20µg).  Experts from three institutions gave a specific dose that should be 
used while the remaining five institutions provided a range of doses that 
anaesthetic service providers should work between. 
 
FIGURE 3.3: Recommended doses of 
anaesthetic 
 
These recommended dosages of fentanyl may be higher than is actually 
required.  Intrathecal fentanyl doses as low as 6.25
provide effective intra-operative analgesia for caesarean section surgery, with 
doses above this level not increasing the effectiveness of the intraoperative 
analgesia (Hunt et al., 1989)
 
There was unanimous agreement that intratheca
used because of concerns regarding the potential delayed respiratory 
depressant effects of morphine following neuraxial administration.  The 
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post-operative obstetric wards in South Africa to be able to detect this 
complication timeously.  One of the experts commented: 
 
“It would worry me if we’re using morphine in our caesar patients because of 
the lack of effective nursing and monitoring in the wards” 
 
The area of the hospital where the patients recover is dependent on the level 
of nursing care available in each hospital. 
 
These opinions are contrary to the recommendations of the Australia New 
Zealand College of Anaesthetists (ANZCA) 2015 Acute Pain Guidelines 
(Schug et al., 2015), which emphasizes the positive analgesic effects of 
intrathecal morphine for patients having caesarean section surgery.  The 
Procedure-specific post-operative pain management (PROSPECT) working 
group also specifically recommends that intrathecal morphine (below 200µg) 
should be used for patients having a spinal anaesthetic for caesarean section 
(PROSPECT Working Group, 2015). 
 
One expert from a different university did however concede that the risk of 
delayed respiratory depression was very low, especially if the doses of 
morphine recommended in the international literature for obstetric patients, 
are used.  In addition, pregnant women are less likely to develop delayed 
respiratory depression due to their high progesterone levels, which causes 
them to develop an increased respiratory rate (McDonnell et al, 2009). 
However, it appears that current teaching in South Africa is governed by fear 
of this low risk of delayed respiratory depression and the inability to detect it 
timeously.  
 
3.6.1.2 The use of epidural anaesthesia for caesarean section 
 
Experts from all the institutions agreed that an epidural anaesthetic technique 
should not be used as the sole anaesthetic for elective caesarean sections.  
The reasons cited for this recommendation included: 
• Longer time required to administer compared to spinal anaesthetic 
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• Cannot be used post-operatively in the general ward 
• Does not provide as good surgical anaesthesia compared to spinal 
anaesthesia 
 
However, there was unanimous agreement across the institutions that the 
technique can be used as part of a combined spinal-epidural (CSE) 
technique.  The epidural should then be used for post-operative analgesia in a 
high-care setting. 
 
For an urgent caesarean section, where the patient already has an indwelling 
epidural catheter, experts from seven institutions (87.5%) agreed that the 
anaesthetic should be a “top-up” of the labour epidural.  At one of the 
institutions the recommendation was that the anaesthetic service provider 
should perform a general anaesthetic if they did not insert the epidural.  If they 
inserted the epidural catheter then it would be appropriate to “top-up” for the 
surgical procedure.  
 
There was a variation in the choice of local anaesthetic that the experts 
recommend for the epidural “top-up”. Six (75%) of the institutions 
recommended 2% lignocaine, so that surgical anaesthesia could be achieved 
quickly for the surgery.  One institution suggested levobupivacaine, citing the 
relative cardiac safety of the agent and one institution recommended using 
bupivacaine.  No reason was provided for this choice. 
 
Of note, is that three of the six institutions, which recommended 2% 
lignocaine as the preferred local anaesthetic for “top-up”, indicated that 0.5% 
bupivacaine could be used if time was not a constraining factor.  The reason 
cited was that it has a longer duration of action and will probably not require 
additional dosing intraoperatively.  One expert commented: 
 
“I think bupivacaine is probably better but lignocaine might be quicker. Could 
be either, but I think lignocaine might be quicker and there again it depends 
on the indication and on your time available” 
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The use of adjuvant drugs for emergency epidural “top-up” 
 
Experts from all the institutions agreed that an epidural top-up is an 
appropriate strategy to use to attain surgical anaesthesia for a laboring patient 
with an in-situ labour epidural that requires a caesarean section.  At one 
institution however, a proviso that the provider who inserted the epidural must 
be the same person administering the anaesthetic for the surgery, was 
stipulated.  The expert at this institution reiterated that if there is a different 
anaesthetic provider for the surgery, then the anaesthetic should be a general 
anaesthetic. 
 
Four institutions advocated for no additive agents being used in the epidural 
top-up, and that the anaesthetic service provider should be limited to using 
local anaesthetic only.  At the remaining four institutions the experts felt that 
using additives is appropriate and that multiple additive agents could be used.  
The additives recommended are listed in table 3.2  
 
TABLE 3.2:  Table of recommended epidural “top-up” additives 
Additives recommended that 
may be used in the epidural 
top-up solution 
Number of 
institutions 
advocating use 
No agents added 4 
Fentanyl  3 
Sodium Bicarbonate 8.4%  3 
Morphine  3 
Adrenaline  2 
Sufentanil  0 
Other 0 
 
Despite fentanyl being a lipophilic opioid, the analgesic effect of epidural 
fentanyl has been shown to occur primarily by a spinal mechanism and not 
from systemic absorption of the drug (Cohen et al., 2002).  This is despite of 
the easier systemic absorption of lipophilic drugs. 
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The analgesic effect of epidural morphine for post-caesarean section patients 
is well established and has been shown to increase with increasing doses of 
morphine up to 3.75mg (Palmer et al., 2000).  Three institutions indicated that 
they recommend the use of epidural morphine for post-operative analgesia 
only if the patient was being transferred to a high-care environment after 
surgery.  The addition of opioids to the epidural local anaesthetic solution is in 
line with the recommendations of the APS (Chou et al., 2016), which 
recommends that epidural anaesthetics (with or without opioid) can be used 
for caesarean sections. 
 
Two institutions’ experts recommended the addition of adrenaline to the 
epidural “top-up” solution.  The associated vasoconstriction and decreased 
systemic absorption of the local anaesthetic drugs was cited as the motivation 
for the addition of adrenaline. One expert made the comment that: 
 
“Adrenaline gives you a slightly better margin of safety because of the 
vasoconstriction and decreased absorption.” 
 
Indeed, laboratory studies have demonstrated that the vasoconstrictive effect 
of adrenaline has a dual influence on the local anaesthetic when used in an 
anaesthetic block.  Vasoconstriction decreases the systemic absorption of the 
local anaesthetic resulting in lower peak plasma concentrations and thereby 
reducing the risks of systemic toxicity, and in addition, the resultant higher 
drug concentration around the nerves (as a result of the reduced absorption) 
prolongs the duration of the drug.  However, this prolongation of effect does 
not apply to the long acting local anaesthetic agents such as bupivacaine or 
ropivacaine.  (Neill, 2007, Hurley et al., 1991) 
 
Sodium bicarbonate is an alkaline solution.  Experts at three institutions 
recommended that the 8.4% sodium bicarbonate solution be used as an 
additive agent for the epidural top-up.  This drug is added to local anaesthetic 
solutions to increase the pH of the solution resulting in an increased ratio of 
unionized to ionized local anaesthetic molecules.  It is the unionized local 
anaesthetic molecules that are able to penetrate the lipophilic cell membrane 
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of the nerves.  This higher concentration of unionized molecules results in a 
more rapid onset of action of the local anaesthetic solution. (Neill, 2007) 
 
The Faculty of Pain Medicine in the Royal College of Anaesthetists in the UK 
issued recommendations in 2010 titled “Best practice in the management of 
epidural analgesia in the hospital setting” (Rowbotham et al., 2010).  The 
document is not specifically for obstetric epidurals but makes general 
recommendations about epidural analgesia. These guidelines do not make 
any recommendations on which drugs are most appropriate to use in epidural 
analgesia but they do make the following stipulations: 
• “ There should be a limited number of solutions approved and available 
for epidural infusions in every hospital” 
• “They should be prepared under strict sterile conditions in specifically 
designed units. Many are available commercially. Any variation from 
this should occur in exceptional circumstances only and with the 
agreement of the responsible consultant after a risk/benefit analysis” 
• “Epidural infusions should be labeled : ‘For epidural use only’ “ 
• “Epidural infusions should be stored in separate cupboards or 
refrigerators from those holding intravenous and other types of 
infusions in order to reduce the risk of wrong route of administration” 
• “The lowest possible effective concentration of local anaesthetic should 
be used in order to preserve motor function as much as possible. This 
improves patient satisfaction and aids detection of neurological 
complications. If higher concentrations are required, the infusion rate 
should be reduced periodically to allow assessment of motor block”  
• “The use of drugs beyond license should be consistent with local 
hospital guidelines and informed by recommendations of the British 
Pain Society” 
The use of additive agents for epidural anaesthetic solutions is not prescribed 
by any international guidelines.  The use of these agents is generally left at 
the discretion of the doctor administering the epidural anaesthetic.  These 
additive agents may provide specific advantages for the patient and therefore 
the use of these agents should be dependent on the clinical scenario. 
 94
3.6.2 Post-operative Monitoring Practices 
 
Monitoring of patients in the post-operative period is an important aspect of 
post-operative care.  The National Institute of Clinical Excellence (NICE) 
guidelines (Griffiths et al., 2011) state: 
 
“After recovery from anaesthesia, observations (respiratory rate, heart rate, 
blood pressure, pain and sedation) should be continued every half hour for 
two hours and hourly thereafter provided that the observations are stable or 
satisfactory.  If these observations are not stable, more frequent observations 
and medical review are recommended” 
 
Efficient monitoring can alert healthcare providers to any complications 
related to the surgery or anaesthesia that may have an adverse effect on the 
patient’s surgical outcome.  Post-operative monitoring begins in the recovery 
room and should continue (albeit less intensively) in the post-operative wards 
(Bettings et al., 2013).  The APS guidelines (Chou et al., 2016) recommend 
that every patient that receives systemic opioids for post-operative analgesia 
should be monitored for sedation, respiratory status and other adverse events 
in the initial hours after surgery, but the guidelines do not stipulate the exact 
duration of monitoring required. 
 
The administration of neuraxial opioids intraoperatively can result in side 
effects that can extend into the post-operative period (Mikuni et al., 2009).  
This is especially applicable to hydrophilic opioids such as morphine, which 
have a long duration of effect following neuraxial administration (Salmah and 
Choy, 2009).  The short-term side effects include symptoms such as pruritus, 
nausea and vomiting.  However, the most feared side effect of neuraxial 
opioids is respiratory depression (Kato et al., 2008). 
 
Experts from all eight institutions agreed that maternity units must have a 
monitoring protocol for patients who receive neuraxial opioids as part of their 
anaesthetic.  The recommended duration of monitoring depended on the 
neuraxial opioid used.  For short acting opioids such as fentanyl and 
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sufentanil, the mean duration of monitoring recommended was 4 hours (0 – 
12 hours).  
 
The majority of the institutions (7/8) recommended a specific duration of 
monitoring.  Only one institution suggested a range (6 - 12 hours) of time that 
patients should be monitored.   At two institutions the experts did not believe 
that monitoring for respiratory depression was necessary beyond the recovery 
room, as they felt that the duration of effect of fentanyl and sufentanil did not 
warrant concern regarding respiratory depression beyond the surgical period.  
The American Society of Anesthesiologists (ASA) guidelines (Horlocker et al., 
2009) recommend that monitoring for respiratory depression following a single 
neuraxial dose of lipophilic opioids should be done for a minimum of two 
hours after administration. 
 
For patients who receive neuraxial hydrophilic opioids, 7/8 (87.5%) institutions 
recommended that these patients must be monitored for 24 hours after the 
administration of the drug.  Only 1/8 (12.5%) of the institutions recommended 
that monitoring should be performed for eight hours.  The ASA guidelines 
(Horlocker et al., 2009) recommend that monitoring of these patients must be 
performed for a minimum of 24 hours after the administration of the 
medication.  The monitoring should be done once per hour for the first 12 
hours and then once every two hours for the second 12 hours.  (Horlocker et 
al., 2009) 
 
Monitoring of patients must be guided by the clinical condition of the patients.  
Patients who are at increased risk for developing respiratory depression 
(obese patients, history of sleep apnoea, elderly, concomitant administration 
of opioids via different routes, and those patients in an unstable medical 
condition) must be monitored for an extended period of time (Horlocker et al., 
2009). 
 
The ASA Task force on Neuraxial Opioids practice guidelines (Horlocker et 
al., 2009) recommends that patients who receive neuraxial opioids should be 
monitored, as a minimum, for adequacy of ventilation, oxygenation and also 
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for level of consciousness.  The recommendations from the interviewed 
experts varied in the number of modalities that should be assessed.  Four 
institutions recommended that respiratory rate, sedation scores and pulse 
oximetry should be monitored. Respiratory rate monitoring and sedation 
monitoring was recommended by two of the institutions.  Only one institution 
recommended that respiratory rate monitoring be used as the sole monitoring 
tool.  
 
Capnography allows the continuous measurement of expired carbon dioxide 
and can serve as a measure of the adequacy of ventilation in a patient 
(Kodali, 2013).  Only five institutions expressed that capnography was a 
useful monitor of respiratory depression following neuraxial opioid 
administration, and should be a preferred monitor.  However the opinion was 
expressed at all eight institutions that the cost of the device was too 
prohibitive for capnography to be implemented as a routine measure in the 
South African public healthcare sector environment.  I have highlighted three 
responses from the expert panel regarding the use of capnography in patients 
who received intrathecal opioids: 
 
“…it’s a sophisticated monitor and certainly costly. If you’re looking at it for 
effective analgesia in state hospitals, its not an option really.” 
 
“…well, it would be great if we could have that. Its not like pulse oximetry and 
the respiratory rate can do everything for you…. yes but I don’t think its 
possible” 
 
“Excellent, if you can get it” 
 
At two institutions, opinions were expressed that patients given intrathecal 
morphine could be nursed in a normal post-operative ward provided that the 
ward was adequately staffed, and that the nursing staff regularly monitored 
patients for respiratory depression using acceptable monitoring protocols.   
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The comments made by both the institutional experts were: 
 
“…. if the nurses are trained, yes, I’ll be happy.” 
 
“Not high-care necessarily, but a ward with equipment and nursing vigilance” 
 
3.6.3 Post-operative pain management   
 
The experience of pain after a caesarean section is influenced by a number of 
different factors including the psychological and emotional preparedness of 
the patient for the birth of her child.  The level of pain that a woman 
experiences following caesarean section surgery has an impact on her ability 
to take care of and bond with her baby (Karlstrom, 2007).  It is therefore 
important that health care providers implement and evaluate analgesia in 
these patients. 
 
The path to successful post-operative pain management begins in the pre-
operative period.  Patients should be educated about the surgical procedure 
and also about what to expect with regards to post-operative pain after 
surgery.  The APS guidelines recommend that patients should be provided 
with information about their post-operative pain management options before 
the surgery so that they are informed and aware of their options in advance 
(Chou et al., 2016).  For patients having caesarean section surgery, these 
options should include regional and systemic analgesic options. 
 
Seven institutional experts felt that epidural analgesia should not be routinely 
used for post-operative pain management in South Africa.  They reasoned 
that this would require that these patients be admitted to a high-care unit in 
order to ensure correct management of the epidural anaesthetic after surgery.  
The same experts also felt that the benefit of the epidural can be closely 
matched using other analgesic techniques, such as intrathecal morphine.  
They did however concede that intrathecal morphine use would also require 
intensive monitoring.  Quotes, from the expert panel, related to the use of 
epidural post-operative analgesia include: 
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“… I don’t think its sustainable care and also there are potential complications 
with the epidural catheter….” 
 
“… because we’ve got other modalities of post-op analgesia….” 
 
“I’d rather give intrathecal morphine and take the epidural out …  and it also 
goes with monitoring.  I can’t send a woman to the post-natal ward with an 
epidural catheter in… “ 
 
Other reasons cited as to why routine use of epidural analgesia was 
inappropriate in the public healthcare sector in South Africa included:  
Inadequate monitoring in postnatal wards (n=6), no additional gain for the 
patient (n=6), no standard epidural protocols available (n=5), nursing staff 
shortages (n=5), lack of nursing staff education in epidural care (n=5), no 
epidural pumps in postnatal wards (n=4) and anaesthesiology staff shortages 
(n=4). 
 
If we compare the response from the interviewees to international practices, 
Palmer et al (2000) reported that the use of epidural morphine for post-
caesarean analgesia may not be optimal and that supplementation with 
systemic analgesics may be required in order to optimise pain management.  
Cooper et al (1999) compared the analgesic efficacy of epidural fentanyl and 
intravenous patient controlled analgesia (PCA) morphine and found that while 
the PCA morphine utilization was significantly lower (p=0.0007) for patients in 
the epidural fentanyl arm of the study, the patient satisfaction levels were 
similar in both groups.  Based on the findings of these studies, the 
recommendations from the experts appears to be justified, especially 
considering the relative shortage of high care beds in South Africa.  The APS 
guidelines are neutral in their recommendations regarding epidural opioids, 
indicating that a local anaesthetic epidural can be used with or without opioids 
(Chou et al., 2016) 
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Patient controlled opioid administration allows patients to administer their 
medication as and when they require it, and is associated with increased 
patient satisfaction with their pain management (Harrison et al., 1988). This 
increased satisfaction is postulated to be due to the more stable plasma 
analgesic levels (when compared with intermittent administration techniques) 
and the greater sense of empowerment for patients (Harrison et al., 1988).  
Despite the documented higher satisfaction levels that PCA offers, experts at 
six of the eight institutions (75%) did not recommend PCA for routine post-
operative analgesia in caesarean section patients.  They felt that the limitation 
on patient mobility (n=5), the risks associated with intravenous (IV) opioids 
(n=4), and the requirement that the IV line be in place for prolonged periods 
(n=3), were factors that collectively made PCA an unsuitable analgesic 
technique for routine use following caesarean section surgery.  There was 
however two institutions that argued that PCA would provide an ideal form of 
analgesia, but they felt that its routine use was currently impractical and 
expensive for both the private and public health care sectors in South Africa.  
These same institutional experts indicated that this modality should be 
reserved for challenging cases where pain is likely to be high (e.g. difficult 
surgery).  The comment from one of these experts was: 
 
“Patients who have had a difficult caesar. So, for example a previous caesar 
X2 who’s now come for another caesar, or a patient who has had a caesar for 
twins or perhaps a patients who needed a classical incision for whatever 
reason or even where a caesar has progressed to hysterectomy… “ 
 
The UK guideline (Griffiths et al., 2011) however, recommends that all 
patients should be offered PCA opioids after their caesarean section. 
 
Despite 75% of institutions not being in favour of PCA, there was unanimous 
agreement (8/8) that when a PCA is used, the most appropriate drug to use is 
morphine.  No direct reasons were offered for this preference however it is 
likely that this is due to the longer duration of action of morphine compared to 
other opioids. 
 
 100
Non-steroidal anti-inflammatory drugs (NSAIDs) are anti-hyperalgesic agents 
that provide good post-operative pain relief due to their anti-inflammatory 
effects (Lavand'homme et al., 2007).  These drugs also have well 
documented benefits for pain associated with uterine incision and uterine 
involution after caesarean section surgery (Tan, 2012).  All the institutional 
experts (8/8, 100%) recommended that NSAIDs should be routinely used after 
caesarean section surgery, except in patients where contraindications to the 
drugs exist.  These contraindications included: bleeding diatheses (n=8), 
severe pre-eclampsia (n=8), and renal dysfunction (n=8).   
 
At one institution, concerns were raised about using NSAIDs in HIV positive 
patients because, anecdotally, they have observed nephropathy developing in 
HIV positive patients following NSAIDs use.   
 
“… I think it’s contra-indicated in a few settings ... We are cautious in HIV 
positive patients because we have seen a few cases of nephropathy 
developing in these patients…. the number one thing here is the renal 
dysfunction.” 
 
This concern regarding NSAIDs used was raised at the first expert interview, 
therefore the point was specifically raised at subsequent interviews.  Other 
institutional experts (7/8) however, did not share this concern, when the issue 
was raised directly with them. 
 
No opinions were expressed with regards to which NSAIDs were preferable 
(TABLE 3.3), and the decision on which NSAIDs to use was based on 
personal experiences with particular drugs their centres. 
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TABLE 3.3: NSAIDs preferences following caesarean section  
NSAIDs Number of 
institutions 
Ibuprofen 4 
Diclofenac 4 
Ketorolac 1 
Parecoxib  1* 
* Stipulated that the drug should only be used as the initial dose of NSAIDs in the operating theatre and 
thereafter the NSAIDs should be changed to another drug in the same class, but administered via a non-
parenteral route.  
 
Similarly, there was no consensus across the institutions regarding the route 
of administration of the NSAIDs.  Half of the institutions advised an oral route 
of administration while the other half recommended rectal suppositories. At 
one institution, the expert stated that there is no scientific justification for rectal 
administration of NSAIDs, and is inappropriate for caesarean sections.  The 
ANZCA 2015 Acute Pain guideline (Schug et al., 2015) provides good 
evidence for the use of NSAIDs in the post-operative period however the 
guideline stated that there was conflicting evidence regarding the benefits of 
using NSAIDs in the post-caesarean section patient.  The UK (Griffiths et al., 
2011) and APS (Chou et al., 2016) guidelines, as well as the PROSPECT 
recommendations (PROSPECT Working Group, 2015), however state clearly 
that NSAIDs should be offered as an adjunctive analgesic after caesarean 
section surgery, provided that there are no contraindications to the use of 
NSAIDs. 
 
Intravenous paracetamol is a good analgesic agent that has a significant 
opioid sparing effect when used in combination with opioids (Remy et al., 
2005).  The drug therefore offers an attractive option to be used as part of a 
post-caesarean section pain management regimen.  The majority of 
institutions (6/8, 75%) agreed that IV paracetamol should be routinely used 
following caesarean section surgery.  These experts agreed that the opioid 
sparing effect of IV paracetamol is superior to other drugs and will therefore 
be beneficial to these patients.  There was however concern expressed by 
this group, that the costs of the drug are prohibitive for widespread application 
 102
in South Africa. At two institutions, it was felt that that the routine use of IV 
paracetamol could not be justified within the resource-constrained 
environment in South Africa.   The PROSPECT guidelines are the only 
international recommendations that make specific mention of IV paracetamol 
use for caesarean section surgery.  No other international guidelines have 
specifically recommended IV paracetamol for use after surgery but 
paracetamol has been recommended by guidelines from two different 
countries (Chou et al., 2016, Schug et al., 2015). 
 
In addition to the medications discussed above, the experts at the eight 
institutions also recommended other oral agents that should be used to 
manage post-caesarean pain, especially after the first 24-hour post-operative 
period. (TABLE 3.4) 
 
TABLE 3.4: Oral analgesic agents to be used for caesarean section 
analgesia 
 
Oral Analgesic Number of 
institutions 
Paracetamol 5 
Codeine 5 
Tramadol 3 
  
Seven institutions recommended that analgesics must be administered as 
regular scheduled doses in order to have maximum effectiveness.  Only one 
institution recommended pro re nata (PRN) administration.  The use of oral 
agents is in line with other international guideline recommendations (Chou et 
al., 2016). 
 
The experts also made recommendations on what they felt was needed in 
South Africa to improve post-caesarean section analgesia.  The highlighted 
areas include the following: 
 
 103
• Development of guidelines for post-caesarean analgesia 
 
“…establishment of the special interest group that would be responsible for 
the establishment of guidelines for post-caesarean analgesia… “ 
 
• Standardise care in the country 
 
“I think we need to standardise management. When I say management I 
mean the peri-operative management and how we manage complicated 
obstetrics” 
 
• Develop a post-operative monitoring chart 
 
“We need to have…. similar to Ireland or the UK (I am not sure which), where 
they have a specific chart for post-op caesar observations…” 
 
• Improved anaesthesia training for obstetric cases 
 
“…my biggest concern is that we are sending out very junior doctors to go and 
do difficult anaesthetics when they’re not ready for it.  We need to improve the 
standards of training, especially for obstetric anaesthesia.” 
 
3.7 Summary of results 
 
Table 3.5 summarises the key results of this study and compares the opinions 
expressed at the eight institutions with currently available international 
guidelines. 
 
 
 
 
 
 104
 
TABLE 3.5: Summary of the recommendations of the South African 
institutional experts compared with current international guidelines 
 
SOUTH AFRICAN EXPERT 
RECOMMENDATIONS 
INTERNATIONAL GUIDELINES 
Method of anaesthesia 
 
Single shot spinal anaesthetic 
 
ASA – Neuraxial anaesthetic 
technique (does not specify 
intrathecal or epidural)(a) 
 
UK – Regional anaesthetic technique 
(does not specify intrathecal or 
epidural)(b) 
 
Type of spinal anaesthetic needle 
 
Pencil point needle 
 
* Quincke needles should not be 
used 
 
ASA – Pencil point needle(a) 
 
* Recommendation is to use pencil 
point needle instead of cutting-bevel 
needle 
 
Local anaesthetic for spinal block 
 
0.5% bupivacaine with dextrose 
 
No recommendations 
 
Use of adjuvant drugs for neuraxial anaesthesia 
 
Opioids – Fentanyl (10 – 25µg)  
 
 
 
ASA – Neuraxial opioids are 
recommended.  No specific drug is 
recommended(a) 
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* Morphine should not be used 
 
UK – Neuraxial diamorphine(b) 
 
APS – Intrathecal and epidural 
opioids. No specific drug is 
recommended(c) 
 
ANZCA – Intrathecal morphine(d) 
 
PROSPECT – Intrathecal morphine (f) 
 
* There are no explicit 
recommendations against morphine 
Post-operative monitoring practices 
 
Monitoring for respiratory depression 
in patients given neuraxial opioids.  
The duration of monitoring depends 
on the drug used: 
 
• Lipophilic opioids - 0 – 12 
hours 
 
• Morphine - 24 hours after the 
administration of the drug 
 
ASA - Monitoring for respiratory 
depression should be done in patients 
who receive neuraxial opioids. The 
duration of monitoring depends on the 
drug used: 
• Lipophilic opioids – minimum of 
two hours after administration(e)  
 
• Morphine - The monitoring 
should be done once per hour 
for the first 12hours and then 
once every two hours for the 
second 12 hours(e)  
 
APS – Sedation and respiratory status 
in the initial hours after surgery for 
patients who receive systemic 
opioids(c)  
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Post-operative pain management practice 
 
Epidural analgesia – should not be 
routinely used for post-operative 
analgesia 
 
 
APS – Epidural analgesia (with or 
without opioids) can be offered(c) 
 
PCA opioids – should be reserved for 
challenging cases  
UK – PCA opioids should be offered 
to patients(b)  
NSAIDS – should be routinely used 
for post-operative pain management 
 
UK – NSAIDS should be routinely 
used(b)  
 
APS - NSAIDS should be routinely 
used(c)  
 
ANZCA – Conflicting evidence 
regarding benefits of NSAIDs use(d) 
 
PROSPECT – Oral NSAIDs should be 
used (f) 
Paracetamol – should be routinely 
used for post-operative pain 
management.  The intravenous 
formulation is preferred but the cost 
is a concern 
 
APS - Paracetamol should be 
routinely used(c)  
 
ANZCA – Paracetamol should be 
routinely used (d) 
 
PROSPECT – Oral paracetamol 
should be used (f) 
(a)
 (Apfelbaum et al., 2016)(b) (Griffiths et al., 2011) (c) (Chou et al., 2016)  
(d)
 (Schug et al., 2015) (e) (Horlocker et al., 2009) (f) (PROSPECT Working 
Group, 2015) 
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3.8 Conclusions 
 
This study was conducted as a series of semi-structured interviews with 
senior representatives of the eight academic anaesthesiology training 
departments in South Africa in 2012.  These experts in anaesthesia were 
asked a series of questions related to the anaesthetic management of 
caesarean sections in the South African environment.  The aim of these 
interviews was to determine a reference standard for performing an 
anaesthetic for caesarean section in South Africa taking into account the 
limited healthcare resources available in a developing country such as South 
Africa.  Given that all training of anaesthesiology registrars in South Africa 
takes place in these eight centres, it is reasonable that the views expressed at 
the institutions informs training standards for obstetric anaesthesia in South 
Africa.  Not all the heads of departments were experts in obstetric 
anaesthesia, but the opinions they provided were considered to be 
representative of the obstetric anaesthesia teaching in their departments.  The 
experts provided input into four areas of anaesthetic management related to 
caesarean section anaesthesia.  These were: i) method of anaesthesia, ii) use 
of adjuvant drugs for neuraxial anaesthesia, iii) post-operative monitoring 
practices and iv) post-operative pain management practice.   
 
Spinal anaesthesia was the recommended anaesthetic technique for elective 
caesarean sections.  The experts recommended that 0.5% bupivacaine with 
dextrose (at doses between 9 and 10.5mg) should be used for these spinal 
anaesthetics.  Fentanyl was the preferred opioid adjuvant for spinal 
anaesthesia.  Morphine was not recommended because of concerns 
regarding the risk of delayed respiratory depression. 
 
For emergency patients with an indwelling epidural catheter, 2% lignocaine 
was recommended to “top-up” the epidural in order to attain surgical 
anaesthesia.  Adjuvant drugs can be added to the top-up solution, including 
fentanyl, sodium bicarbonate and adrenalin.  The experts indicated that the 
addition of morphine to the epidural solution should be reserved for patients 
who are going to be nursed in a post-operative high care unit. 
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All patients who had received neuraxial opioids intraoperatively need to be 
monitored for respiratory depression in the post-operative period.  The 
opinions on the duration of monitoring varied, depending on the type of opioid 
used.  For lipophilic opioids such as fentanyl, recommended monitoring times 
range between 0 – 12 hours.  For patients in whom intrathecal morphine was 
used, the recommended duration of monitoring ranged between 8 – 24 hours.  
Most experts recommended that respiratory rate, pulse oximetry and level of 
consciousness should be monitored as part of the monitoring process. 
 
A number of different post-operative analgesic techniques were discussed 
with the experts in order to try and develop a common protocol that can be 
applied in South Africa.  Epidural analgesia, PCA pumps and intrathecal 
morphine were not recommended for the routine analgesic regimen for 
caesarean section patients in South Africa.  There was agreement that 
NSAIDs must be included in the pain management protocol.  The majority of 
the experts recommended using IV paracetamol, but concerns were raised 
about the cost sustainability of this.  Other oral analgesics such as 
paracetamol, tramadol and codeine have also been recommended. 
 
Some of the therapeutic options recommended by the South African experts 
are contrary to international guidelines and established effective global 
analgesic options.  These expert recommendations will be compared to the 
actual practice of obstetric anaesthesia in South Africa in chapter four. 
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CHAPTER FOUR: National survey of anaesthesia practices for 
caesarean sections in South Africa 
 
4.1 Introduction 
 
Improving maternal health is the fifth millennium development goal of the 
Millennium Declaration, which was endorsed by 189 countries at the United 
Nations in September 2000 (United Nations Foundation, 2016).   Obstetric 
anaesthesia services are an important component of a maternal healthcare 
package of services that are required for us to achieve this goal in South 
Africa (SA) and around the world.  South Africa has a reported caesarean 
section rate of 16 – 20% (Moodley, 2010).  This rate implies that up to one 
fifth of all pregnant women in South Africa will require an anaesthetic for the 
delivery of their babies.  Good anaesthetic management has the potential to 
improve patients’ birth experiences and decrease the risk of post-operative 
morbidity (Tan, 2012). 
 
In order to understand the training and educational needs of the anaesthetic 
profession with regards to obstetric anaesthesia practices, it is important to be 
aware of the current anaesthetic practices in the country.  This information will 
allow South Africa to benchmark its obstetric anaesthesia services against 
international standards and will also provide valuable information of training 
and educational needs of the country’s anaesthesiology professionals. 
 
In 1978 Buley et al (1978) published data on obstetric anaesthesia practises 
in South Africa and South West Africa (Namibia), but since then no 
comprehensive assessments of these practises have been undertaken in the 
region. Since that 1978 study there have been many changes and 
improvements in the practise of obstetric anaesthesia and analgesia.   
 
In chapter three, the results of interviews with South Africa academic 
anaesthesiology leaders, to determine the current training standard for 
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obstetric anaesthesia practice in South Africa, was presented. In this chapter, 
we explore what practitioners are doing in the field.  We conducted a national 
survey amongst doctors who work as anaesthesia service providers in the 
Republic of South Africa.  A detailed description of the survey methodology 
and results will be discussed in this chapter. 
 
4.2 Aim 
 
The aim of this study was to describe the post-operative pain management 
practises of doctors managing caesarean section patients in South Africa. 
 
4.3 Objectives 
 
The specific objective of this study was to determine what the preferences are 
amongst: 
I. Specialist anaesthesiologists working in the public and private sector 
with regards to anaesthesia for caesarean section relating to: 
a. Preferred method of anaesthesia  
b. Use of adjuvant drugs for neuraxial anaesthesia 
c. Post-operative monitoring practices 
d. Post-operative pain management 
 
II. Non-specialist medical practitioners (registrars, medical officers and 
general practitioners) who predominantly administer anaesthetics  in 
the public and private sector with regards to anaesthesia for caesarean 
section relating to: 
a. Preferred method of anaesthesia  
b. Use of adjuvant drugs for neuraxial anaesthesia 
c. Post-operative monitoring practices 
d. Post-operative pain management 
4.4 Demarcation of the study field 
 
The survey was conducted in the Republic of South Africa. 
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4.5  Ethical considerations 
 
• This study was conducted in accordance with the ethical principles of 
the Declaration of Helsinki (World Medical Association, 2013) and 
Good Clinical Practice (Department of Health, 2006). 
• The protocol was reviewed and approved by the Human Research 
Ethics Committee – Medical (HREC) of the University of the 
Witwatersrand - Approval number M140123  (APPENDIX H). 
 
4.6  Research Methodology 
4.6.1 Sample Size Calculation 
 
There are 1700 names on the membership database of the South African 
Society of Anaesthesiologists (SASA). The Health Professions Council of 
South Africa also has a register of specialist anaesthesiologists registered 
with the Council, however neither this list nor SASAs database represents all 
anaesthetic providers in South Africa because some registered specialists 
may no longer be practising in South Africa. In addition, there are a large 
number of non-specialist anaesthesiologists working as anaesthetic providers 
in South Africa. Assuming a total population of anaesthetic providers 
(specialist and non-specialist) of 2500 practising in South Africa, a 5% margin 
of error and a 95% confidence level, a minimum sample of 333 respondents 
was deemed a statistically representative sample of the population.   
 
4.6.2 Sample Method 
 
A consecutive convenience sampling method was used.  The convenience 
sampling method was chosen due to limited accessibility to the study 
population.  All eligible doctors (specialists and non-specialists) were 
approached either at anaesthesiology-community events, or electronically, 
using the database of the South African Society of Anaesthesiologists, and 
invited to participate in the survey. Participants were asked not to complete 
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the survey more than once.  All participants voluntarily completed the 
questionnaire. It is acknowledged that a convenience sample may not fully 
represent the study population (Hultsch et al., 2002) 
 
4.6.3 Methodology 
 
A modified version of the questionnaire used by Tagaloa et al (2009), in the 
United States, to address a similar aim was used in this study.  The 
questionnaire developed by Tagaloa et al (2009) can be seen in APPENDIX 
B.  The questionnaire was modified to take into account the local South 
African environment.  The changes made related to the following points: 
 
• Demographic details specific to South Africa (Questions 1, 2 and 3) 
• Practitioners exposure to anaesthesia and to obstetric anaesthesia 
(Questions 4 and 5) 
• Allowances were made for the respondents to not have a preference for or 
not know the type of spinal needle or the needle gauge used for spinal 
anaesthesia (Questions 9 and 11) 
• Drugs used for spinal anaesthesia were adjusted to include only drugs 
available in South Africa and also allowed for volume to be indicated 
(Questions 13, 14 and 15) 
• Drugs used for epidural anaesthesia were adjusted to include only drugs 
available in South Africa (Questions 20) 
• More details were asked on the use of epidural morphine (Question 21 
and 26) 
• Practitioners were given more alternatives regarding their choice of 
management of a labouring patient requiring a caesarean section 
(Question 22) 
• Monitoring of patients following neuraxial opioid administration (Question 
30) 
• Responsibility of care regarding analgesia following caesarean section 
(Questions 31 and 32) 
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• More options were added regarding the use of the epidural catheter for 
post-operative analgesia (Question 33) 
• The options for NSAIDs were adjusted to include more drugs available in 
South Africa (Question 39) 
• Route of administration of NSAIDs was included (Question 41) 
• Use of IV paracetamol was included (Question 42) 
• Oral analgesic options were adjusted to include drugs available in South 
Africa (Questions 43) 
• Patient satisfaction regarding post-operative analgesia (Question 44) 
The questions that were added to or modified from the Tagaloa et al (2009) 
questionnaire are listed in APPENDIX I. 
 
To ensure face validity of the questionnaire, the modified questionnaire was 
reviewed by 12 senior members of staff of the Department of Anaesthesiology 
at the University of the Witwatersrand. Feedback was used to refine the 
survey questionnaire further.  Following the validation process, changes were 
made to the punctuation of certain questions, and, in addition, two questions 
(Question 10 and Question 12) were added to the questionnaire in order to 
assess the impact shortages of consumables had on practices. 
 
The final questionnaire (APPENDIX J) was distributed to all eligible doctors in 
South Africa.  Distribution of the survey was done at selected anaesthetic-
community events, between March and December 2014, throughout the 
Republic of South Africa.  The survey was distributed in person, by the 
principal investigator (PI), so that any queries about the study, raised by the 
invited doctors, could be addressed.  In addition, an electronic version of the 
survey (using the Survey Monkey® platform) was distributed to the database 
of the South African Society of Anaesthesiologists.  The electronic survey was 
sent out in October 2014 and followed by two reminder e-mails (two weeks 
and four weeks after the original invitation to participate was sent out).  The 
survey was closed on the 31st December 2014.  The survey was completed 
anonymously.  In order to improve the response rate to the survey, 
participants were offered the opportunity to be entered into a lucky draw 
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competition to stand a chance to win a tablet computer.  The names of those 
participants who chose to enter the competition were separated from the 
survey answers before the data were analysed.      
 
4.6.4 Data Analysis 
 
We analysed the prospectively collected data from survey respondents.  Data 
from manually completed questionnaires were entered into a spreadsheet 
using Microsoft® EXCEL® for MAC (Version 14.6.2).  Data from the 
electronically completed survey were imported from the Survey Monkey® 
server into a Microsoft® EXCEL® spreadsheet.  Continuous parametric data 
were described using mean and standard deviation.  Continuous non-
parametric data were described using median and interquartile ranges.  
Categorical data were described using frequencies and percentages. Baseline 
characteristics of the study sample were summarized using simple 
proportions.  Data were analysed using StatPlus, AnalystSoft Inc. - statistical 
analysis program for Mac OS® (Version v6) and the statistical analysis 
program R (Version 3.2.3) (R Core Team, 2015). 
 
Comparisons were made between specialists and non-specialists in areas 
that may be impacted on by clinical insight and level of training (Questions: 8, 
9, 13, 14, 15, 22, 30 and 31). Comparisons were also made between 
practitioners in the public and private sectors, in areas where resources may 
have an impact on the ability to provide clinical services (Questions: 4, 5, 6, 7, 
9, 10, 13, 27, 28 and 29). 
 
 
 
 
 
 
 
 
 
 4.7 Results and Discussion
 
Nine hundred and seventy
Forty of these responses were excluded from analysis (Figure 4.1): 38 were 
incomplete questionnaires and two questionnaires were completed by doctors 
who were not practising in South Africa. 
 
FIGURE 4.1: Summary of survey responses
 
There were approximately 1700 doctors on the database of the SASA.  From 
my interactions with a large number of doctors while carrying out this survey, I 
determined that there are many doctors involved in the provision of 
anaesthesia who do not practice an
did not answer the survey, which may have contributed to the survey 
response rate being less than 60%.  The average response rate for surveys 
conducted by the Obstetric Anaesthetists Association between 1998 and 2012
was 65% (Robson et al
comparable.  Tagaloa 
electronic survey distributed amongst 1081 members of the Society for 
Obstetric Anesthesia and Perinatology.
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2 not practising 
in SA
 
-three survey questionnaires were completed.  
 
 
y obstetric anaesthesia.  These doctors 
., 2015).  The response rate of 57% in this survey is 
et al (2009) reported a 36% response rate to their 
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4.7.1  Demographics of the Respondents 
4.7.1.1 Geographical distribution 
 
There were responses from practitioners across all nine provinces in South 
Africa.  The largest proportion of respondents was from Gauteng province 
(53%), followed by the Western Cape (19%) and KwaZulu-Natal (17%).  
Responses from the other 6 provinces in the country were relatively small. 
The geographical distribution of the survey responses is listed in Table 4.1. 
 
Table 4.1: Geographical distribution of survey responses  
 
Province 
 
Number of 
Responses 
 
Percentage 
of total 
responses 
Percentage 
of the 
national 
population * 
Percentage of 
national gross 
domestic 
product $ 
Gauteng 493 52.8 23.7 34.5 
Western Cape 179 19.2 11.3 14.2 
KwaZulu Natal 155 16.6 19.8 15.7 
Free State 35 3.7 5.3 5.3 
Eastern Cape 26 2.8 12.7 7.5 
North West 23 2.5 6.8 6.5 
Mpumulanga 12 1.3 7.8 7.0 
Limpopo 7 0.8 10.4 7.1 
Northern Cape 3 0.3 2.2 2.2 
Total 933 100 100 100 
*
 (Lehohla, 2011) $ (Bouwer, 2011) 
 
This geographical distribution of the respondents is not surprising considering 
that Gauteng, KwaZulu-Natal and the Western Cape are the most populated 
provinces in South Africa (Lehohla, 2011) and are home to six of South 
Africa’s eight academic anaesthesiology departments.  Gauteng province has 
three medical schools and is considered the economic hub of the country, 
contributing 35% to the national economy in 2011 (Bouwer, 2011).  The 
distribution of anaesthetic service providers across the provinces in South 
 Africa does not however match the general population distribution across the 
country.  The membership distribution of the SASA across the provinces of 
SA is as follows:  Gauteng 
15.4%, Free State- 5.7%, E
Mpumulanga – 1.2%, Limpopo 
(SASA, 2016).  The geographical distribution of the survey responses is 
similar to the geopgraphical 
across South Africa. 
 
4.7.1.2 Anaesthesiology qualifications
 
Five-hundred-and-forty (57.9%) specialist anaesthesiologists and 393 (42.1%) 
non-specialists answered the survey.  Of the non
diploma in anaesthetics, while 90 only had a basic
degree.  (Figure 4.2)  
 
FIGURE 4.2: Qualifications of survey respondents
 
Many doctors who do not have any experience in anaesthesiology will join 
anaesthesiology departments in the public sector hospitals to be trained.  The 
minimum requirement for these jobs is an undergraduate medical degree.  
During their training, these doctors are able to write the exam for the Diploma 
540
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in Anaesthetics.  Diplomates have completed at least 6 months of 
anaesthesia training in an accredited centre, and have passed the diploma 
exam from the College of Anaesthetists of South Africa. In comparison, 
specialist anaesthesiologists have completed four years of registrar training in 
an academic institution and passed the fellowship exam of the College of 
Anaesthetists of South Africa.   
 
The Practice Guidelines of the South African Society of Anaesthesiologists 
(SASA) (Bettings et al., 2013) states that no doctor should administer an 
anaesthetic unsupervised without having passed the exam for the Diploma in 
Anaesthetics.  These guidelines permit the administration of anaesthesia to 
patients by non-specialist doctors based on the clinical risk profile of the 
patient.  This risk profile is determined by the American Society of 
Anaesthesiology (ASA) physical status classification system (Appendix K). 
Diplomates are only permitted to provide an unsupervised anaesthetic for 
ASA1 and ASA2 patients.  They may administer an anaesthetic for an ASA3 
patient under the supervision of a specialist.  The diplomate should not treat 
ASA 4 and ASA 5 patients for elective procedures.  There is no limitation on 
the provision of anaesthetic care to the obstetric patient provided that the ASA 
physical status of the patient is ASA 3 or less. 
 
4.7.1.3 Main area of work 
 
South Africa has a dual health care system.  The private sector caters mainly 
to the middle and upper classes.  Patients who access the private health 
sector services are generally employed and are members of private medical 
aid schemes (CMS, 2015).  There is a small percentage of the patients who 
are privately funded.  The private healthcare system functions on a fee-for-
service model, with healthcare providers invoicing the patients or funders for 
the cost of the service that is rendered.    The private health system has a 
health budget equivalent to about 4.3% of gross domestic product (GDP) and 
covers about 16% of the population (HST, 2015, Benatar, 2013).  
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The public health system is funded by the government and is responsible for 
the health care of about 84% of the population, delivered on a budget 
equivalent to about 4% of the GDP (Benatar, 2013, Blecher et al., 2011). The 
public health system caters mainly for the lower income classes and the 
indigent.  Each provincial department of health manages the public health 
services within the provinces.  The public health services are divided into 
district, regional, tertiary, central and specialist services.  Anaesthesiology 
services are available at all tiers of care in the hospital environment (except in 
dedicated psychiatric hospitals).  Caesarean sections can be performed at all 
hospitals where obstetric services are offered. 
All specialist training is done within the public health care system.  However, 
most specialists move into the private sector after qualifying (about 77% of 
specialist members of SASA are in full time private practice).  This may be 
due to the higher remuneration structure for doctors in the private sector and 
the perception of better working conditions and easier access to better drugs 
and equipment. 
 
There was an equitable distribution of respondents to this survey between the 
public and private heath care systems.  Four-hundred-and-sixty-five (49.8%) 
respondents were from the private sector, and 468 (50.2%) from the public 
sector.  The majority of all respondents from the private sector had specialist 
qualifications (83%), but there was a variation between each of the provinces.  
The highest number of private sector non-specialists was in Gauteng (56/232, 
24%).  There were no private sector non-specialist respondents from the Free 
State, Mpumalanga or the Northern Cape provinces. (Figure 4.3) 
 
 FIGURE 4.3: Provincial distribution
the private sector cohort
 
Nationally there were 79 private sector non
survey.  Of these, 19 (24%) only had a basic undergraduate medical degree.  
Based on the recommendations of t
al., 2013), these individuals should not be providing unsupervised 
anaesthesia to patients, yet they are working unsupervised in the private 
sector. 
 
Of the 468 public sector doctors who responded to the survey, 148
were specialists, 191/468(41%) were registrars, 58/468 (12%) were medical 
officers with more than 5 years of experience in anaesthesia, and 
71/468(15%) were junior medical officers. (Figure
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FIGURE 4.4: Distribution of specialists and non-specialists in the public 
sector cohort 
 
The majority of all respondents from the public sector were non-specialist 
doctors except from Limpopo and the Northern Cape provinces.  However this 
discrepancy is most likely due to the low number of respondents from these 
provinces. (Figure 4.5) 
 
 
FIGURE 4.5: Provincial distribution of specialists and non-specialists in 
the public sector cohort 
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Table 4.2 provides a breakdown of the respondents from each province, 
based on their qualification and their primary area of employment. 
 
TABLE 4.2: Summary of the respondents based on province, sector of 
employment and qualifications 
 
 
4.7.1.4 Work Load 
 
The workload of anaesthetic providers varied depending on the level of 
seniority of the doctor, and the sector in which they were primarily employed. 
 
The number of anaesthetics that respondents to this survey were involved 
with on average each month is summarized in Figure 4.6.  The median 
number of cases performed by private sector doctors was 100 while the 
median number of cases performed by public sector doctors per month was 
80.  The Wilcoxon-Mann-Whitney-U statistical analysis of this data indicates 
that there is a statistical difference between the medians of the two groups 
(p<0.001) indicating that practitioners in private practice perform statistically 
more anaesthetics per month than their public sector colleagues. 
Specialists Non-specialists Specialists Non-specialists
Eastern Cape 15 4 2 5
Free State 14 0 8 13
Gauteng 176 56 65 196
KZN 46 6 40 63
Limpopo 3 1 2 1
Mpumalanga 6 0 0 6
Northern Cape 2 0 1 0
North West 9 4 2 8
Western Cape 115 8 26 30
TOTALS 386 79 146 322
Public SectorPrivate Sector
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FIGURE 4.6: Summary of the average number of anaesthetics performed 
per month  
 
These results have been plotted as a histogram below showing the spread of 
the responses (Figures 4.7) 
 
FIGURE 4.7: Histogram of the total number of anaesthetics performed by 
private sector and public sector doctors in one month 
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The caesarean section rate in SA is high (Moodley, 2010), however obstetric 
anaesthesia only forms a portion of the caseload that any one doctor will be 
exposed to.  In this survey, the doctors were asked to state approximately 
how many caesarean section anaesthetics they administered each month.  
The median number of caesarean section anaesthetics performed by private 
sector doctors was 10.  In the public sector, the median number of caesarean 
section anaesthetics was 15 (Figure 4.8).  Wilcoxon-Mann-Whitney-U 
statistical analysis of this data indicates that there is a statistical difference 
between the medians of the two groups (p<0.001), such that the public sector 
practitioners are doing more caesarean section anaesthetics than the doctors 
in the private sector.  
 
The very high number of caesarean section anaesthetics that is being 
performed by some practitioners in the public sector is anomalous when 
compared to the responses of the majority of the respondents.  However, 
individual practices differ and there are some public sector hospitals where 
there is a high rate of caesarean sections, which may lead to anaesthetic 
service providers performing a very high number of caesarean section 
anaesthetics. 
 
Despite doctors in the private sector performing more anaesthetics, on 
average, per month than their public sector counterparts, they are doing 
significantly fewer caesarean section anaesthetics than doctors in the public 
sector.   
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FIGURE 4.8: Average number of caesarean section anaesthetics 
administered per month 
 
These results have been plotted as a histogram below showing the spread of 
the responses (Figures 4.9) 
 
 
FIGURE 4.9: Histogram of the total number of caesarean section 
anaesthetics performed by private sector and public sector doctors in 
one month 
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The majority of respondents in both the public and private sector are involved 
in obstetric anaesthetics during office-hours and after-hours.  There is a small 
percentage of people who either only perform anaesthetics for caesarean 
sections during the day, or on call.  A few respondents indicated that they only 
perform anaesthetics for caesarean sections for dire emergencies or in a 
supervisory capacity (in the public sector).  These results are summarized in 
Table 4.3 below: 
 
TABLE 4.3: Degree of involvement with obstetric anaesthesia by both 
health care sector doctors 
 
  
Daytime 
Only 
On Call 
Only 
Daytime 
and On Call 
Other p-value 
Public Sector 49 56 350 13 
 
p < 0.01 
Private Sector 51 104 279 31 
 
Chi square analysis of these results shows that there is a statistically 
significant difference in the work exposure of doctors in the private and public 
sectors with regards to performing anaesthetics for caesarean sections 
(p<0.01), such that doctors in the public sector have a statistically greater 
exposure to caesarean section anaesthetics than their private sector 
colleagues.  The greater involvement of doctors with both daytime and on-call 
duties is similar to international data (Tagaloa et al., 2009). 
 
Obstetric anaesthesia caseload is dependent on the frequency with which a 
doctor works in the obstetric anaesthesia environment.  In this survey, 
406/933(44%) of the respondents were involved with obstetric anaesthesia <1 
day per week.  388/933(42%) perform obstetric anaesthetics 1-2 days/week, 
while only 139/933(14%) do obstetric cases >2 days/week.  There was a 
higher percentage of doctors in the public sector who work in obstetric 
anaesthesia for 1-2 days per week. (Figure 4.10) 
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FIGURE 4.10: Clinical involvement in obstetric anaesthesia 
 
There was a higher percentage of respondents in the 2009 survey of SOAP 
members in the United States of America (USA) who worked in obstetric 
anaesthesia >2 days per week (43%) compared to the respondents in this 
survey (14%) for the same clinical exposure period (Tagaloa et al., 2009).  
However, the SOAP membership is predominantly made up of 
anaesthesiologists who have an interest in obstetric anaesthesia, which may 
explain the greater exposure to obstetric anaesthesia each week.  This South 
African survey was conducted amongst all doctors involved with all 
anaesthetic services in South Africa.  From these data, the general 
anaesthetic service provider in South Africa, spends a small proportion of time 
providing obstetric anaesthesia. 
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 4.7.2  Intraoperative anaesthetic management
4.7.2.1 Preferred anaesthetic technique
 
Anaesthesia for caesarean section can be performed using a general 
anaesthetic or regional anaesthetic technique.  The choice of technique is 
dependent on the individual patient’s clinical condition and preference, the 
skill of the anaesthetic service prov
consumables needed to provide each type of anaesthetic.  The risks 
associated with general anaesthesia in the pregnant patient has steered 
provider preferences toward regional neuraxial anesthetic techniques for 
patient group (Tan, 2012)
majority of respondents (97.8%) preferred to use a single shot spinal 
anaesthetic technique for caesarean section anaesthesia
number of respondents chose other ana
techniques of choice (Figure 4.11
 
FIGURE 4.11: Preferred technique
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An analysis of the responses of specialists and non-specialists in the cohort 
reveals that there is no statistical difference in the preference for spinal 
anaesthetics between the two groups (Table 4.4). 
 
TABLE 4.4: Doctors’ choices for caesarean section anaesthetic 
technique 
 
 Single Shot Spinal Other Techniques p-value 
SPECIALISTS 524 16  
p = 0.08 NON-SPECIALISTS 388 5 
 
The high use of a single shot spinal anaesthetic technique is similar to the use 
of this technique reported in Germany (91.4%) (Stamer et al., 2005).  Tagaloa 
et al (2009) reported a preference for single shot spinal anaesthetics in 85% 
of respondents from a study in the USA.  The use of the combined-spinal-
epidural (CSE) and epidural techniques were reported as 11% and 4% 
respectively in the American survey (Tagaloa et al., 2009).  This is similar to 
our results.  Data from a Malaysian survey of anaesthetic practise indicates 
that regional anaesthesia is performed in only 41.9% of caesarean section 
cases. Of these, the majority is performed as spinal anaesthetics (84.6%) 
(Chan and Ng, 2000).   
 
General anaesthesia did not feature at all in the anaesthetic preferences in 
the Tagaloa et al (2009) study. In our study, 7/933 (0.8%) of the respondents 
(6/465 private sector doctors and 1/468 public sector doctors) preferred to 
perform a general anaesthetic for caesarean sections.  This was a decrease 
from the 90% prevalence of general anaesthesia being performed for 
caesarean sections in a previous South African survey (Buley et al., 1978).  
Despite the developments in anaesthesiology that make obstetric spinal 
anaesthesia safer, more cost effective and technically easier, general 
anaesthesia continues to be practiced around the world, especially in 
developing countries.  In West Africa, general anaesthesia is the predominant 
anaesthetic technique used for caesarean sections (Okafor, 2006).  This 
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practise is however not isolated to developing countries.  Van Houwe et al 
(2006) reported that one hospital, in their 2004 survey in Belgium, performed 
general anaesthesia in 34% of caesarean sections.  General anaesthesia was 
however only used in 5% of cases when all hospitals were included in the 
results in this survey (Van Houwe et al., 2006).  The increased risk associated 
with general anaesthesia in the obstetric patient behooves us to ensure that 
we move away from this form of anaesthesia in this patient population, unless 
there is an appropriate contraindication to performing a regional anaesthetic 
technique. However, some experts argue that it is important that practitioners 
remain clinically adept at performing general anaesthetics in the obstetric 
patient population so that this skill can be used when the need arises during 
an unexpected emergency situation (Dyer, 2011). 
 
4.7.2.2 Preference of Spinal Needles 
 
The design and gauge of a spinal anaesthetic needle has an effect on the 
risks of complications associated with spinal anaesthesia.  Larger gauge 
needles and needles with a cutting tip (such as the Quincke© needle) 
increase the risk of cerebrospinal fluid (CSF) leakage from the spinal canal, 
and resultant development of post-dural puncture headache (PDPH). 
(O'Connor et al., 2007) 
 
The Wittacre© spinal anaesthetic needle was the most popular needle for 
administering a spinal anaesthetic (299/933, 32%) in our survey.  The next 
most popular choice was the Quincke© needle (282/933, 30%).  Figure 4.12 is 
a graphical representation of the preferred choices of spinal needles for doing 
a spinal anaesthetic for the obstetric patient  
 
 
 
 
 FIGURE 4.12: Preferred spinal needle choices for pe
anaesthetic for caesarean section anae
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 64 non-specialists and 68 specialists (Figure 4.13).  Chi
revealed that there was no statistical difference in the
these two categories of doctors (p=0.11).
 
FIGURE 4.13: Doctors who have no spinal needle preference
 
When the responses with regards to the spinal needle preference are 
categorized according to the employment sector of the 
that 70/468(15%) of public sector doctors have no needle preference or don’t 
know what needle they prefer as opposed to 62/465 (13%) of private sector 
doctors.  (Figure 4.14) 
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Seventy-eight of the 398 public sector doctors (19.5%) who had a needle 
preference for administering a spinal anaesthetic reported that their preferred 
needle was not available, compared to 26 of the 403 private sector doctors 
(6%) with a needle preference.  The difference between the two sectors was 
statistically significant (p<0.01).  This difference hints at greater restrictions on 
the selection of needles available in the public sector compared to the private 
sector, but unfortunately we did not probe the reason for a preferred needle 
being available.  The implication of these data is that there is reduced 
freedom of choice to doctors in the public sector vs. the private sector with 
regards to the spinal anaesthetic needle that the doctor would prefer to use.  
This is not surprising considering that the private sector has greater levels of 
funding and access to consumables than the public sector (Benatar, 2013). 
 
The gauge of the spinal needle used is also an important factor to consider 
when administering a spinal anaesthetic.  Large gauge needles (22G) are 
known to increase the risk of PDPH.  Current literature recommends that 
smaller gauged needles should be used to perform a spinal anaesthetic as 
this reduces the risk of complications (O'Connor et al., 2007).  In our study, 
460/933(49%) of the respondents preferred to use a 26G spinal needle to 
perform a spinal anaesthetic for a caesarean section. There were 294/933 
(31.5%) of the respondents who preferred the 25G needles.  Only 28/933(3%) 
of doctors preferred to use the 22G needle, which is known to increase the 
risks of PDPH (O'Connor et al., 2007). (Figure 4.15) 
 
 FIGURE 4.15: Gauge preference of spinal anaesthetic needles
 
4.7.2.3 Drugs used for spinal a
 
There are a number of different local ana
spinal anaesthesia.  The physiochemical properties of the drug, including the 
baricity and concentration, influence the quality of the anaesthetic block 
(Kleinman, 2002). 
 
There were 886/933 (95%) respondents who prefer
bupivacaine with dextrose as the local anaesthetic for obstetric spinal 
anaesthesia.  This is a hyperbaric local anaesthetic solution that spreads in a 
cephalad direction towards the normal thoracic kyphosis when the patient lies 
supine (Kleinman, 2002)
in a higher block level.   Tagaloa et el (2009) reported that 90% of 
respondents in their survey in the USA preferred using hyperbaric 
bupivacaine, however the concentration preferred in t
In South Africa, 0.75% bupivacaine is not available for clinical use.
 
There was a similar distribution in the use of hyperbaric bupivacaine between 
the specialist and non-specialist doctors (Figure 4.16), as well as between the 
public and private healthcare sectors 
naesthesia 
esthetic agents that can be used for 
red to use 0.5% 
.  This upward spread of the local anaesthetic results 
heir study was 0.75%.  
(Figure 4.17).  
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 FIGURE 4.16: Distribution between specialists and non
amongst doctors who prefer to use 0.5% bupivacaine with dextrose for 
spinal anaesthetics 
 
FIGURE 4.17: Distribution between 
who prefer to use 0.5% bupivacaine with dextrose for spinal 
anaesthetics 
 
Bupivacaine is an amide local anaesthetic.  The 0.5% concentration solution 
contains 5mg/ml of local anaesthetic.  Its duration of action, following spinal 
administration, is up to 150 minutes 
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Figure 4.18: Preferences of private and public sector doctors who 
not to use 0.5% bupivacaine with dextrose for spinal anaesthetics
 
The median volume of local anaesthetic used by the 886/933 doctors who 
prefer to use 0.5% bupivacaine with dextrose was 2.00ml (10 mg).  Van 
Houwe et al (2006) reported that the aver
used in their study, conducted in Belgium, was 9mg (1.8ml of the 0.5% 
solution); lower than the median dose reported here.
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TABLE 4.5: Volume of 0.5% bupivacaine used in spinal anaesthetics 
 SPECIALISTS NON-SPECIALISTS 
NUMBER 509 377 
MAX (ml) 4 5 
MIN (ml) 1.44 1.25 
MEDIAN (ml) 2.00 1.80 
 
In spinal anaesthesia, the volume of local anaesthetic administered is a 
significant factor affecting the extent of the spread of the anaesthetic and 
therefore the level of the block (King and Wooten, 1995).  Pregnant patients 
have a higher intra-abdominal pressure and this exerts an effect on the spinal 
canal, effectively reducing the volume of the spinal canal (Hirabayashi et al., 
1996).  These patients therefore require a lower volume of intrathecal local 
anaesthetic to achieve the same block level as a non-pregnant patient.  A 
higher block level increases the risks associated with spinal anaesthesia such 
as hypotension, nausea and cardiac arrest.  However, using a higher volume 
of local anaesthetic decreases the risk of a failed spinal anaesthetic (Axelsson 
et al., 1982).  One possible explanation for the higher volume used by the 
specialists is that these doctors are better trained to deal with the side effects 
of a high spinal block, and they may be more inclined to ensure their spinal 
anaesthetic is successful (so as to avoid general anesthesia for these 
patients) rather than fearful of the effects of a higher block. 
 
The addition of additive agents to an intrathecal local anaesthetic mix is used 
to potentiate the effect of the local anaesthetic in the spinal canal, or to offer 
additional benefits via stimulation of central receptors in the spinal cord 
(McDonnell et al, 2009).  There are a number of drugs that can be used for 
this purpose.  These include agents such as opioids, neostigmine and 
clonidine.   
 
In our survey, the doctors were asked what agents they routinely add to their 
intrathecal local anaesthetic mix for caesarean sections.  They could choose 
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multiple drugs from the list provided.  Table 4.6 summarizes the responses to 
this question. 
 
TABLE 4.6: Preferences of specialists and non-specialist doctors for 
intrathecal additives 
 Specialists Non-specialists Total p-value 
Fentanyl 342 312 654 p<0.001 
Morphine 24 8 32 p=0.067 
Sufentanil 88 33 121 p<0.01 
No Drugs Routinely 
Added 
96 44 140 p<0.01 
Other 3 2 5  
 
Fentanyl is the most commonly used additive agent for spinal anaesthesia for 
caesarean sections, accounting for 80% of additives used (Table 4.6). 
Although the use of fentanyl was high in both specialists (61%) and non-
specialists (78%), fentanyl use was marginally (but significantly) greater 
amongst non-specialists (Fisher’s Exact, p<0.001).  Tagaloa et al (2009) 
described that 54% of respondents in their study used a combination of 
fentanyl and morphine. 
 
The average dose of intrathecal fentanyl used by specialists was 15.12 µg 
and by non-specialists is 13.77 µg (Students t-test, p=0.04) (Table 4.7). 
 
TABLE 4.7: Doses of intrathecal fentanyl used by specialists and non-
specialists 
 SPECIALISTS 
(n = 340)* 
NON-SPECIALISTS 
(n = 308)* 
MAXIMUM (µg) 100 100 
MINIMUM (µg) 5 2 
MEAN (µg) 15.12 13.77 
SD 7.75 8.66 
*2 specialists and 4 non-specialists did not stipulate the dose of fentanyl used and were excluded from this 
calculation 
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The minimum dose of fentanyl used by the non-specialist group was 2 µg and 
5 µg by the specialist group.  These are extremely low doses of fentanyl and 
will probably have no analgesic effect on the patient.  The minimal effective 
dose of intrathecal fentanyl has been documented to be 6.25 µg (Hunt et al., 
1989). 
 
Sufentanil is a synthetic lipophilic opioid analgesic that is very similar to 
fentanyl (Fukuda, 2005).  In this survey, sufentanil was reported to be used by 
121 doctors as an intrathecal additive drug.  There was a statistically higher 
ratio of sufentanil users and non-users between the specialist and non-
specialist groups of doctors (Fishers exact test, p<0.01) (Table 4.6).  
 
Morphine was used by a very small number of the respondents in this survey.  
Only 24 specialists and 8 non-specialists added morphine to their intrathecal 
spinal anaesthetic mix.  A statistical comparison of this data, using the Fishers 
Exact test, indicated that there was no statistical difference in the ratio of 
intrathecal morphine users and non-users between specialists and non-
specialists (p=0.067) (Table 4.6). Tagaloa et al (2009) reported that 79% of 
respondents in their survey used morphine as an additive agent for spinal 
anaesthesia.  The high use of morphine in their study is most likely related to 
the well-documented superior analgesic effect of intrathecal morphine for 
post-operative caesarean section patients (Palmer et al., 1999, Girgin et al., 
2008, Carvalho and Tenório, 2013).  In contrast, a similar survey conducted in 
Israel (Orbach-Zinger et al., 2014), reported that 72% of obstetric anaesthesia 
units never used intrathecal morphine for caesarean sections, while only 12% 
of units reported routine use of intrathecal morphine.  The main reason cited 
for not using intrathecal morphine in these units was the lack of nursing staff 
to monitor patients for respiratory depression.  In South Africa, the low use of 
intrathecal morphine for caesarean sections is most probably due to the 
teaching in the academic institutions that this drug is not safe to use in the 
South African setting, as discussed in chapter three.  However, concerns 
about nursing care may also have been a consideration of the practitioners 
influencing their choice of intrathecal opioid. 
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One hundred and forty people did not add any additive drug routinely to their 
spinal anaesthetic mix for caesarean sections.  There were a statistically 
greater number of specialists who do not use intrathecal additives compared 
to non-specialists (Fishers Exact Test, p<0.01) (Table 4.6). 
 
4.7.2.4 Management of anaesthesia for non-elective caesarean sections 
 
In a labouring woman with an in situ epidural catheter, who requires an urgent 
caesarean section, 662/933 (71%) respondents chose to “top-up” the epidural 
in order to proceed with surgery.  Only 48/933 (5%) people would proceed 
with an emergency general anaesthetic for these patients.  209/933 (22%) 
respondents indicated that they would remove the epidural catheter and 
perform a spinal anaesthetic.  Table 4.8 summaries the responses of the 
survey respondents regarding the choice of anaesthetic in a laboring woman 
requiring a caesarean section. 
 
TABLE 4.8: Choice of anaesthetic in a labouring woman requiring a 
caesarean section  
 TOTAL SPECIALISTS NON-SPECIALISTS p-value 
Top-Up 
Epidural 
662 416 246 p<0.01 
Spinal 
Anaesthetic 
209 102 107 p<0.01 
General 
Anaesthetic 
48 17 31 p<0.01 
Other 14 5 9 p=0.106 
 
A Fishers Exact test of the differences between specialists and non-
specialists for each of the four anaesthetic options reveals that there is a 
statistical difference in the ratios of users and non-users for top-up epidurals 
(specialists > non-specialists, p<0.01), spinal anaesthetics (non-specialists> 
specialists, p<0.01) and general anaesthesia (non-specialists > specialists, 
p<0.01).   
  
Of the 662 people who chose “topping up” the epidural as their choice of 
anaesthetic for this type of patient, 314(47%
221(33%) would choose 2% lignocaine, 111(17%) would use 0.75% 
ropivacaine and 3(0.45%) would choose 0.5% levobupivacaine (Figure 4.19
 
FIGURE 4.19: Choice of local anaesthetic
 
Similar results were reported by Regan 
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lignocaine.  This is markedly higher than the 33% preference for 2
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 was the most common drug used (281/662, 42%).  Fentanyl was also the 
most commonly used add
Adrenalin and sodium bicarbonate (NaHCO3) are the next two most common 
agents used in our survey respondents.  Only 4/662 (0.6%) people used 
morphine routinely as an additive agent into the epidural mi
 
FIGURE 4.20: Use of additive agents for epidural 
 
4.7.3 Post-operative monitoring practices
 
All patients who have an anaesthetic need to be monitored for a requisite 
period of time after their anaesthetic 
are given intrathecal opioids, the duration of observation may be increased in 
order to detect any delayed effects of the intrathecal opioids.  This duration of 
observation will depend on the intrathecal opioid that is used.
 
In this survey, there were 389/933 (42%) individuals who practiced in 
hospitals that have a protocol for monitoring patients who had received 
neuraxial opioids. These were divided into 216/389 (56%) from the private 
sector and 173/389 (44%) from the public sect
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300
 (46%) people worked in the private sector and 295/544 (54%) worked in the 
public sector.  A similar survey question in the USA revealed that 93% of 
respondents worked in an institution that had a protocol for monitoring 
patients (Tagaloa et al
doctors regarding their hospitals’ post
 
FIGURE 4.21: Availability of post
hospitals 
 
Using the Fishers Exact statistical test we compared the use of a monitoring 
protocol for patients receiving intrathecal opioids between public sector and 
private sector hospitals and found that 
ratio of the use-of to no
such that protocols are more often used in the private sector compared to the 
public sector. 
 
The 389 doctors who follow a post
how many hours patients are monitored for signs of respiratory depression 
after neuraxial opioid administration.  Their responses are graphically 
illustrated in Figure 4.22
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FIGURE 4.22: Duration of monitoring of patients following neuraxial 
opioid administration 
 
The ASA task force on neuraxial opioids recommended that monitoring should 
be continued for up to two hours in patients who are treated with intrathecal 
fentanyl and for up to 24 hours in patients who have received intrathecal 
morphine (Horlocker et al., 2009).  In our study, we did not determine if the 
type of neuraxial opioid used influenced the monitoring practice.  However, as 
95% of doctors who use intrathecal additives, are using lipophilic opioids it is 
likely that these monitoring practices are associated with the use of lipophilic 
opioids in the majority of responses. 
 
Respondents were asked to indicate all the monitoring modalities used to 
monitor these patients.  Each respondent could choose multiple options.  The 
results are listed in Table 4.9. 
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TABLE 4.9: Choice of monitoring modalities used to assess patients for 
respiratory depression 
 
Monitoring 
Modality 
Total number 
of responses 
Private 
Sector 
Public 
Sector 
p value 
Respiratory rate 320 181 139 p = 0.424 
Sedation score 167 102 65 p = 0.064 
Pulse oximetry 263 136 127 p < 0.05 
Other 5 3 2 p = 1 
 
The most commonly used modality for monitoring patients for respiratory 
depression is respiratory rate monitoring.  Pulse oximetry is used statistically 
more in the public sector than in the private sector (Fishers Exact test, 
p<0.05).  There was no statistical difference in the use of the other monitoring 
modalities between the public and private sectors.  Measurements indicated 
in the “Other” category include blood pressure monitoring (n=1), 
electrocardiogram (ECG) (n=1) and return of mobility (n=1).  There is currently 
insufficient evidence in the literature to support any recommendation of which 
monitoring modalities should be used (Horlocker et al., 2009). 
 
The 544 respondents, who indicated that their hospitals do not have a post-
operative monitoring protocol in place, were asked if they think it is necessary 
to monitor patients for respiratory depression after neuraxial opioid 
administration. The majority (504/543*, 92.8%) responded that this is 
necessary. (Table 4.10) 
 
 
 
 
 
 
* One person did not answer this question 
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TABLE 4.10: Responses of specialists and non-specialists regarding the 
need for post-operative monitoring following intrathecal opioid 
administration  
 
 SPECIALISTS NON-SPECIALISTS p-value 
YES 274 230 
p = 0.409 
NO 24 15 
 
These responses were analysed according to level of qualification to 
determine if there was a difference in the opinions of the more highly trained 
specialists compared to the non-specialists.  There was no statistical 
difference in the responses between specialists and non-specialists to this 
question (p=0.409). 
 
4.7.4 Post-operative pain control 
 
When asked who should be responsible for the management of the patient’s 
post-operative analgesia, the majority of respondents (587/933, 62.9%) felt 
that the anaesthesiologist should be the only health care professional 
responsible for this aspect of care.  Only 39/933(4.1%) doctors felt that the 
post-operative pain should be managed using a team approach involving the 
obstetrician, anaesthesiologist and the nurse.  186/933(19.9%) of the 
respondents were of the opinion that the obstetrician should be the only 
person responsible for the patient’s post-operative pain control.   The 
responses to this question are tabulated in Table 4.11. 
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TABLE 4.11: Choices of respondents regarding who should be 
responsible for the management of patients’ post-operative pain control 
 
Professional who should be responsible Number of responses 
Anaesthesiologist + Obstetrician + Nurse 39 (4.2%) 
Anaesthesiologist + Obstetrician  76 (8.2%) 
Anaesthesiologist + Nurse 6 (0.6%) 
Obstetrician + Nurse 1 (0.1%) 
Anaesthesiologist  587 (63%) 
Obstetrician  186 (20%) 
Nurse 34 (3.6%) 
No one 3 (0.3%) 
 
As a generally accepted principle of pain management, a team approach to 
address a patient’s pain is always better than one individual being solely 
responsible (Ballantyne, 2012).  The team approach allows for different 
aspects of the patient’s pain to be taken into consideration and also facilitates 
discussion between the members of the team, which can prevent important 
aspects of management being overlooked.  It is unfortunate that there were 
three respondents in this survey (one specialist and two non-specialists – both 
of whom do not have a diploma in anaesthesia) who felt that no one should be 
responsible for the patient’s post-operative pain management.  
 
While a team approach to the management of the patients’ post-operative 
pain control is ideal, the elucidated actual state of practice in South Africa was 
that the anaesthesiologist is the professional responsible for the patient’s 
analgesia in 62% of cases.   
 
The responses are illustrated in Figure 4.23. 
 
 
 
 
 FIGURE 4.23: Professionals who are 
control 
 
The majority of the survey respondents (853/933, 91%) did not routinely use 
an epidural catheter for post
section patient.  80/933 (9%) indicated that they use a labour epi
catheter for post-op analgesia.  This is similar to the published practise in 
Israel, where only 8% of obstetric anaesthesia units use the labour epidural 
catheter post-operative
Zinger et al., 2014).  None of the respondents in our study indicated that they 
would insert an epidural catheter for post
not have one pre-operatively. (
FIGURE 4.24: Use of epidural catheter for post
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Only 164/933 (17%) of people in this survey would routinely use a patient 
controlled analgesic pump (PCA) to manage post-operative pain for the 
caesarean section patient.  When this pain control technique is utilized, the 
most popular medication used in the PCA is morphine (110/164).  Other drugs 
used are: pethidine (mepiridine) (49/164, 40 specialists and 9 non-specialists) 
and fentanyl (3/164, 3 specialists).  Tagaloa et al (2009) reported that 12% of 
respondents in their survey would routinely use a PCA pump for post-
operative analgesia.  In Israel, where the routine use of intrathecal morphine 
is low (similar to our findings in South Africa), the routine use of PCA pumps 
for post-operative analgesia is 4% (Orbach-Zinger et al., 2014), which is much 
lower than the findings in our study.  The low preference of PCA pumps for 
post-operative analgesia in South Africa may be related to the relative 
limitation of movement that this form of analgesia may cause for the patient.  
This is related to the fact the patient will have an intravenous line connected 
to a stand that may hinder movement.  Figure 4.25 illustrates the choice of 
respondents for PCA use, as well as the preference of drugs used in the 
PCA’s. 
 
 
FIGURE 4.25: Preference of use of PCA pumps and drugs used in these 
pumps 
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Seventy five percent of the respondents in this survey routinely prescribed 
NSAIDs for post-operative analgesia after caesarean section (Figure 4.26).  
These results are similar to results published by Tagaloa et al (2009) from the 
USA, where 81% of respondents in their survey reported using NSAIDs for 
post-operative analgesia.  Orbach-Zinger et al (2014) reported that only 
54.5% of obstetric anaesthesia units in Israel use NSAIDs post-operatively as 
part of an analgesic regimen. The most commonly used NSAID in our study 
was diclofenac (445/933).  Indomethacin (146/933) and parecoxib (75/933) 
were also popular choices of NSAID’s.  The rectal administration route was 
preferred by 49.1% of the respondents.  Rectal administration of NSAIDs has 
a proven opioid sparing effect following caesarean section surgery (Dahl et 
al., 2002) 
 
 
FIGURE 4.26: NSAIDs use after caesarean section surgery and preferred 
route of administration 
 
Intravenous (IV) paracetamol is categorized as a schedule 3 drug in SA 
(Division of Clinical Pharmacology, 2012) and is available for use in hospitals.  
The drug is known to have an opioid sparing effect (Remy et al., 2005) and 
has also been shown to have superior analgesic effects compared to 
intravenous pethidine in the post-operative period (Inal et al., 2006).  In this 
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study, 64% of respondents reported routinely prescribing intravenous 
paracetamol after caesarean section surgery. (Figure 4.27) 
 
 
FIGURE 4.27: IV paracetamol use after caesarean section surgery 
 
Paracetamol was the most popular oral analgesic used for post-operative pain 
management.  It was prescribed by 501(54%) respondents in this survey as 
part of their patients’ analgesic regime.  This is similar to the results reported 
by Tagaloa et al (2009).  Forty-five percent of respondents in their survey 
used oral paracetamol for post-operative pain relief (Tagaloa et al., 2009).  
Tramadol, despite not being registered in SA for use in breastfeeding 
mothers, is a very popular drug (prescribed by 369 respondents (40%) in our 
survey). 
 
4.7.5 Patient satisfaction 
 
Based on their current obstetric anaesthesia practise, 76% of the respondents 
to this survey are of the opinion that their patients are satisfied with their post-
operative analgesia.  This is the perception of the anaesthetic service provider 
and not the actual level of satisfaction of their patients.  These results are 
illustrated in Figure 4.28. 
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FIGURE 4.28: Practitioners
their post-operative analgesia 
 
4.8 Study Limitations  
 
There was a risk of selection bias in the study population.  The respondents to 
this survey were doctors attending anaesthesiology
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These findings may therefore not be indicative of the overall practice of 
obstetric anaesthesia in SA.
 
4.9 Conclusions 
 
We conducted a national survey to determine the current obstetric 
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Data from 933 respondents to this survey were analysed.  The response rate 
was 57%.  All provinces were represented however the majority of the 
respondents were from Gauteng, the Western Cape and KwaZulu-Natal.  
There was similar representation from both the private and public sectors. 
 
The median number of obstetric anaesthetics performed each month by 
private sector respondents was 10 while public sector doctors performed a 
median of 15 obstetric anaesthetics per month.  There was a statistical 
difference between the exposure of doctors in the private and public sectors 
to obstetric anaesthesia.  The majority of the survey respondents were 
involved in obstetric anaesthesia services during daytime hours and after 
hours.  
 
97.8% of all respondents in this survey preferred to use a single shot spinal 
anaesthetic technique for patients having an elective caesarean section.  This 
popular choice of anaesthetic technique is similar to results from other 
international studies (Tagaloa et al., 2009, Stamer et al., 2005).  The most 
commonly used spinal anaesthetic needle was the Whittacre needle, which is 
a pencil point needle.  However, up to 30% of the survey respondents 
preferred to use a cutting spinal anaesthetic needle.  These needles increase 
the risk of developing PDPH (O'Connor et al., 2007).  There was a greater risk 
of not being able to use one’s preferred spinal needle for doctors working in 
the public sector compared to those doctors working in the private sector.   
 
The most commonly used local anaesthetic for obstetric spinal anaesthetics 
was 0.5% bupivacaine with dextrose.  The median volume of 0.5% 
bupivacaine with dextrose, used by the respondents, was 2.00ml (10mg).  
There was however a statistically significant difference in the volume of local 
anaesthetic used between specialists and non-specialists.  The majority of the 
survey respondents added an additive agent to the local anaesthetic mix for 
the spinal anaesthetic block, and the most commonly used additive agent was 
fentanyl.  Morphine was used by a very small number of individuals. 
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In the labouring patient requiring an emergency caesarean section, the 
majority of respondents preferred to “top-up” a pre-existing labour epidural for 
the surgery.  The preferred local anaesthetic for this epidural “top-up” was 
0.5% bupivacaine. 
 
With regards to post-operative monitoring practices, the majority of 
respondents (58%) did not work in hospitals that have protocols for monitoring 
patients who have received neuraxial opioids.  Despite working in this 
environment, 92.8% of these doctors felt that it was necessary to monitor 
these patients for respiratory depression. 
 
For the majority of the respondents (62%) the anaesthesiologist was the 
person who is responsible for the patient’s post-operative pain management.  
PCA pumps and epidural analgesia were not popular techniques utilized for 
post-operative analgesia.  NSAIDs and intravenous paracetamol were 
commonly used drugs for post-operative pain control.  Oral tramadol was also 
a popular drug. 
 
Based on current practices, 76% of the respondents felt that their patients are 
satisfied with their post-operative analgesia after their caesarean section. 
 
Table 4.12 compares the results of our study with the results reported by 
Tagaloa et al (2009). 
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TABLE 4.12: Comparison of the national survey results with the results 
of the USA study reported by Tagaloa et al (2009) 
 
TAGALOA et al STUDY SOUTH AFRICAN NATIONAL 
SURVEY 
Survey Response Rate 
36 %  57% 
 
Clinical Time Doing Obstetric Anaesthesia 
< 1 day per week = 18% 
1 – 2 days per week = 39% 
> 2 days per week = 43% 
< 1 day per week = 44% 
1 – 2 days per week = 42% 
> 2 days per week = 14% 
 
Level of Involvement in Obstetric Anaesthesia 
Daytime cover = 9% 
On Call only = 4% 
Daytime and on call = 87% 
Daytime cover = 11% 
On Call only = 17% 
Daytime and on call = 67% 
Other = 5% 
Preferred method of anaesthesia 
Single shot spinal anaesthetic = 85% 
Epidural = 4% 
General Anaesthetic = 0% 
CSE = 11% 
Single shot spinal anaesthetic = 97.8% 
Epidural = 0.2% 
General Anaesthetic = 0.8% 
CSE = 1.2% 
Type of spinal anaesthetic needle 
Pencil point needle = 94% 
Quincke© needle = 5% 
Pencil point needle = 70% 
Quincke© needle = 30% 
Gauge of Spinal Anaesthetic Needle 
24G = 13% 
25G = 63% 
27G = 16% 
Other needle sizes = 8% 
 
22G = 3% 
24G = 2.6% 
25G = 31.5% 
26G = 49% 
27G = 11.4% 
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Local anaesthetic for spinal block 
*Hyperbaric 0.75% bupivacaine = 90% 
Plain 0.5% bupivacaine = 8% 
 
* 0.75% hyperbaric bupivacaine is not available in South 
Africa 
*Hyperbaric 0.5% bupivacaine = 95% 
Plain 0.5% bupivacaine = 4% 
 
* 0.75% hyperbaric bupivacaine is not available in South 
Africa 
 
Median Dose of Hyperbaric Bupivacaine 
 
12mg  
 
10mg  
Use of adjuvant drugs for neuraxial anaesthesia 
Adjuvant drugs used: 
• 
*Fentanyl = 77% 
• 
*Sufentanil = 2% 
• 
*Morphine = 79% 
* Reported as percentage of respondents who indicated 
that they use these drugs 
Adjuvant drugs used: 
• 
*Fentanyl = 80% 
• 
*Sufentanil = 15% 
• 
*Morphine = 4% 
* Reported as percentage of respondents who indicated 
that they use these drugs 
 
Choice of local anaesthetic for labour epidural “top up” for surgery 
2% lignocaine = 74% 
*
 Chloroprocaine = 21% 
Others = 5% 
*
 Chloroprocaine not available in South Africa 
0.5% bupivacaine = 47% 
2% lignocaine = 33% 
0.75% ropivacaine = 17% 
0.5% levobupivacaine = 0.45% 
 
Post-operative monitoring practices 
Respondents who work in a hospital 
with a monitoring protocol = 93% 
The duration of monitoring varies.   
• < 6hrs = 3%  
• 6 – 12hrs = 3% 
• Up to 12hrs = 12% 
• 24hrs = 63% 
• Up to 36hrs = 0% 
• Up to 48hrs = 0% 
Respondents who work in a hospital 
with a monitoring protocol = 42% 
The duration of monitoring varies.   
• < 6hrs = 27%  
• 6 – 12hrs = 17% 
• Up to 12hrs = 12% 
• 24hrs = 42% 
• Up to 36hrs = 1% 
• Up to 48hrs = 1% 
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Post-operative pain management practices 
79% of respondents will not routinely 
use an epidural for post-operative 
pain management 
91% of respondents will not routinely 
use an epidural for post-operative 
pain management 
12% of respondents will routinely use 
a PCA pump for post-operative 
analgesia 
17% of respondents will routinely use 
a PCA pump for post-operative 
analgesia 
NSAIDs are used by 81% of 
practitioners 
NSAIDs are used by 75% of 
practitioners 
IV paracetamol not specifically 
reported. 
 
 
45 % of respondents use oral 
paracetamol 
64% of respondents prescribe IV 
paracetamol for their patients in the 
post-operative period. 
 
54% of respondents use oral 
paracetamol 
 
The large cohort of this study has provided an accurate demonstration of the 
current state of obstetric anaesthesia in South Africa.  The results of this study 
have provided us with new information on the practice of obstetric 
anaesthesia in South Africa.  The survey has highlighted some important and 
interesting differences in anaesthetic practices for caesarean sections 
between the public sector and private sector.  In addition, we have also 
highlighted issues relating to differences in the practices between specialists 
and non-specialists providing obstetric anaesthetic services in South Africa.  
This study has brought to the fore major concerns relating to the practice of 
anaesthesia by practitioners with no anaesthetic qualifications, which is in 
direct contravention to the practice guidelines of the SASA (Bettings et al., 
2013), and also the inappropriate use of Quincke needles by a large number 
of practitioners.  This study has also highlighted the stark differences in the 
obstetric anaesthetic practices in South Africa compared to other published 
global practices (Table 4.13). 
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Based on the results of the study presented in chapter three, there are a 
number of areas where the practises of South African anaesthetic service 
providers do not conform to the suggested reference standards for 
anaesthetic management for caesarean sections.  These include the 
widespread use of cutting Quincke© spinal anaesthetic needles to perform 
spinal anaesthesia for pregnant women, and the high percentage of 
practitioners that work in hospitals that do not have post-operative monitoring 
protocols for patients who have received neuraxial opioids.  Areas where 
current practice complies with the expert recommendations include the 
widespread use of regional anaesthesia for caesarean sections and the 
preference for using 0.5% bupivacaine with dextrose as the local anaesthetic 
for spinal anaesthesia in these patients.  Practitioners also prefer to use 
fentanyl as an intrathecal additive to all other opioids including morphine 
(which is not recommended by South African experts).  NSAIDs and 
paracetamol are commonly prescribed drugs for post-operative analgesia, 
which complies with recommendations from the expert panel. 
 
Table 4.13 compares the results of our study with recommendations made by 
the national experts (Chapter three) and with published international 
guidelines. 
 164 
 
TABLE 4.13: Comparison of the national survey results with the recommendations of the South African institutional 
experts and current international guidelines 
 
SOUTH AFRICAN EXPERT 
RECOMMENDATIONS 
INTERNATIONAL GUIDELINES RESULTS OF THE SOUTH 
AFRICAN NATIONAL SURVEY 
 
Method of anaesthesia 
Single shot spinal anaesthetic ASA – Neuraxial anaesthetic technique 
(does not specify intrathecal or epidural 
techniques)(a) 
 
UK – Regional anaesthetic technique 
(does not specify intrathecal or epidural 
techniques)(b) 
Method of anaesthesia reported: 
• Single shot spinal anaesthetic = 97.8% 
• Epidural = 0.2% 
• General Anaesthetic = 0.8% 
• CSE = 1.2% 
 
Type of spinal anaesthetic needle 
Pencil point needle 
 
* Quincke© needles should not be 
used 
ASA – Pencil point needle(a) 
 
*Recommendation is to use pencil point 
needle instead of cutting-bevel needle 
Pencil point needle = 70% 
Quincke© needle = 30% 
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Gauge of Spinal Anaesthetic Needle 
25G, 26G and 27G No recommendations 22G = 3% 
24G = 2.6% 
25G = 31.5% 
26G = 49% 
27G = 11.4% 
Local anaesthetic for spinal block 
0.5% bupivacaine with dextrose No recommendations 
 
0.5% bupivacaine with dextrose = 
95% 
Use of adjuvant drugs for neuraxial anaesthesia 
Opioids – Fentanyl (10 – 25µg)  
 
 
* Morphine should not be used 
ASA – Neuraxial opioids are 
recommended.  No specific drug is 
recommended(a) 
 
UK – Neuraxial diamorphine(b) 
 
APS – Intrathecal and epidural opioids. 
No specific drug is recommended(c) 
 
Adjuvant drugs used: 
• 
*Fentanyl = 80% 
• 
*Sufentanil = 15% 
• 
*Morphine = 4% 
* Reported as percentage of respondents who indicated 
that they use these drugs  
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ANZCA – Intrathecal morphine(d) 
 
PROSPECT – Intrathecal morphine (f) 
* There are no explicit 
recommendations against morphine 
Post-operative monitoring practices 
Monitoring for respiratory 
depression in patients given 
neuraxial opioids.  The duration of 
monitoring depends on the drug 
used: 
 
• Lipophilic opioids - 0 – 12 
hours 
 
• Morphine - 24 hours after the 
administration of the drug 
ASA - Monitoring for respiratory 
depression should be done in patients 
who receive neuraxial opioids. The 
duration of monitoring depends on the 
drug used: 
 
• Lipophilic opioids – minimum of 
two hours after administration(e)  
 
• Morphine - The monitoring 
should be done once per hour 
for the first 12hours and then 
once every two hours for the 
second 12 hours(e)  
Only 42% of respondents work in 
hospitals with a protocol for 
monitoring patients who have 
received neuraxial opioids.  The 
duration of monitoring varies.   
• < 6hrs = 27%  
• 6 – 12hrs = 17% 
• Up to 12hrs = 12% 
• 24hrs = 42% 
• Up to 36hrs = 1% 
• Up to 48hrs = 1% 
We did not however determine if the 
duration of monitoring varied with the 
type of neuraxial opioid used. 
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APS – Sedation and respiratory status 
in the initial hours after surgery for 
patients who receive systemic opioids(c)  
 
Respiratory rate monitoring is the 
most commonly used monitoring 
modality.  Pulse oximetry and 
sedation scores are also used. 
 
Post-operative pain management practice 
Epidural analgesia – should not be 
routinely used for post-operative 
analgesia 
APS – Epidural analgesia (with or 
without opioids) can be offered(c) 
 
91% of respondents will not routinely 
use an epidural for post-operative 
pain management 
PCA opioids – should be reserved 
for challenging cases  
 
UK – PCA opioids should be offered to 
patients(b)  
 
17% of respondents will routinely use 
a PCA pump for post-operative 
analgesia 
NSAIDS – should be routinely used 
for post-operative pain management 
 
UK – NSAIDS should be routinely 
used(b)  
 
APS - NSAIDS should be routinely 
used(c)  
 
 
NSAIDs are used by 75% of 
practitioners 
 
49.1% of practitioners prefer to 
administer NSAIDs as a rectal 
suppository 
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ANZCA – Conflicting evidence 
regarding benefits of NSAIDs use(d) 
 
PROSPECT – Oral NSAIDs should be 
used (f) 
Paracetamol – should be routinely 
used for post-operative pain 
management.  The intravenous 
formulation is preferred  
APS - Paracetamol should be routinely 
used(c)  
 
ANZCA – Paracetamol should be 
routinely used (d) 
 
PROSPECT – Oral paracetamol should 
be used (f) 
64% of respondents prescribe IV 
paracetamol for their patients in the 
post-operative period. 
 
Oral paracetamol is used by 54% of 
respondents 
(a)(Apfelbaum et al., 2016) (b)(Griffiths et al., 2011) (c)(Chou et al., 2016) (d)(Schug et al., 2015) (e)(Horlocker et al., 2009) (f) (PROSPECT Working Group, 2015) 
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The results of this study can be used to modify and improve anaesthetic 
training programmes so as to improve the obstetric care of women in South 
Africa. 
 
4.10 Summary 
 
In this chapter the results of the national survey of anaesthetic practices in 
South Africa was presented.  In the next chapter we will present the results of 
a clinical trial investigating the differences in the analgesic effects of three 
different intrathecal opioid regimens for the management of post-operative 
caesarean section pain. 
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CHAPTER FIVE: The influence of two different intrathecal 
morphine doses compared to intrathecal fentanyl on the post-
operative pain experiences of women undergoing neuraxial 
anaesthesia for caesarean section 
 
5.1 Introduction 
 
Adequate and appropriate pain management post-caesarean section 
constitutes an essential component of post-operative care of the new 
parturient.  Mothers in pain have greater difficulty taking care of their 
newborns, including the ability to breastfeed, therefore appropriate pain 
management can facilitate the bonding process between mother and baby in 
the early post-operative period (Karlstrom, 2007).  Indeed, from the patient 
perspective, in a survey amongst pregnant patients at Stanford University, 
USA, patients ranked pain associated with caesarean section surgery as one 
of their greatest concerns related to their pregnancies (Carvalho et al., 2005).    
 
Intrathecal opioids, and morphine in particular, have been shown to provide 
good post-operative analgesia for women after caesarean section surgery 
(Carvalho and Tenório, 2013).  Morphine is poorly lipophilic in comparison to 
the more lipophilic opioids, fentanyl and sufentanil (Fukuda, 2005).  As a 
result of its relative hydrophilicity (compared to fentanyl and sufentanil), 
intrathecal morphine does not penetrate the nervous tissue quickly and this 
results in the drug having a relatively long onset of action and a prolonged 
duration of effect.  Internationally, intrathecal morphine is considered the gold 
standard for providing post-caesarean section analgesia, and is the therapy 
against which other therapies are measured (Palmer et al., 1999, Dahl et al., 
1999, Tan, 2012, Sarvela et al., 2002).  
 
Based on our investigations (chapters 3 and 4), the vast majority of 
anaesthetic service providers in South Africa do not use intrathecal morphine 
for post-caesarean section analgesia.  This may be due to individual 
 176
practitioners’ preferences and not drug availability, as morphine is listed as an 
essential medicine on the South African formulary (Zeeman, 2012) and is 
readily available for use in hospitals and for outpatient use in both the public 
and private healthcare sectors. 
 
5.2 Aim 
 
The aim of this study was to evaluate the analgesic effect of two intrathecal 
opioids (morphine and fentanyl) in women who have undergone caesarean 
section surgery in a South African public sector hospital. 
 
5.3 Objectives 
 
The specific objectives of the study were: 
 
i. To evaluate the analgesic effect of three different intrathecal opioid 
mixtures (100μg morphine, 50μg morphine and 25μg fentanyl) in 
women who had undergone caesarean section surgery, relating 
specifically to: 
a. Post-operative analgesic requirements at two time points (12 
hours and 24 hours) after surgery.  This was the primary 
outcome. All subsequent objectives listed here address 
secondary outcomes. 
b. Pain scores at two time points (12 hours and 24 hours) after 
surgery. 
c. Sedation scores at two time points (12 hours and 24 hours) after 
surgery. 
d. Post-operative nausea scores at two time points (12 hours and 
24 hours) after surgery. 
e. Post-operative pruritus scores at two time points (12 hours and 
24 hours) after surgery. 
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ii. To determine the impact that the patients’ post-operative pain had on 
their activities (movements in and out of bed, deep breathing or 
coughing, and sleeping), their emotional states and their perception of 
relief in the first 24 hours after surgery. 
 
5.4  Demarcation of the study field 
 
The study was performed at a single center, the Rahima Moosa Mother and 
Child Hospital (RMMCH), Johannesburg, South Africa. RMMCH is a tertiary, 
public sector hospital, serving the western areas of Johannesburg.  There are 
approximately 12000 deliveries per year at the hospital, with a caesarean 
section rate of approximately 30% (data extracted from hospital records). 
RMMCH is a teaching hospital affiliated to the Faculty of Health Sciences at 
the University of the Witwatersrand. 
 
5.5  Ethical considerations 
 
• This study was conducted in accordance with the ethical principles of 
the Declaration of Helsinki (World Medical Association, 2013) and 
Good Clinical Practice (Department of Health, 2006). 
• The protocol was reviewed and approved by the Human Research 
Ethics Committee – Medical (HREC) of the University of the 
Witwatersrand (Approval number M141181-  APPENDIX L). 
• The following ethical considerations were taken into account when 
planning this study 
o Beneficence – The investigated treatment options in this trial 
would potentially improve the post-operative pain management 
of the patients recruited into the clinical trial. 
o Non-maleficence – All planned interventions in the clinical trial 
were aimed at improving the patient’s post-operative 
experience.  The increased patient follow up afforded to the trial 
participants ensured that no harm came to the patients. 
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o Autonomy – All women at the hospital received equal and fair 
treatment.  Patients who were invited to participate in the trial 
were reassured that they would get the same treatment as all 
other patients irrespective of whether they participated in the 
trial or not. 
o Justice – This trial was aimed at investigating a cost-effective 
and accessible pharmaceutical option for post-operative 
analgesia for women after caesarean section surgery.  Evidence 
generated from this study could be utilized to make analgesia 
more accessible to patients having caesarean sections in SA 
• The study has been registered on the www.clinicaltrials.gov website. 
Registration number: NCT02577809. 
 
5.6  Research Methodology 
5.6.1 Study design 
The study was a single-centre, double-blind, parallel-group, randomised trial 
of two doses of intrathecal morphine versus a single dose of fentanyl.  Two 
doses of intrathecal morphine were compared with the current hospital 
standard of care (25μg fentanyl) in order to determine what was the lowest 
effective dose of intrathecal morphine in our patient population. 
 
5.6.2 Study Population  
The study population included all patients having caesarean section surgery 
under single shot spinal neuraxial anaesthesia at RMMCH, and who provided 
informed consent to take part in the study. 
 
Sample Size Calculation 
• The sample size was calculated taking into account the primary 
objective of the study (post-operative analgesic requirements after 
surgery), in order to ensure that the study was adequately powered. 
The calculation was based on an F-test with repeated measures (two 
time periods) and interaction (three groups), and assumed 0.5 
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correlation between repeated measures, a small effect size of 0.2, and 
90% power to detect a difference 
The calculated sample size was 28 patients per group or 84 patients in 
total. 
• We aimed to recruit 100 patients into the study in order to allow for loss 
of patients from the study. 
 
5.6.3 Sample Method 
A consecutive convenience sampling method was used.  The convenience 
sampling method was chosen because of the time constraints and scope of 
the research. The most readily accessible patients presenting for surgery 
were included. It is acknowledged that a convenience sample cannot fully 
represent the study population (Hultsch et al., 2002). 
 
5.6.4 Criteria for the study 
5.6.4.1 INCLUSION CRITERIA: 
All patients > 18years having caesarean section surgery under single shot 
spinal neuraxial anaesthesia at RMMCH. 
 
5.6.4.2 EXCLUSION CRITERIA 
• Pre-operative: 
a) Patient refusal or inability to give informed consent  
b) Severe pre-eclampsia 
c) Eclampsia 
d) Patient unable to understand how to use the Patient Controlled 
Analgesia (PCA) pump, after appropriate counseling and training 
• Intra-operative: 
a) Obstetric Complications: 
i) Post-partum Haemorrhage 
ii) Ruptured Uterus 
iii) Still Birth 
b) Conversion to general anaesthesia intra-operatively 
c) Administration of supplementary intravenous opioid analgesics 
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• Post-operative: 
a) Patients who had babies that required additional care, for a 
prolonged period, after birth (eg. Neonatal intensive care unit 
(ICU) admission for ≥ 12 hours or congenital abnormalities). 
b) Patients who require ICU or high-care admission post-operatively 
for any intra-operative complications 
5.6.5 Methodology 
• The trial was conducted from July – September 2015.  The trial ended 
after 100 patients were recruited. 
• Patients were approached pre-operatively and the study was explained to 
them.  They were then invited to participate in the study.   
• A graphical representation of the patient flow is illustrated in Figure 5.1 
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FIGURE 5.1: Patient flow diagram 
 
The CONSORT checklist for this study is in APPENDIX M. 
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• After obtaining written informed consent from the patients (APPENDIX N), 
the following data were recorded on the patient data sheet (APPENDIX O) 
o Baseline weight  
o Baseline blood pressure  
o Age 
o Parity 
o Previous pregnancy losses 
o Relevant medical history and relevant pre-operative investigation 
results 
o ASA status 
o Indication for caesarean section  
• Each patient was taught how to use a PCA pump. 
• The standard of care, in the hospital, for intraoperative aspiration 
prophylaxis for obstetric patients is 10ml sodium citrate given orally and 
10mg metoclopramide administered intramuscularly.  Both these drugs 
were administered by the nursing staff in the ward prior to the patient 
being transferred to theatre. 
• Patients were randomized, by the principal investigator (PI), when they 
arrived in the waiting area in the theatre complex, after the doctor 
performing their anaesthetic evaluated them. 
• Patients were randomised using a computer generated block 
randomisation list generated from www.sealedenvelope.com (Sealed 
Envelope Ltd, 2015)  
• Patients were randomized into one of three groups.  The group that they 
were allocated into determined the intrathecal medication that they 
received as part of their anaesthetic: 
o Group M100 - 1.8ml 0.5% hyperbaric bupivacaine with 100μg 
morphine (mixed in 0.4ml normal saline to a volume of 2.3ml)  
o Group M50 – 1.8ml 0.5% hyperbaric bupivacaine with 50μg 
morphine (mixed in 0.4ml normal saline to a volume of 2.3ml) 
o Group F25 - 1.8ml 0.5% hyperbaric bupivacaine with 25μg fentanyl 
(2.3ml volume) 
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• Once the patient was randomised, the PI (S Chetty) handed over the 
sealed randomisation envelope to the anaesthetist delivering the 
anaesthetic service so that the appropriate medication could be used in 
the spinal anaesthetic.  The sealed envelope contained an instruction 
sheet to the anaesthetist informing them of the patient’s group allocation 
and giving them instructions on how to mix the intrathecal local 
anaesthetic mixture (APPENDICES P, Q and R).  The PI remained blinded 
to the group that the patient was allocated to and hence the medication 
that was used in the spinal anaesthetic. This design (i.e., the anaesthetic 
service provider knowing the drug) was used for safety reasons in the 
event of complications occurring during or after the procedure.  
• In the operating theatre, standard American Society of Anesthesiologists 
(ASA) monitoring was used (blood pressure, electrocardiogram (ECG) and 
pulse oximetry) 
• Each patient was pre-loaded with a 500ml bolus of colloid solution 
(hydroxyethyl starch) prior to the procedure.  Thereafter an infusion of 
Modified Ringer’s Lactate was infused at a rate of 60ml/hr.  This protocol 
was used to decrease the risk of post-spinal hypotension and is the 
current standard of care at the hospital. 
• Spinal anaesthesia was performed, by the attending anaesthetist, with the 
patient in the sitting position, using an aseptic technique, inserting a spinal 
needle into the lumbar spine. 
• Once there was back-flow of cerebrospinal fluid (CSF), the patient was 
given 2.3ml of the local anaesthetic solution with opioid (as per the 
allocated group indicated in the randomisation instructions).  Thereafter, all 
instruments were removed from the patient’s back and a dressing was 
applied to the skin. 
• After the performance of the spinal anaesthesia procedure, the patient was 
placed in a supine position with 15º left uterine displacement using a 
Crawford wedge. 
• The level of sensory loss to temperature was determined by the attending 
anaesthetist using a cold metal instrument in theatre eg. forceps. Surgery 
only commenced after a satisfactory sensory blockade was achieved.  
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• Oxygen at 8 l/min flow was administered via a 40% venturi face mask. 
• Blood pressure was monitored at one minute intervals until the baby was 
delivered then continued every three minutes thereafter until the end of 
surgery. 
• In this study, hypotension was defined as a 20% reduction from baseline 
systolic blood pressure (SBP) or a SBP of 100mm Hg or less. Should this 
have occurred in theatre after the spinal anaesthetic, the patient was 
treated with a rapid infusion of 100ml of Ringers Lactate solution and 
intravenous boluses of 50μg of phenylephrine (unless the patient had a 
bradycardia (heart rate <40 beats per minute) – in which case 5mg 
boluses of intravenous ephedrine was used) .  
• At the end of the surgery, a 100mg indomethacin suppository was inserted 
into the patient’s rectum by the surgeon, as per standard hospital practice. 
• After surgery, the patient was transferred to the recovery room for 
monitoring. 
• The investigator issued the post-operative analgesia prescription for the 
patient before the patient left the recovery room.  The post-operative 
prescription used for all patients was: 
o Morphine PCA pump 
o Indomethacin suppository 100mg per rectum 12 hourly 
o Prochlorperazine Maleate 12,5mg intramuscular (IM) 8hourly 
o Antibiotic (as per the surgeon’s request) 
• In the recovery room the patient was shown again how to use the 
intravenous PCA pump.  The PCA pump contained morphine.  The PCA 
pump had the following settings:  
o dilution of 1mg/ml of morphine  
o 1ml bolus  
o 5 minute lock-out period 
o 10mg/hr maximal dose 
o no background infusion 
• The baby remained in the incubator in the recovery room (as per the 
standard hospital procedures) 
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• After 30 minutes of monitoring in the recovery room, if the patient met the 
standard hospital discharge criteria for the recovery area, the patient was 
discharged to the obstetric ward for observations.  
• Standard ward monitoring of vital signs was performed by the ward staff 
• Study observations 
o Data was collected using the study data collection form (APPENDIX 
O) at 12 hours ± 1 hour and 24 hours ± 1 hour after surgery  
o Data was collected on the following parameters: 
 Time from end of surgery to the first demand of analgesia 
from the PCA pump and the total amount of morphine used 
after 12hours and 24 hours after surgery.  
 Pain scores at time of assessment using an 11 point 
numerical rating scale (0 – 10)  
 With cough 
 At rest 
 Side-effects of morphine at two time points (12 hours and 24 
hours) after surgery as follows: 
 
a) Level of sedation, using the following scoring system: 
   0 = Awake 
  1 = Mild drowsiness 
  2 = Moderate drowsiness, easily awaken 
  3 = Difficult to arouse 
Sedation was considered clinically relevant if the patient was not easily 
awakened. 
 
b) Respiratory rate – Respiratory depression was defined as 
respiratory rate of less than eight breaths per minute.  
Any respiratory rate of less than 8 was reported to the attending doctors for 
intervention with nalaxone  
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c) Nausea and vomiting, using the following scale:  
  0 = No nausea 
  1 = Presence of nausea without vomiting 
  2 = Mild to moderate vomiting (not requiring treatment) 
  3 = Severe vomiting (treatment required) 
Severe vomiting (more than two episodes) was treated with intravenous 
metoclopramide 10mg* 
 
d) Pruritus, using the following scale:  
  0 = No pruritus 
  1 = Mild to moderate pruritus (not requiring treatment) 
  2 = Severe pruritus (treatment required) 
Severe pruritus (more than two episodes) was treated with 25mg Phenergan*  
 
* Patients who received treatment for nausea, vomiting and pruritus were 
excluded from the statistical analysis of the particular side effect parameter for 
which they received treatment (nausea & vomiting or pruritus) for the 
subsequent assessments.  This was done so as to negate the false-negative 
side effect profile that the administration of the treatment would create. 
 
o Data were also collected using the Pain OUT registry format  (PAIN 
OUT, 2016).  The patient questionnaire (APPENDIX S) was 
completed at two time points (12 hours and 24 hours) after surgery.  
The process form (APPENDIX T) was completed after the second 
patient evaluation. 
• After 24 hours, the PCA pump was removed and the patient was 
continued on standard oral analgesic treatment (as per the hospital 
protocol). 
 
All data were collected by the principal investigator and/or the research 
assistants (who were anaesthesiology registrars doing their acute pain 
rotation).   
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5.6.6 Data Analysis 
 
We analysed the prospectively collected data from patients who completed all 
trial requirements (per protocol cohort).  Clinical data from manually 
completed data collection sheets (APPENDICES O, S and T) were entered 
into a spreadsheet using Microsoft® EXCEL® for MAC (Version 14.6.2).   
 
Data was analysed using StatPlus, AnalystSoft Inc. - statistical analysis 
program for Mac OS®. (Version v6) and the statistical analysis program R 
(Version 3.2.3) (R Core Team, 2015) 
 
Continuous parametric data was described using mean and standard 
deviation.  Continuous non-parametric data was described using median and 
interquartile ranges.  Categorical data was described using frequencies and 
percentages. 
 
Baseline characteristics of the study sample were summarized using simple 
proportions and means or medians with ranges.  Kruskal Wallis statistical 
analysis was performed on patient baseline data relating to age, weight, 
systolic and diastolic blood pressures and duration of surgery.  Chi-squared 
statistical tests were performed on the patient baseline data of parity, previous 
pregnancy losses (data of all primiparous patients were removed from this 
statistical calculation), number of emergency procedures and number of 
patients who experienced a drop in blood pressure following administration of 
spinal anaesthesia. The post-operative analgesic requirements were 
described as median doses and interquartile ranges for each group, and 
compared using a Kruskal Wallis test.  Further comparisons between pairs of 
treatment groups were performed using the Wilcoxon sum-ranked test.   
 
5.7 Results and Discussion 
 
The results and discussion of the primary objective (analgesic requirements 
post-operatively) are presented in this chapter (chapter five).  The results and 
discussion of all secondary objectives are presented in chapter six. 
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One hundred patients were recruited into the trial.  Seven of these patients 
were excluded from the data analysis due to protocol violations (two in Group 
M100, four in Group M50 and one in Group F25).  The details of these 
patients are listed in table 5.1. 
 
Six of the seven patients excluded from the data analysis were because their 
babies were admitted to the high-care unit.  As per the study protocol, any 
patient whose baby was not with them at the time of the 12-hour assessment 
was excluded from the data analysis.  The rationale behind this exclusion was 
that these patients may have been very anxious about the condition of their 
infants and these high levels of anxiety may have had impact on their pain 
perception.  One patient was excluded from data analysis because she chose 
to withdraw from the trial before the first 12-hour assessment.  All patients 
(including excluded patients) were monitored until the end of the study period 
at 24-hours after surgery 
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TABLE 5.1: Characteristics of the excluded patients 
 
Treatment 
Group 
Age 
(years) 
ASA 
Status 
Parity Previous 
Pregnancy 
Loss 
Weight 
(kg) 
Indication  
for  
Caesarean Section 
Emergency 
or  
Elective 
Reason for Exclusion 
F25 27 1 1 0 105 Previous Caesar Elective Baby in ICU for > 12hours  
M100 45 2 4 0 74 CPD Emergency Baby in ICU for > 12hours 
M50 24 1 1 0 67 Breech Presentation Emergency Baby in ICU for > 12hours 
M50 23 2 1 0 53 Pre-eclampsia Emergency Baby in ICU for > 12hours 
M50 32 1 4 0 85 Previous Caesar Elective Baby in ICU for > 12hours 
M100 40 2 3 2 154 Multiple previous 
miscarriages 
Elective Baby in ICU for > 12hours 
M50 26 1 1 0 92 Failed VBAC Emergency Patient chose to withdraw from study after surgery 
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The data from 93 patients were included in the analysis. Following unblinding 
of the patient allocations, there were 32 patients in Group M100, 29 patients 
in Group M50 and 32 patients in Group F25, after the excluded patients were 
removed from their respective groups.  Based on the study sample size 
calculation, these group numbers met the requirements of the study power 
calculation.   
 
The characteristics of the patients in each treatment group are summarized in 
Table 5.2. 
 
TABLE 5.2: Characteristics of the study patients 
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The three groups of patients were homogenous in terms of patients’ 
characteristics.  There were no statistically significant differences between the 
groups in terms of age, weight, number of primiparous patients, previous 
pregnancy losses, ASA status, blood pressure measurements, number of 
emergency procedures, the number of patients who experienced hypotension 
and the durations of the surgeries. 
 
5.7.1 Post-operative analgesic requirements 
 
The morphine used in the first 12 hours, second 12 hours and in total for the 
24 hours after surgery was compared for each of the treatment groups.  
These results are summarized in table 5.3.   
 
TABLE 5.3: Summary of the post-operative analgesic requirements of 
the three treatment groups 
 
Group M100 
(n = 32) 
Group M50 
(n = 29) 
Group F25 
(n = 32) p-value 
Morphine used in first 
12 hours (mg)  
[MEDIAN(IQR)] 
 
8.0 
(9.25) 
 
8.0  
(13.0) 
 
16.0  
(14.5) 
 
p < 0.001 
Morphine used in the 
second 12 hours (mg)  
[MEDIAN(IQR)] 
 
3.5 
(6.0) 
 
5.0  
(4.0) 
 
10.0  
(9.25) 
 
p = 0.01 
Total morphine used in 
24 hours (mg)  
[MEDIAN(IQR)] 
 
12.5 
(14.25) 
 
15.0 
(16.0) 
 
26.5  
(19.3) 
 
p < 0.001 
 
There was a statistically significant difference in the dosage of morphine used 
between the three groups for all three of the periods analysed.  This is 
illustrated in figures 5.2, 5.3 and 5.4 
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FIGURE 5.2: Box and Whisker plot of morphine doses used at 12-hour 
assessment  
 
FIGURE 5.3: Box and Whisker plot of morphine doses used between 12 
and 24 hours  
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FIGURE 5.4: Box and Whisker plot of morphine doses used over the full 
24-hour period   
 
Using the Wilcoxon sum-rank test we compared each of the three groups with 
each other and also found that there was a statistically significant difference in 
the doses of morphine used between groups M100 and F25 and also between 
groups M50 and F25 for all of the time periods analysed (Figures 5.2, 5.3 and 
5.4).  Both the intrathecal morphine patient groups (Groups M100 and M50) 
used significantly less PCA morphine in all three time periods analysed, 
compared to the intrathecal fentanyl patient group (Group F25).  When 
comparing the 50μg intrathecal morphine group (Group M50) with the 100μg 
intrathecal morphine group (Group M100), there was no difference in the 
morphine used between these groups for all the time periods analysed. 
 
Based on the study exclusion criteria, 7 patients were excluded from the data 
analysis.  In order to examine the results in the intention to treat cohort, we 
additionally analysed the data for all randomized patients. We used last 
observation carried forward (LOCF) to interpolate missing values in 
participants with missing 24-hour data. For the single patient who withdrew 
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before the 12-hour measurement, we used the median morphine dose at each 
time point from the group she was randomized to (Group M50).  
 
TABLE 5.4: Summary of the post-operative analgesic requirements of 
the intention to treat cohort  
 Group M100 
(n = 34) 
Group M50 
(n = 33) 
Group F25 
(n = 33) p-value 
Morphine used in first 
12hours (mg)  
[MEDIAN(IQR)] 
 
9.0 
(9.0) 
 
8.0  
(11.0) 
 
16.0  
(16.0) 
  
p < 0.001 
Morphine used in the 
second 12hours (mg)  
[MEDIAN(IQR)] 
 
4.5 
(6.0) 
 
6.0  
(5.0) 
 
10.0  
(9.0) 
 
p < 0.001 
Total morphine used 
in 24hours (mg)  
[MEDIAN(IQR)] 
 
13.5 
(14.5) 
 
15.0 
(12.0) 
 
27.0  
(20.0) 
 
p < 0.001 
 
The Kruskal Wallis statistical calculation performed on this data set indicated 
that there was a statistical difference between the three treatment groups for 
all three of the periods analysed (first 12 hours, second 12 hours and the full 
24 hour period after surgery).  This was in keeping with the statistical results 
of the original data analysis.  This implied that the data from the excluded 
patients did not affect the statistical outcomes with regards to the analysis of 
the post-operative opioid requirements. 
 
Emergency surgery can be considered to be a confounding factor that may 
have an influence on a patient’s post-operative pain experience.  In this study 
there were 9 patients in group M100, 10 patients in group M50 and 11 
patients in group F25 who had emergency surgery.  The emergency surgery 
population sample size was however too small to perform a meaningful 
analysis and this was therefore not done.  The sample is underpowered to 
determine if this is a significant confounder. 
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The efficacy of intrathecal opioids for post-operative analgesia is well 
established in the obstetric anaesthesia setting.  Palmer et al (1999) 
evaluated eight different doses of intrathecal morphine, ranging from 25μg to 
500μg, and found that intrathecal morphine doses above 75μg were 
significantly more efficacious than placebo in providing post-operative 
analgesia following caesarean section surgery.  When isolating the results of 
the two doses of intrathecal morphine that were investigated in our study, the 
Palmer et al (1999) study revealed that mean PCA morphine use in the 50μg 
and 100μg groups were 30± 26mg and 26± 23mg respectively. These doses 
are higher than the cumulative PCA morphine used in our study (18.2 ± 
13.6mg and 15.4 ± 15.5mg) over the same time period.  Girgin et al (2008) 
showed very similar PCA morphine requirements (28 ± 18mg) as Palmer et al 
(1999), in the group of patients who were given 100μg intrathecal morphine.  
These authors also reported that the PCA requirements of the 400μg 
morphine group were 20 ± 14mg, which is more similar to the PCA morphine 
requirement of the 100μg group in our study.   
 
The discrepancy in PCA morphine doses between these two previous studies 
and our study may be explained, in part, by the fact that all patients in our 
study were given rectal NSAIDs as part of their analgesic regimen.  Cardoso 
et al (1998) compared different doses of intrathecal morphine, with and 
without the use of intramuscular (IM) diclofenac, and showed that the addition 
of NSAIDs to the analgesic regimen had a significant opioid sparing effect.  
The author recommended that doses as low as 25μg intrathecal morphine, in 
combination with NSAIDs, can provide very effective analgesia after 
caesarean section surgery, with a reduced side-effect profile. 
 
Palmer et al (1999) demonstrated that the post-operative PCA morphine 
requirements decreased as the dose of intrathecal morphine increased in their 
study.  However these authors did not perform a direct comparison between 
50μg and 100μg doses of intrathecal morphine.  The results of our study 
however do not concur with this trend.  There is no statistical difference 
between the PCA morphine doses used by patients in Group M100 and 
Group M50 despite the Group M100 patients receiving double the dose of 
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intrathecal morphine compared to patients in Group M50.  The similarity in the 
efficacy of the two doses of intrathecal morphine assessed is suggestive that, 
in this group of patients, 50μg intrathecal morphine, in combination with rectal 
NSAIDs, can provide as good analgesia as 100μg intrathecal morphine.   
 
This assumption of clinical equivalence between the two intrathecal morphine 
doses investigated in our study, was corroborated by Carvalho and Tenório 
(2013).  These authors also compared the efficacy of the 50μg and 100μg 
doses of intrathecal morphine, and concluded “intrathecal 50μg provided the 
same quality of analgesia as 100μg, with a lower incidence of side effects”.  
These authors did not use PCA morphine requirements as the basis of their 
conclusions and instead used patient pain Visual Analogue Scale (VAS) 
scores and overall patient satisfaction scores to make their determinations.  
Despite similar pain VAS scores in both groups, 70% of patients in the 50μg 
group reported pain to be their main reason for discomfort after surgery, 
compared with only 32% in the 100μg group.   
 
The patients in Group F25 in our study had significantly higher post-operative 
PCA morphine requirements compared to those of each of the morphine 
groups. These results are similar to results published by Salmah and Choy 
(2009).  These authors compared the analgesic efficacy of 100μg intrathecal 
morphine with that of 25μg intrathecal fentanyl, in women having caesarean 
section surgery under spinal anaesthesia.  Patients in their morphine group 
had a mean post-operative PCA morphine consumption of 9.2 ± 1.2mg 
compared to 30.8 ± 2.3mg in the fentanyl group (p<0.05).  These results were 
not surprising considering that the expected duration of action of intrathecal 
fentanyl ranges from one to four hours (Lundgren et al., 2016).  Fentanyl is 
more lipophilic than morphine (Fukuda, 2005) and is able to penetrate into the 
nerves in the spine more quickly giving it a quick onset of action, and making 
it suitable for intra-operative analgesia.  However, its short duration of action 
means that it is not able to provide adequate post-operative analgesia for 
most of the first 24-hours after surgery, and therefore patients will have higher 
analgesic requirements during this period. 
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The results and discussion of the secondary objectives of this study are 
presented in chapter six. 
 
5.8 Conclusions 
 
We investigated the effects of three different regimens of intrathecal opioids 
(Group M100 - 100μg morphine, Group M50 - 50μg morphine, and Group F25 
- 25μg fentanyl) as part of the spinal anaesthetic for women having caesarean 
section surgery at RMMCH.  A comparison of the analgesic effects, side 
effects and the impact on patients’ post-operative experiences of all three 
regimens, were evaluated and compared in this randomized double-blinded 
study. 
 
One hundred patients were recruited into the study.  The data from 93 
patients were analysed and reported on.  There was no statistical difference in 
the basic characteristics of the patient populations between the three 
treatment groups. 
 
Patients in the two morphine groups (Group M100 and Group M50) used less 
PCA morphine than patients in Group F25 during the 24-hour evaluation 
period following surgery (Kruskal Wallis, p<0.001).  This difference in PCA 
morphine use was established in the first 12-hour evaluation period (Kruskal 
Wallis, p<0.001) and continued into the 2nd 12-hour evaluation period (Kruskal 
Wallis, p=0.01).  There was however, no statistical difference in the PCA 
morphine use between Group M100 and Group M50, implying that the 
analgesic efficacy of these two treatment regimens is the same.  It is 
important to note that the analgesic regimen that was used in this study 
included rectal indomethacin suppositories for 24 hours after surgery.  The 
synergistic effects of NSAIDs with intrathecal morphine have been previously 
demonstrated in patients having caesarean section surgery (Cardoso et al., 
1998).  The post-operative opioid requirements of the entire intention to treat 
cohort (n = 100) was also analysed, and corresponded with the results 
calculated for the 93 patients who fulfilled the study inclusion criteria.  This 
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implied that the data of the seven excluded patients did not materially affect 
the study outcome. 
 
The results of this objective of the study confirmed that intrathecal morphine, 
included as a component of the neuraxial anaesthetic solution for women 
having caesarean section surgery under single shot spinal anaesthesia at 
RMMCH, decreased the post-operative opioid requirements of these patients 
in the first 24 hours after surgery. 
 
5.9 Summary 
 
In this chapter the results of the primary objective of the clinical trial 
investigating the influence of different intrathecal opioid regimens on the post-
operative pain experiences of women having caesarean sections at RMMCH 
has been presented.  In the next chapter, the results of the secondary 
objectives of this study will be presented and discussed.  The study limitations 
and acknowledgements related to this study will also be presented. 
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CHAPTER SIX: The influence of two different intrathecal 
morphine doses compared to intrathecal fentanyl on patients’ 
post-operative pain experiences and its impact on the 
activities and emotions of women undergoing neuraxial 
anaesthesia for caesarean section 
 
6.1 Introduction 
 
Poorly treated pain can have an adverse psychological effect on a patient 
(Stephens et al., 2003).  The use of intrathecal morphine during anaesthesia 
for caesarean sections can provide good analgesia for the patient for a 
significant period after discharge from the recovery room (Palmer et al., 
1999).  Despite international evidence of the analgesic effects of intrathecal 
morphine for post-operative caesarean section analgesia, this method of 
analgesia is not popular in South Africa, as described in chapters 3 and 4. 
 
The background to the study, the study design, and description of the cohort 
were provided in chapter 5, and are therefore not recalculated here. For 
clarity, I have repeated the description of the secondary objectives of the 
study. 
 
6.2 Secondary objectives 
 
The specific secondary objectives of the study were: 
 
iii. To evaluate the analgesic effect of three different intrathecal opioid 
mixtures (100μg morphine, 50μg morphine and 25μg fentanyl) in 
women who had undergone caesarean section surgery, relating 
specifically to: 
a. Pain scores at two time points (12 hours and 24 hours) after 
surgery. 
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b. Sedation scores at two time points (12 hours and 24 hours) after 
surgery. 
c. Post-operative nausea scores at two time points (12 hours and 
24 hours) after surgery. 
d. Post-operative pruritus scores at two time points (12 hours and 
24 hours) after surgery. 
 
iv. To determine the impact that the patients’ post-operative pain had on 
their activities (movements in and out of bed, deep breathing or 
coughing, and sleeping), their emotional states and their perception of 
relief in the first 24 hours after surgery. 
 
6.3 Research Methodology 
The research methodology for this study was presented in chapter five. 
 
6.3.1 Data Analysis 
 
We analysed the prospectively collected data from patients who completed all 
trial requirements (per protocol cohort).  Clinical data from manually 
completed data collection sheets (APPENDICES O, S and T) were entered 
into a spreadsheet using Microsoft® EXCEL® for MAC (Version 14.6.2).   
 
Data were analysed using StatPlus, AnalystSoft Inc. - statistical analysis 
program for Mac OS®. (Version v6) and the statistical analysis program R 
(Version 3.2.3) (R Core Team, 2015) 
 
Continuous parametric data was described using mean and standard 
deviation.  Continuous non-parametric data was described using median and 
interquartile ranges.  Categorical data was described using frequencies and 
percentages. 
 
The post-operative pain scores at rest and with cough for both evaluation 
periods (12 hours and 24 hours) were described with minimum, maximum, 
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median values with interquartile ranges and compared using the Kruskal 
Wallis test.  The side effect profiles of each treatment group for respiratory 
depression, sedation, nausea and pruritus were described using the 
frequencies of each of the allocated scores and compared using a Kruskal 
Wallis statistical test.  The effect of pain on patient activities in bed (moving in 
bed, breathing deeply or coughing and sleeping), and out of bed were 
described using frequencies of the score categories and compared using a 
Chi-squared statistical analysis.  The effects of pain on the patients’ levels of 
anxiety were presented as a summary of the Numerical Rating Scale (NRS) 
scores of each group using minimum, maximum, median and interquartile 
ranges.  These were compared between the three treatment groups using a 
Kruskal Wallis statistical test.  The data were also categorized into four groups 
based on the impact of the pain on the patients’ levels of anxiety.  These data 
were described using the frequencies of the categories and compared using 
the Chi-squared test.  The effects of pain on the patients’ feelings of 
helplessness were presented as a summary of the NRS scores of each group.  
These were compared between the three treatment groups using a Kruskal 
Wallis statistical test.  Pairwise comparisons between the three treatment 
groups were also performed using the Wilcoxon rank sum test.  The patients’ 
perception of their pain relief was described as a summary of the scores of 
each group and a comparison between the groups was made using the 
Kruskal Wallis statistical test.  These data were also categorized into four 
groups based on the degree of pain relief that the patients felt, and reported 
as frequencies of the categories.  The patients need for additional pain 
treatment was reported as the frequencies of two categories (yes and no), 
and the three treatment groups were compared using a Chi-squared test.  
Patients’ scores of their level of satisfaction with their pain treatment was 
presented as a summary of the NRS scores of each group using minimum, 
maximum, median values and interquartile ranges.  Comparisons between the 
three treatment groups were performed using a Kruskal Wallis statistical test.  
The data were also categorized into four groups based on the levels of 
satisfaction with treatment.  These data were described using the frequencies 
of the categories and compared using the Chi-squared test. 
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6.4 Results and Discussion 
 
The results and discussion of the primary objective of this study were 
presented in chapter five.  In this chapter, the results and discussion related to 
the secondary objectives will be presented.  The patient characteristics of the 
study population and the list of excluded patients have been presented in 
chapter five. 
 
6.4.1 Post-operative pain scores 
 
Patients’ pain scores at rest and with cough were evaluated, using the NRS, 
at 12 hours and 24 hours after surgery.  These results are summarized in 
table 6.1. 
 
TABLE 6.1: NRS pain scores of patients at 12 and 24 hours after surgery 
Pain 
Assessment 
Group M100 
(n=32) 
Group M50 
(n=29) 
Group F25 
(n=32) p-value 
 
Pain at rest  
at 12-hour 
assessment  
Median = 1 
Min = 0 
Max = 6 
IQR = 2.25 
Median = 1 
Min = 0 
Max = 6 
IQR = 2 
Median = 1 
Min = 0 
Max = 9 
IQR = 3.25 
 
p = 0.1 
 
Pain with cough 
at 12-hour 
assessment  
Median = 2 
Min = 0  
Max = 9 
IQR = 5 
Median = 2 
Min = 0 
Max = 7 
IQR = 3 
Median = 3.5 
Min = 0 
Max = 10 
IQR = 7 
 
p = 0.08 
 
Pain at rest  
at 24-hour 
assessment  
Median = 2 
Min = 0 
Max = 8 
IQR = 2.5 
Median = 1 
Min = 0 
Max = 7 
IQR = 3 
Median = 2.5 
Min = 0 
Max = 10 
IQR = 4 
 
p = 0.3 
 
Pain with cough 
at 24-hour 
assessment  
Median = 3 
Min = 0 
Max = 8 
IQR = 4.25 
Median = 3 
Min = 0 
Max = 8 
IQR = 4 
Median = 5 
Min = 1 
Max = 10 
IQR = 5 
 
p = 0.08 
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In our study, pain was evaluated at rest and with cough at 12 and 24 hours 
after surgery.  Pain measurement with cough was used to determine the level 
of pain that the patient experienced on movement as opposed to lying still in 
bed.  Evaluation of pain with movement was a more accurate reflection of the 
real world situation that these women are exposed to, where they have to take 
care of their newborn babies. 
 
Our results showed that there was no statistically significant difference in the 
pain scores at rest or with cough between the three groups at either of the two 
evaluation periods.  The minimum pain score in all the groups at all evaluation 
times was zero. Maximum pain score reached 10/10 only in Group F25 for 
three out of the four evaluation points.  This was in contrast to the statistically 
different pain VAS scores noted by Cardoso et al (1998).  The authors of this 
study found that the pain scores of patients decreased as the dose of 
intrathecal morphine increased from 25μg to 50μg to 100μg.  In addition, with 
each different dose of intrathecal morphine, the pain VAS scores were also 
reduced in the groups of patients who received regular doses of intramuscular 
diclofenac.  However, pain scores in our study are in line with the results 
reported by Carvalho and Tenório (2013), who also evaluated the same doses 
of intrathecal morphine at two time periods after surgery (12 and 24 hours).  
Similar to our results, these authors did not find any statistically significant 
difference in patient pain scores between the two groups, at rest or with 
cough, at either time period evaluated. The patients in their study did not have 
access to PCA morphine in the post-operative period.  Patients were given 
tramadol hydrochloride as rescue analgesia when required.  Girgin et al 
(2008) also reported no difference in pain VAS scores at four hours and 24 
hours after surgery between all the intrathecal opioid groups they evaluated 
(100μg, 200μg, 300μg and 400μg), and also in comparison with the control 
group (no intrathecal opioid used).  Despite the similar pain VAS scores in 
these groups, there was a significant decrease in PCA morphine used with 
the increasing doses of intrathecal morphine evaluated, which is similar to 
what we have observed in our study. 
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One explanation of why there is no statistical difference in the pain NRS 
scores between each of the three groups in our study is that patients were 
repeatedly counseled on how to use the PCA pump to manage their pain, and 
could therefore freely administer analgesics to themselves (within the confines 
of the safety parameters set on the PCA pumps).  The patients were therefore 
able to effectively manage their pain with intravenous opioids, and 
subsequently the pain NRS score reflected good analgesia and cannot be 
considered to be a true reflection of the effectiveness of their intrathecal 
opioid.   
 
6.4.2 Side effects profile 
 
Patients were monitored and evaluated for the common side effects 
associated with intrathecal opioids i.e. respiratory depression, sedation, 
nausea and vomiting, and pruritus. 
 
6.4.2.1 Respiratory Depression 
 
Respiratory depression is an important side effect of opioid use and is of 
particular concern with regards to the use of intrathecal opioids, as discussed 
in chapters 3 and 4.  Current literature states that the risk of respiratory 
depression after the use of intrathecal morphine is low.  Dahl et al (1999) 
calculated that the number needed to harm (NNH) for respiratory depression 
with all types of opioids and using multiple doses, is 476 and is not 
significantly different from control groups. 
 
We assessed the respiratory rate of patients in our study at two time points 
after surgery (12 hours and 24 hours).  The Box and Whisker plot illustrating 
the respiratory rates for each of the three patient groups at the 12-hour and 
24-hour assessments is shown in Figures 6.1 and 6.2.  
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FIGURE 6.1: Box and Whisker plot of respiratory rates at 12-hour 
assessment 
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FIGURE 6.2: Box and Whisker plot of respiratory rates at 24-hour 
assessment 
 
There were no cases of bradypnoea in our study.  The median respiratory rate 
was 14 for all three treatment groups at both the 12-hour and 24-hour 
assessments.  The lowest respiratory rate documented was ten, and was 
documented at the 24-hour assessment in Group F25.  Since intrathecal 
fentanyl only has a duration of action of one to four hours (Lundgren et al., 
2016), it is unlikely that this respiratory rate of ten was related to the 
intrathecal opioid.  Statistical comparisons of the three treatment groups 
confirmed that there was no significant statistical difference in the respiratory 
rates between the three groups at the 12-hour assessment (Kruskal Wallis, 
p=0.9) or the 24-hour assessment (Kruskal Wallis, p=0.8). 
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The consequences of respiratory depression can be catastrophic, especially if 
a serious case is not detected and treated appropriately, however the risk of 
this side effect appears to be very low, especially when using low doses of 
intrathecal morphine, as was done in our study.  Kato et al (2008) conducted 
a retrospective review of 1915 obstetric patients who had received 150μg 
intrathecal morphine during their spinal anaesthetics, over a seven-year 
period, and reported that only 5/1915 patients experienced respiratory 
depression that could be attributed to the intrathecal opioids.  Of these 
patients, only one patient had severe respiratory depression that required 
naloxone therapy.  Abouleish et al (1991) studied the effects of 200μg 
intrathecal morphine in 856 women having caesarean section surgeries.  
These authors defined respiratory depression as an arterial oxygen 
saturation(SpO2) < 85% or a respiratory rate < 10 breaths per minute.  Only 
8/856 (0.93%) of patients were documented to experience respiratory 
depression.  All of these patients were noted to be markedly obese.  The 
morphine doses used in our study were 33% (Group M100) and 66% (Group 
M50) lower than the doses studied in the Kato et al (2008) review and also at 
least 50% lower than the dose evaluated in the Abouleish et al (1991) study.  
Based on the results of their clinical investigations, Palmer et al (1999) 
concluded that the side effects of intrathecal morphine are directly 
proportional to the dose of morphine used, however their study was not 
designed to detect respiratory depression.  The very low doses of intrathecal 
morphine that we have studied are therefore less likely to cause to respiratory 
depression, than the risks quoted by both Kato et al (2009) and Abouleish et 
al (1991).   
 
The dose of intrathecal morphine that is used in an obstetric spinal 
anaesthetic is an important factor to consider when evaluating the risk of 
respiratory depression.  Carvalho and Tenório (2013) reported no cases of 
respiratory depression in their series of 123 patients using doses of intrathecal 
morphine similar to what we used in our study (50μg and 100μg).  The 
authors noted that the absence of respiratory depression in their cohort did 
not mean that the risk is negligible but rather that the sample size of their 
study may have been too low to detect it considering that this is a rare side 
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effect.  Mikuni et al (2009) also investigated the effects of 50μg and 100μg 
intrathecal morphine and reported no cases of respiratory depression in their 
study of 76 patients.  Cardoso et al (1998) and Salmah and Choy (2009) 
reported that no patients experienced respiratory depression in their studies of 
120 and 60 patients respectively.  While we also had no cases of respiratory 
depression in any of our treatment groups, our study was not powered to 
detect respiratory depression differences.  The results that we obtained in our 
study, with regards to the incidence of respiratory depression, does however 
appear to be corroborated by similar findings of comparatively sized studies 
investigating similar doses of intrathecal opioids. 
 
6.4.2.2 Sedation 
 
Patients’ levels of sedation were evaluated at the two post-operative 
evaluation periods using the three-point scale described in the methodology 
section of chapter five (section 5.6.5) 
 
The levels of sedation were low in all patients.  The majority of patients had a 
sedation score of zero or one in all the treatments groups at both time points.  
No patients were evaluated to have a sedation level of three in any of the 
treatment groups.  We determined that there was no statistical difference in 
the sedation scores of patients between any of the treatment groups at 12 
hours (Kruskal Wallis, p=0.8) and 24 hours (Kruskal Wallis, p=0.2).  These 
results are illustrated in Figures 6.3 and 6.4. 
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FIGURE 6.3: Box and Whisker plot of sedation scores at 12-hour 
assessment 
 
 
FIGURE 6.4: Box and Whisker plot of sedation scores at 24-hour 
assessment 
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Using the same intrathecal morphine doses that we have used, Carvalho and 
Tenório (2013) reported that there were no cases of sedation in their cohort of 
123 patients being evaluated for differences in efficacy and side effects of the 
two different doses of intrathecal morphine.  In a double-blinded placebo 
controlled evaluation of oral treatments to manage the side-effects of 
intrathecal morphine, Abboud et al (1990) reported a 23% incidence of 
somnolence in patients receiving 250μg intrathecal morphine as part of their 
anaesthetic for their caesarean section.  Side effects associated with 
intrathecal morphine tend to increase as the dose of morphine increases 
(Palmer et al., 1999).  The lower doses of morphine used in our study, and in 
the study by Carvalho and Tenório (2013), were mostly likely to be the reason 
that somnolence was not a problem for any of the patients in these studies. 
 
The goal of improved analgesic levels in women after caesarean section 
surgery is to support mother-baby interactions in the early post-operative 
period.  High levels of sedation would be counter-productive to this goal.  The 
absence of high levels of sedation in our study was therefore an important 
finding, as this could facilitate bonding between the mother and baby in the 
post-operative period.   
 
6.4.2.3 Nausea  
 
We evaluated patients for nausea at 12 and 24 hours after surgery.  The 
majority of patients had no nausea at the 12-hour assessment (68/92) and 24-
hour assessment (78/82).  There were however six patients (5/32 (15%) in 
Group M100 and 1/31 (3%) in Group F25) who had severe vomiting and 
required treatment at the 12-hour assessment.  Their data were excluded 
from the 24-hour analysis.  One patient in Group F25 had severe vomiting 
which required treatment prior to the 12-hour assessment, and therefore this 
patient’s 12-hour assessment was excluded from analysis.  At the 24-hour 
assessment only 2/30 (6.7%) patients in Group F25 reported severe vomiting 
requiring treatment.  The nausea and vomiting scores are illustrated in 
Figures 6.5 and 6.6. 
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FIGURE 6.5: Box and Whisker plot of nausea scores at 12-hour 
assessment 
 
 
FIGURE 6.6: Box and Whisker plot of nausea scores at the 24-hour 
assessment 
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The occurrence of post-operative nausea and vomiting (PONV) following 
neuraxial morphine administration is reported to occur in up to 80% of patients 
(Dominguez and Habib, 2013).    In our study only 15% of patients had severe 
nausea and there was no statistical difference between the three groups of 
patients for the occurrence of nausea and vomiting at 12 hours (Kruskal 
Wallis, p=0.3) and 24 hours (Kruskal Wallis, p=0.1). 
 
Mikuni et al (2009) compared similar doses of intrathecal morphine as we 
have investigated, and reported PONV in 8% (2/25) of patients in the 50μg 
morphine group and 20% (5/25) in the 100μg morphine group, but did not find 
a statistical difference in the occurrence of PONV between any of the patient 
groups (0μg, 50μg and 100μg intrathecal morphine).  Sarvela et al (2002) also 
found that PONV occurred in 16% of patients in the 100μg intrathecal 
morphine group and this increased to 28% in the 200μg intrathecal morphine 
group, but again there was no statistical difference in the occurrence of PONV 
between these groups.  The results of these studies and of our study concur 
with the opinions expressed by Palmer et al (1999), that there does not 
appear to be a relationship between the dose of intrathecal morphine used 
and the occurrence of PONV.  Salmah and Choy (2009) found a high 
incidence of PONV in both the fentanyl and the morphine groups (48.1% vs. 
63.6%) in the first six hours after surgery in their study.  There was also a 
statistically higher number of patients, in the 100μg intrathecal morphine 
group, that required intravenous treatment for PONV compared to the 25μg 
fentanyl group (54.5% vs. 14.8%) (p<0.04).  These results are higher than 
those found in our study where only 15%(5/32) and 6.3%(2/32) of patients 
required treatment for PONV in the 100μg morphine and 25μg fentanyl groups 
respectively.  No patients required treatment for PONV in the 50μg morphine 
group.  Based on the results of Salmah and Choy (2009) and of our study, it 
appears that 50μg intrathecal morphine is the most suitable dose to use, with 
regards to having the lowest risk of PONV.  However, our study was not 
powered to detect any differences in PONV between the three treatment 
groups and the recommendations regarding the appropriate dose of 
intrathecal morphine must be read with this in mind. 
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6.4.2.4 Pruritus 
 
Itchiness after surgery is an issue of great concern for patients who are 
having a caesarean section (Carvalho et al., 2005).  Pruritus can have a 
negative influence of a patient’s level of satisfaction with the post-operative 
care after a caesarean section.  We scored patients’ pruritus based on their 
experiences at two time points after surgery (12-hours and 24-hours).  The 
results of these evaluations are illustrated in Figures 6.7 and 6.8. 
 
 
FIGURE 6.7: Box and Whisker plot of pruritus scores at the 12-hour 
assessment 
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FIGURE 6.8: Box and Whisker plot of pruritus scores at the 24-hour 
assessment 
 
Most patients in the study had no pruritus or only mild to moderate pruritus 
that did not require treatment.  Only 1/32 (3.125%) patient from Group M100, 
and 1/32 (3.125%) patient from Group F25 had severe pruritus, which 
required treatment, in the first 12 hours after surgery.  These patients’ data 
were excluded from the pruritus data analysis at the second assessment 
because they received treatment for pruritus at the 12-hour assessment.  At 
the 24-hour assessment 1/29 (3.4%) patient in the M50 group had severe 
pruritus, however the patient refused treatment, and was included in the data 
analysis.  There was no statistical difference between the three groups for 
pruritus at either the 12-hour assessment (Kruskal Wallis, p=0.3) or the 24-
hour assessment (Kruskal Wallis, p=0.8). 
 
Dahl et al (1999) conducted a systematic review of randomized controlled 
trials addressing the analgesic efficacy and adverse effects of intrathecal 
opioids used for anaesthesia for caesarean section surgery.  The authors 
calculated that the NNH for pruritus with intrathecal morphine was 2.6 
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(95%CI, 2.1 – 3.3) and with fentanyl was 2.2 (95%CI, 1.8 – 2.7).  McDonnell 
et al (2009) estimated that 43% of patients would experience pruritus when 
given a 100μg dose of intrathecal morphine.  The results of our study do not 
agree with this calculation.  Only 3% of patients in Group M100 in our study 
experienced pruritus that required treatment.  If we include the patients who 
experienced mild pruritus  (not requiring treatment), the incidence of pruritus 
for patients in Group M100 is still only 9/32 (28%) at the 12-hour evaluation 
and 5/31 (16%) at the 24-hour assessment.  Mikuni et al (2009) found no 
difference in the frequency of pruritus between patients in the 50μg and 
100μg intrathecal morphine groups, but did find a statistically significant 
difference in the frequency of pruritus between the 100μg morphine group and 
the control group.  The frequency of pruritus was 10/25(40%) in the 50μg 
group and 16/25(64%) in the 100μg morphine group in their study.  This was 
higher than the occurrence of pruritus in the same groups in our study.  
Carvalho and Tenório (2013) reported that in both their 50μg and 100μg 
intrathecal morphine groups there was a higher incidence of pruritus 
experienced at the first post-operative evaluation (12 hours) compared to the 
second evaluation (24 hours) (67% and 83% vs. 17% and 30% respectively).  
In their 100μg group, patients ranked pruritus as the 2nd most important factor 
that caused them discomfort over the 24 hours after surgery.  Pain was 
ranked as the most important factor.  Cardoso et al (1998) used a 
combination of intrathecal morphine and IV NSAIDs to treat post-caesarean 
section pain and also found a statistically greater incidence of pruritus in the 
100μg morphine groups irrespective of whether NSAIDs were used.  Palmer 
et al (1999) found that the risk of developing pruritus and the need for 
treatment increases in direct proportion to the dose of intrathecal morphine.  
In our study there was no statistical difference in the occurrence of pruritus 
between the two morphine groups despite the increased dosage used in 
Group M100.  Salmah and Choy (2009) compared 100μg intrathecal 
morphine to 25μg intrathecal fentanyl and similar to our study, found no 
difference in the incidence of pruritus between the morphine and fentanyl 
groups.  However, the incidence of pruritus in each group was 54.1% vs. 
51.8% respectively.  This is much higher than the incidence observed in our 
study.  
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The low incidence of pruritus in all groups in our study is not in keeping with 
comparative studies investigating the efficacy of similar doses of intrathecal 
opioids.  This discrepancy may be explained by our patient population having 
a higher tolerance of pruritus, or a fear to report the side effects.  Investigating 
the reasons behind this statistical anomaly is warranted for future studies but 
is beyond the scope of this study. 
 
6.4.3 Effect of pain on patient activities  
 
Pain and medication side effects are important considerations when 
evaluating the success of post-operative analgesia, however it is also 
important to assess the effect that pain has on the patients activities in the 
post-operative period. 
 
Good pain management after surgery will enable the recovering patient to be 
more physically active and mentally alert (Breivik, 1995).  It is important for a 
new mother to be mobile in order to allow her to take care of, and bond with, 
her newborn baby.  Pain can have a negative impact on her ability to do this 
by limiting the mother’s ability to move around and also because of the 
negative emotional impact that it can have on her psyche (Stephens et al., 
2003). 
 
We evaluated the effect that the patients’ pain had on their post-operative 
experiences in the first 24-hours after surgery addressing issues related to 
their activities, the impact on their emotional state and also their level of 
satisfaction with their analgesia after surgery.  These results are discussed 
below. 
 
 
 
 
 
 
  
6.4.3.1 Activities in bed
 
Patients were asked to rate, on a scale from 0 to 10, how much their pai
interfered with or prevented them from:
 
a) Doing activities in bed
The responses were categorized into groups based on the score they 
allocated to the level of interference.  The results of the impact of the pain on 
their activities in bed are illustrated 
 
FIGURE 6.9: Influence of pain on patients’ activities in bed
 
In our study, 9/32 (28%) of patients in 
severely impaired (scores = 8 
This was compared with 3/32 (9%) in 
M50.  Analysis of these results indicated that there was no statistical 
difference between the different groups responses regarding the impact 
pain on their activities (Chi
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 b) Breathing deeply or coughing
Patients scored the level of interference that their pain 
breath deeply or cough.  This data was sorted into four categories according 
to level of impact and is gr
 
FIGURE 6.10: Influence of pain on patients’ ability of breath deeply or 
cough 
 
30/93 (32%) of patients across all three treatment groups (
Group M50 - 14, Group F25
(scores = 4 - 7) affected their ability to breathe deeply or cough in the 24 
hours after surgery. Surprisingly, more patients in 
indicated that their breathing was severely affected
than in Group M50 (1/29), despite the fact that the patients in 
received a lower dosage of intrathecal morphine. Reduction of breathing 
movements can result in lower tidal volumes, and decreased minute 
ventilation during the post
alveoli and a reduction in oxygen transport across the pulmonary membranes 
(Stephens et al., 2003).  Pulmonary complications following surgery can have 
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their ability to 
 
 - 9, 
 
 (5/32) 
– 10) by pain 
Group M50 
showed 
 regards to the effect of pain on the patients’ abilities to breathe deeply or 
cough (Chi-squared, p=0.185).
 
c) Sleeping 
Most patients only regarded their pain as mildly affecti
(scores = 1 – 3), and there was no statistical difference between the three 
treatment groups in this study (
responses to this question is illustrated in Figure 6.11
 
FIGURE 6.11: Influence of pain on patients’ ability to sleep
 
6.4.3.2 Activities out of bed
 
Patients were asked, if they had been out of bed, how much did their pain 
interfere with or prevent them from doing activities out bed
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bed at the time of the 24
this question.  The results of this questio
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 and one patient in Group F25 had not been out of 
-hour assessment and therefore did not respond to 
n are illustrated in Figure 6.12
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. 
 FIGURE 6.12: Influence of pain on patients’ activities 
 
Of the 91/93 patients who had mobilized out of their bed by the time the 24
hour assessment was done, there were 6/31 (19%) patients from 
who indicated that the pain severely limited 
while out of bed.  Fewer pat
3.4%) found the pain to be severely limiting to their out of bed activities.  
There was however no statistical difference between the three groups with 
regards to the interference caused to out
p=0.25).  The post-operative
developing a DVT (Stephens 
important preventative measure to avoid this complication.  Practically, the 
limitation of out-of-bed activities will impact the mother’s ability to bath and 
change her baby in the first day after birth.  Karlstrom 
that half of the patients in their study described their 
having a large negative im
Feeding and caring for the newborn infant is an important part of bonding 
process between the mother and baby, and therefore should be assisted by 
good pain control as much as possible.
the intrathecal morphine groups having their activities severely affected by 
their pain, implies that patients in these treatment groups may have been 
more likely to take care of their babies with less strain.
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6.4.4 Effect of pain on emotional state 
 
The International Association for the Study of Pain defines pain as “an 
unpleasant sensory or emotional experience associated with actual or 
potential tissue damage or described in terms of such damage” (Merskey et 
al., 1979).  Pain can therefore have an important influence on a patient’s state 
of mind.  This is especially true in the post-partum patient, who is 
experiencing changes in their hormone levels (Smith et al., 1990), which 
places them at increased risk of emotional lability. 
 
We asked patients to rate the impact that their pain had on their emotional 
state with particular reference to their levels of anxiety and of feelings of  
helplessness. 
 
Patients were asked how much the pain caused them to feel: 
 
a) Anxious 
 
These results are summarized in table 6.2. 
 
TABLE 6.2: Summary of NRS scores on the impact of pain on patients’ 
state of anxiety 
Assessment Group M100 
(n=32) 
Group M50 
(n=29) 
Group F25 
(n=32) p-value 
 
Level of 
Anxiousness 
Median = 0 
Min = 0 
Max = 9 
IQR = 4 
Median = 3 
Min = 0 
Max = 10 
IQR = 5 
Median = 2 
Min = 0 
Max = 8 
IQR = 5 
 
p = 0.25 
 
The median score in all three groups was low.  There was no statistical 
significance between the three treatment groups (Kruskal Wallis, p=0.25). 
 
 In order to make this data more meaningful
groups based on the significance of the impact on their state of anxiety: no 
impact (score = 0), mild impact (scores = 1
7), extreme impact (scores = 8
6.13.  
 
FIGURE 6.13: Summary of the categories of impact of pain on anxiety  
 
Pain and discomfort can have a profound impact on a patient’s perception of 
their quality of life and their sense of health 
inadequate pain management or increased side effects from analgesics can 
reduce a patient’s quality of life, especially if this poor analgesia occurs over 
an extended period (Breivik, 1995)
treatment groups in our study, did not think that their pain had any impact on 
their level of anxiety (
12/32) by indicating a score of zero.  There is no significant difference, either, 
in the categories of impact between
p = 0.87).  However, this does not necessarily imply that patients were not 
experiencing anxiety.  It merely means that the patients did not think that their 
pain was impacting their anxiety.  As all patients in th
mothers, it is not unreasonable to assume that they all were experiencing 
some level of anxiety associated with being a new parent. This study was 
however not designed to evaluate levels of anxiety in the treatment groups.
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.  In addition, 
Group F25-
Chi-squared, 
 
p=0.87
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b) Helplessness 
The scores of each of the three treatment groups for this question are 
summarized in Figure 6.14. 
 
 
FIGURE 6.14: Summary of NRS scores on the impact of pain on patients’ 
level of helplessness   
 
Initial analysis of the scores rating the impact of pain on patients’ feelings of 
helplessness, using the Kruskal-Wallis analysis, showed that there was a 
statistical difference between the three treatment groups with regards to the 
effect that their pain had on their state of helplessness (Kruskal Wallis, 
p=0.04).  We then conducted pairwise comparisons using the Wilcoxon rank 
sum test on the data, to determine exactly where this difference occurs.  The 
more detailed analysis of the groups showed that there was no statistical 
difference between the groups.  This anomaly in the statistical significance 
was due to the sample not being powered to determine a difference in this 
parameter.    
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Our results seemed to indicate that there was a trend that pain has an 
increased impact on patients’ perceptions of helplessness in the treatment 
Group F25.  This was also the group that used a statistically higher amount of 
PCA morphine in the first 24-hours after surgery.  This may imply that poor 
pain control contributes to greater feelings of helplessness, however this 
relationship will have to be investigated further in a study powered to assess 
this relationship. 
 
6.4.5 Patient satisfaction 
 
The level of patient satisfaction after surgery is a complex issue to probe.  
There are many confounding factors that will influence whether a patient is 
satisfied with their post-operative experience.  Pain forms one part of this 
complex issue.   
 
Patients were asked how much pain relief (in percentage) they have received 
since their surgery.  The results of this question are summarized in Figure 
6.15. 
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FIGURE 6.15: Summary of scores of percentage of pain relief perceived 
by the patient  
 
The pain relief experienced by patients in all three treatment groups was very 
similar.  The maximum relief recorded in all groups was 100% and all groups 
had a similar median (Group M100=75, Group M50=70, Group F25=70). No 
patient in this study, irrespective of their allocated treatment group expressed 
that they had no pain relief.  Statistical analysis showed that there was no 
statistical difference between the three treatment groups (Kruskal Wallis, 
p=0.8).   
 
Categorizing the same data into groups, based on impact, also reveals that 
the majority of patients in all groups in our study experienced a high level of 
pain relief after surgery. These results are illustrated in figure 6.16. 
 
  FIGURE 6.16: Categories of scores of the patients’ perceptions of pain 
relief 
 
One explanation for this is that all patients, irrespective of the treatment group 
to which they were allocated, had access to PCA morphine, and could 
therefore freely and effectively manage their pain after surgery.  This is a 
confounding factor in studie
PCA morphine (which is used to primarily evaluate the effect of the 
intervention being investigated) and this access will influence the patients’ 
pain NRS scores and also their perception of the success of t
treatment.  
 
Patients were asked if they would have liked more pain treatment than they 
received.  These results are summa
 
TABLE 6.3: Perceptions of need for more pain treatment
Assessment Group M100
(n=32)
Need for more 
pain treatment 
YES = 13(45%)
NO = 19(65%)
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YES = 6(21%) 
 
NO = 23(79%) 
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NO = 17(53%) 
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p-value 
 
p = 0.8 
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The majority of women in all the treatment groups did not want more pain 
treatment than they received.  This finding extended across all the treatment 
groups and there was no statistical difference between the three treatment 
groups (Chi-squared, p=0.8).  Karlstrom et al (2010) had similar findings in 
their study, where despite 44% of the women reporting a VAS score ≥ 4, most 
of the patients felt that they received the all pain relief that they needed.  One 
possible reason for these findings is that many women seem to have a 
perception that there should be pain as part of the birthing process and 
therefore are accepting of any pain that they may have after their caesarean 
section surgery. 
 
Patients were asked to rate their level of satisfaction with their pain relief since 
their surgery, on a scale of 0 to 10.  The results of this question are tabulated 
in Table 6.4. 
 
TABLE 6.4: Scores of satisfaction with pain relief provided 
Assessment Group M100 
(n=32) 
Group M50 
(n=29) 
Group F25 
(n=32) p-value 
 
Level of 
satisfaction  
Median = 9 
Min = 1 
Max = 10 
IQR = 2.25 
Median = 8 
Min = 0 
Max = 10 
IQR = 3 
Median = 8 
Min = 0 
Max = 10 
IQR = 4 
 
p = 0.5 
 
Statistical analysis shows that there is no statistical difference between the 
three treatment groups with regards to the patients’ satisfaction of their pain 
management following surgery (Kruskal Wallis, p=0.5). 
 
Categorizing the data into groups based on the levels of satisfaction shows 
that most patients are extremely satisfied (scores = 8 – 10) with their 
analgesia across all the treatment groups.  These results are illustrated in 
figure 6.17. 
 
 As stated above, there are many factors that contribute towards satisfaction 
levels following surgery.  This
results. 
 
FIGURE 6.17: Categories of scores of the patients’ level of satisfaction 
of their pain relief 
 
In the group of patients who rated their satisfaction as 8/10 or above, the 
highest percentage of satisfied patients are from 
there is no statistical significance to this finding (
 
6.5 Study limitations 
 
• A consecutive convenience sampling 
into the study.  This is not an ideal method to recruit patients into a clinical 
trial as the method may result in a false 
population. The convenience sampling 
time constraints and scope of the research.
future investigation into this topic should ensure that consecutive patients 
are recruited for the clinical trial. 
• The patient treatment group allocat
the treating anaesthetic service provider was aware of the patients’ group 
allocation.  This was necessary in order to allow the treating doctor to 
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administer the correct medication in the spinal anaesthetic and also to be 
aware of the medication that the patient was given in the event that an 
emergency occurred during surgery.  The PI however remained blinded to 
the treatment groups until the study was completed and the patient 
groupings were unblinded. 
• The exclusion of women whose babies were not with them by the 12-hour 
assessment may have masked potential side effects of the study 
medication in these babies.  However, all these babies were (for other 
clinical indications) admitted to the paediatric intensive care unit and 
therefore any medication side effects would have been detected and 
treated.  Furthermore, it is extremely unlikely that any of the study 
medication could have been transferred to the baby due to the fact that the 
medication was administered intrathecally to the mother and the baby was 
delivered shortly after this administration, leaving very little time for 
systemic absorption in the mother and transfer to the baby via the 
placenta. 
• The study was only powered to detect a significant difference for the 
primary objective.  Some of the secondary objectives revealed results that 
pointed towards trends in the data but no statistically significant results 
were found. 
• Many of the secondary objectives investigated e.g. activities out of bed, 
levels of anxiety and feeling helplessness are not validated measures  
 
6.6 Conclusions 
 
The analgesic effects of three different intrathecal opioid regimens were 
evaluated in 100 patients undergoing caesarean section surgery at RMMCH. 
The treatment groups were Group M100 - 100μg morphine, Group M50 - 
50μg morphine and Group F25 - 25μg fentanyl.  Seven patients were 
excluded from the data analysis.  The data from 93 patients were analysed. 
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We presented and discussed the results related to the impact of the three 
treatment regimens on post-operative analgesic requirements in chapter five. 
 
In chapter six, we have presented and discussed the results of this study 
pertaining to the side effects of intrathecal opioids and also on the effect of the 
investigated intrathecal opioid regimens on the patients’ post-operative 
activities, their emotional states and the perception of their pain relief in the 
first 24 hours after surgery. 
 
Despite the statistically significant difference in PCA morphine use between 
the different treatment groups in our study, we found that there was no 
difference in the side effect profile between the three treatment groups.  No 
serious side effects occurred in this study.  The side effects profile with 
regards to sedation, nausea, pruritus and respiratory depression were similar 
across all the treatment groups.  We also found that the pain NRS scores 
between the groups at rest and with cough were similar.  This discrepancy 
between the PCA morphine use and the patients’ pain scores is most likely 
due to the patients having access to PCA morphine and therefore they were 
able to effectively manage their pain and keep their pain scores low.   
The effect of the pain on the patients’ activities and emotions were similar 
between the three treatment groups.  There was also no statistical difference 
in the levels of patient satisfaction between the treatment groups in this study. 
 
Based on the results of this study presented in chapters five and six, patients 
treated with 50μg and 100μg intrathecal morphine require less post-operative 
analgesia than patients who are treated with 25μg fentanyl in the first 24 
hours after caesarean section surgery.  There is no difference in the physical 
or emotional side effects of the three treatment regimens.  It is therefore 
feasible and advisable that the use of 50μg intrathecal morphine should be 
advocated in patients having caesarean sections in South Africa. 
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6.7 Summary 
 
In this chapter the results of the secondary objectives of the clinical trial 
investigating the influence of different intrathecal opioid regimens on the post-
operative pain experiences of women having caesarean sections at RMMCH 
has been presented.  In the next chapter, the conclusion of this PhD research 
project will be presented. 
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CHAPTER SEVEN: Conclusion 
 
The caesarean section rate in South Africa is high and is above the World 
Health Organisation (WHO) recommended rate of 10 – 15% (Moodley, 2010).  
This phenomenon is not unique to South Africa.  There appears to be a global 
trend towards increasing surgical deliveries (Macfarlane et al., 2015).  The 
rise in surgical deliveries is likely to be due to the more defensive practice of 
obstetrics, due to an upsurge in malpractice litigation against obstetricians, as 
well as from an increase in maternal requests.  As a result of this high 
percentage of caesarean section deliveries, the anaesthetic management of 
the obstetric patient in South Africa has become increasingly important.  This 
refers to both the intra-operative and post-operative management of these 
patients.  Good anaesthetic management has the potential to improve 
patients’ birth experiences and decrease the risk of post-operative morbidity.   
 
There are a number of international guidelines (Apfelbaum et al., 2016, 
Griffiths et al., 2011, Horlocker et al., 2009, Schug et al., 2015) available with 
recommendations about the anaesthetic management of patients who are 
having caesarean section surgery.  However all these guidelines have been 
established in developed countries that have relatively sophisticated health 
care systems and lower resource constraints as compared to South Africa 
and other developing countries.   
 
My PhD research study has developed a reference standard for caesarean 
section anaesthesia in South Africa by canvassing the expert opinion of 
anaesthesiology academic leaders in the country on this topic. This South 
African reference standard has been discussed in relation to current 
international standards from more affluent countries and compared to the 
practice of South African anaesthetic service providers, which has been 
determined from a national survey of anaesthetic practice that I conducted 
over a 10-month period in South Africa in 2014.  The national survey also 
attempted to establish the opinions of practitioners about their impressions of 
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their patients’ levels of satisfaction with their post-operative pain management 
following caesarean section surgery. 
 
The final component of my PhD research study was a double blind clinical trial 
comparing the analgesic effects of the current standard of caesarean section 
anaesthetic care in South Africa with analgesic modalities proposed in the 
international literature, taking cognisance of the resource limitations within the 
South African health care environment.  This clinical trial was the first 
randomized double-blinded clinical trial to evaluate the effect of different 
intrathecal opioids on post-operative pain experiences in women who have 
undergone caesarean section surgery in South Africa.  The unique South 
African health care environment, and our patient populations that are different 
from the populations in developed countries, makes this a distinctive clinical 
investigation. 
 
7.1 Summary of the results 
 
To develop a reference standard for the anaesthetic management of patients 
having caesarean section surgery in South Africa, the heads of department of 
the eight academic anaesthesiology departments in South Africa were invited 
to participate in a process to develop such a standard.  All South African 
trained specialist anaesthesiologists train in one of these departments and 
therefore the standard set by the academic departments ultimately determines 
the reference standard of anaesthetic care for patients having caesarean 
sections in South Africa.  All universities participated in this process of 
reference standard setting.  Departments were represented either by the head 
of department and/or the obstetric anaesthesia expert from the department. 
 
The national survey of obstetric anaesthesia practices in South Africa was the 
only survey of this kind ever conducted in South Africa.  Anaesthesiology 
service providers were invited to participate in this survey to provide details on 
their practice of obstetric anaesthesia.  The responses of 933 anaesthetic 
service providers were analysed.  Practitioners from all nine provinces in 
South Africa participated in the study, with the majority of the respondents 
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being from the three most populated provinces in the country – Gauteng, 
Western Cape and KwaZulu-Natal.  There was equivalent representation from 
the public and private health care sectors.  Analysis of the responses showed 
that there was a statistical difference between the obstetric anaesthesia work 
exposure of doctors in the private and public sectors in South Africa. 
 
In the clinical trial one hundred patients were randomized into three different 
treatment groups, each of which received different intrathecal drugs / dosages 
(Group M100 - 100μg morphine, Group M50 - 50μg morphine and Group F25 
- 25μg fentanyl).  Patients were evaluated on their post-operative analgesic 
requirements, pain scores, side effects profile and level of satisfaction with 
treatment. 
 
During the expert interviews, the South African experts unanimously proposed 
single shot spinal anaesthesia as the preferred anaesthetic technique for 
patients having elective caesarean sections.  They also recommended 0.5% 
bupivacaine with dextrose, at a dose of 1.8 – 2.1 ml (9 – 10.5mg), as the 
preferred local anaesthetic for obstetric spinal anaesthesia.  The national 
practice survey revealed that the majority of the respondents (97.8%) 
performed single shot spinal anaesthesia as their primary anaesthetic for 
elective caesarean sections.  The preferred choice of local anaesthetic for the 
neuraxial block, for 95% of the survey respondents was 0.5% bupivacaine 
with dextrose.  The median volume of this local anaesthetic used by 
specialists was 2.00ml and 1.80ml by non-specialists.  This difference in 
volume of local anaesthetic used in the spinal anaesthetic (0.20ml) was 
statistically significant (p<0.001) and may be reflective of the difference in the 
understanding by these two categories of doctors of the importance of 
ensuring a successful spinal block in the parturient.  
 
The lipophilic opioid, fentanyl, at a dose of 10 – 25mcg, was recommended as 
the reference standard adjuvant drug to be added to the spinal anaesthetic 
mixture.  The use of intrathecal morphine was not recommended due to 
concerns about side effects of this drug.  The majority of respondents 
(654/933) in the survey reported that they used fentanyl as an adjuvant agent 
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in their spinal anaesthetic solution.  Of these, 342 were specialists and 312 
were non-specialists. Statistical analysis showed that there was a statistical 
difference in the use of fentanyl between specialists and non-specialists.  The 
mean dose of fentanyl used by each group was also statistically different.  
Specialists used a mean fentanyl dose of 15.12μg while the non-specialists 
used a mean dose of 13.77μg.  Both these dosages fell within the dosage 
range recommended by the experts for use in South Africa.  A much lower 
number of anaesthetic service providers used sufentanil as an adjuvant agent 
in their spinal anaesthetics.  There was also a statistical difference in the use 
of this agent between specialists and non-specialists.  Only 32/933 people 
responded that they used intrathecal morphine for their obstetric spinal 
anaesthetics.  This was in line with recommendations from South African 
experts and this was most likely due to the current teaching practices in the 
anaesthesiology academic departments.  The recommendation that morphine 
not be used in post-caesarean section patients was in line with the South 
African Acute Pain Management guidelines (Lundgren et al., 2016) but was 
contrary to multiple international studies which demonstrated that intrathecal 
morphine offered good, safe and effective analgesia for post-caesarean 
section pain (Cardoso et al., 1998, Palmer et al., 1999, Salmah and Choy, 
2009, Abboud et al., 1988, Girgin et al., 2008, Swart et al., 1997). 
 
With regards to the needle that should be used to perform the spinal 
anesthetic, all the experts interviewed agreed that the pencil point needles 
(Wittacre, Sprott, Pencan or Eldor) were the recommended spinal anaesthetic 
needles. There was also consensus that the cutting Quincke spinal needle 
should not be used to perform a spinal anaesthetic for obstetric patients.  The 
Qunicke needle is associated with a greater risk of developing post-dural 
puncture headaches (PDPH) (O'Connor et al., 2007).   The majority of 
respondents to the survey reported that they preferred to use a pencil point 
needle to perform the spinal anaesthetic.  However there were still 30% of the 
doctors who indicated that they choose to use the cutting Quincke spinal 
needle.  This practice was contrary to the proposed reference standards of 
practice for South Africa, and may be considered to constitute negligent 
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practice, considering the increased risks associated with using this type of 
needle. 
 
For emergency cases, where the patient has an indwelling labour epidural 
catheter, a “top up” of the epidural was recommended to create an adequate 
level of surgical anaesthesia for the procedure.  The recommended local 
anaesthetic for the epidural top-up was 2% lignocaine.  No consensus was 
reached by the experts, on the appropriate adjuvant agent that should be 
added to the local anaesthetic solution for the epidural top-up.   The experts 
recommended that fentanyl, morphine, sodium bicarbonate and adrenalin 
could be considered.  The current South African practice was that 71% of 
anaesthetic service providers choose to “top-up” the epidural anaesthetic for 
the caesarean section in a labouring patient with an in situ epidural catheter.  
This was in accordance with the reference standard proposed.  There were 
22% of the survey respondents who removed the epidural catheter and 
performed a spinal anaesthetic, while only 5% would perform a general 
anaesthetic for these patients.  There was a statistical difference between the 
practises of specialists and non-specialists for each of these three anaesthetic 
techniques.  0.5% bupivacaine was the local anaesthetic of choice for the 
epidural “top-up” in 47% of respondents while 33% of respondents preferred 
to use 2% lignocaine.  It appeared that a large proportion of practitioners in 
South Africa do not use the local anaesthetic recommended by the proposed 
reference standard.   Fentanyl was the most common drug additive used for 
epidural “top-up’s” however a similar number of respondents preferred not to 
use any additive agent in the “top-up” solution.  This division in common 
practises regarding epidural adjuvants is most probably a reflection of the 
non-committed standpoint of the experts regarding this issue. 
 
Epidural anaesthesia was not recommended, by the experts, as a primary 
anaesthetic technique for caesarean sections unless it was part of a 
combined-spinal-epidural (CSE) technique, and the patient was then 
managed in a high-care environment post-operatively, where the epidural 
could be utilized for post-operative analgesia. 
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The reference standard with regards to post-operative monitoring practices 
was that all patients who received neuraxial opioids as part of their 
anaesthetic should be monitored for respiratory depression in the post-
operative period.  The recommended duration of monitoring was dependent 
on the type of opioid used.  For lipophilic opioids, monitoring for up to 12 
hours was recommended.  When hydrophilic opioids were administered 
neuraxially, the recommended duration of monitoring was 24 hours.  No 
consensus was reached on the ideal mechanism of monitoring, however at 
least one type of monitor should be used.  The recommended monitors were 
sedation score measurements, pulse oximetry and respiratory rate monitoring.  
Capnography was accepted as a good monitor however the cost of the 
equipment was prohibitive and it was therefore not recommended for use in 
South Africa.  Only 41.7% of the survey respondents worked in hospitals that 
had a protocol for monitoring patients who received neuraxial opioids.  
Respiratory rate monitoring was the most popular monitoring technique used 
to monitor these patients.  Of those doctors who worked in hospitals without a 
monitoring protocol, the majority of them were in the public sector.  92.8 % of 
the 544 doctors who worked in hospitals without monitoring protocols agreed 
that monitoring these patients was important.   
 
There were 4.1% of the survey respondents who felt that a multidisciplinary 
team, made up of the anaesthesiologist, obstetrician and nurse, should 
manage the patient’s post-operative pain.  The majority of respondents 
(587/933, 62.9%) felt that the anaesthesiologist should be the only health care 
professional responsible for the patient’s post-operative analgesia.  There 
were three respondents who felt that no one should take responsibility for the 
patients’ post-operative pain. 
 
Routine use of epidural analgesia and patient controlled analgesia (PCA) 
pumps was not recommended within the reference standards of care.  Non-
steroidal anti-inflammatory drugs (NSAIDs), IV paracetamol and other oral 
analgesics were recommended for routine post-operative analgesia for 
caesarean section patients.  Survey results indicated that epidural analgesia 
and PCA pumps were not popular choices for post-operative pain 
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management.  None of the anaesthetic service providers surveyed would 
insert an epidural catheter exclusively for post-operative analgesia and only 
9% of the respondents would use a labour epidural catheter for post-operative 
analgesia.   There were only 17% of respondents who routinely used a PCA 
pump for post-operative pain management.  Morphine was the most popular 
analgesic agent used in the PCA pumps.  The reported practices regarding 
post-operative epidural analgesia and PCA pump use were in accordance 
with the recommended reference standards for obstetric anaesthesia care in 
South Africa.  NSAIDs suppositories and IV paracetamol were very popular 
forms of analgesia prescribed for post-caesarean analgesia.  Oral 
paracetamol and tramadol were the most commonly prescribed oral 
analgesics used for post-operative pain in women who had caesarean 
sections. 
 
Based on their practice, 76% of the survey respondents were of the opinion 
that their patients were satisfied with their post-operative analgesia.  When 
patients enrolled in the clinical trial were asked to rate their level of 
satisfaction with their treatment, 75% of patients in Group M100 rated their 
level of satisfaction between 8 and 10 (out of a maximum of 10).  This is 
compared to 65.5% of the patients in Group M50 and only 56.3% of the 
patients in Group F25.  These differences may be indicative of a trend 
towards greater satisfaction in the intrathecal morphine groups however these 
results were not statistically significant.  Considering that the majority of the 
national survey respondents preferred to use fentanyl as the adjuvant drug in 
their obstetric spinal anaesthetics, it is very likely, based on the above results, 
these doctors are overestimating their patients’ levels of satisfaction with their 
post-operative analgesia. 
 
Analysis of the data from the clinical trial revealed that there was a statistically 
significant difference in the post-operative opioid requirements between the 
morphine groups (M100 and M50) and the fentanyl group (F25).  Patients in 
the fentanyl group required more opioid analgesics in the first 12 hours, 
second 12 hours and cumulatively for the full 24-hour period after surgery.  
There was no difference in the post-operative opioid requirements between 
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groups M100 and M50, which implied that the two different doses of 
intrathecal morphine provided equivalent levels of analgesia in this study.  
There was however no difference in the pain scores between the three 
treatment groups.  This unexpected result was most likely due to the fact that 
patients had unrestricted access to PCA analgesia and therefore could 
adequately manage their pain (and ensure their pain scores were lowered) 
with higher doses of intravenous opioids, when the pain was greater. 
 
There was no statistical difference in the side effects experienced by patients 
in all three groups with reference to levels of sedation, respiratory depression, 
pruritus or nausea and vomiting.  Of importance in this study was that there 
were no cases of respiratory depression (immediate or delayed) in the entire 
study cohort.  The impact of the pain on the patients’ activities (in and out of 
bed) and emotional states were also similar in all the treatment groups.   
 
7.2 Discussion of the results 
 
The first study (chapter three) established a reference standard of care for 
obstetric anaesthesia in South Africa.  These standards allow us to compare 
the expected standard of care for South Africa to other international regions 
and may possibly also be extrapolated to other developing countries in Africa 
and globally.  In addition South African practitioners would also able to 
benchmark their individual obstetric anaesthesia practices with the reference 
standards for the country. 
 
The standards of care with regards to the anaesthetic technique used for the 
obstetric spinal anaesthesia is very similar to those proposed by current 
guidelines from the United States of America (USA) (Apfelbaum et al., 2016) 
and the United Kingdom of Great Britain and Northern Ireland (UK) (Griffiths 
et al., 2011).  Neuraxial anaesthetic techniques are proposed to be safer and 
more effective forms of anaesthesia for pregnant patients than general 
anaesthesia and are also associated with lower neonatal morbidity.  The 
decision on what anaesthetic technique to use for each patient however 
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needs to be individualized and depends on a number of different factors 
including the patient’s clinical condition and patients’ anaesthetic preferences.   
 
A small gauge pencil point needle was strongly recommended as the needle 
of choice for performing obstetric spinal anaesthetics.  This recommendation 
was in line with recommendations from the American Society of 
Anesthesiologists (ASA) (Apfelbaum et al., 2016). 
 
The choice of the local anaesthetic agent to be used in the spinal anaesthetic 
was not stipulated in any current international guidelines.  However, the South 
African experts recommended that 0.5% bupivacaine with dextrose be used 
as the reference standard of care in South Africa.  This hyperbaric drug 
facilitates the cephalad spread of the local anaesthetic towards the thoracic 
kyphosis when the patient is in a supine position (Kleinman, 2002).  This 
ensures that the spinal block is established at a high enough level so that the 
patient does not feel any pain during the caesarean section surgery.  This 
recommendation will mostly address the 5.04% of South African practitioners 
who are using different local anaesthetics for their obstetric spinal 
anaesthetics. 
 
The median volume of 0.5% bupivacaine recommended for obstetric spinal 
anaesthesia was 1.9ml (9.5mg).  There were no international guidelines that 
made dosage recommendations for the local anaesthetic drug however the 
South African recommendations were substantiated by results of the review 
by Arzola and Wieczorek (2011), which found that using low doses of 
bupivacaine (≤8mg) in the spinal anaesthetic compromises the anaesthetic 
efficacy of the neuraxial block.  Kiran and Singal (2002) also demonstrated a 
greater incidence of visceral pain in patients where ≤10mg bupivacaine was 
used in the spinal anaesthetic.  
 
The use of intrathecal opioids for post-operative pain management was 
advocated by both the ASA and National Institute of Clinical Excellence 
(NICE) guidelines (Apfelbaum et al., 2016, Griffiths et al., 2011).  The South 
African recommendations (chapter three) on the use of intrathecal opioid 
 245
adjuvant drugs were however controversial when discussed in relation to 
international publications on the analgesic efficacy of intrathecal opioids for 
post-operative analgesia following caesarean section surgery.  The South 
African reference standard was to use fentanyl at doses between 10 – 25 
mcg.  Intrathecal fentanyl has better post-operative analgesic effects than 
using no intrathecal opioids (Hunt et al., 1989).  However, when compared to 
intrathecal morphine, fentanyl’s shorter duration of action offers very limited 
post-operative analgesic benefits (Salmah and Choy, 2009).  The motivation 
of the expert panel for the use of fentanyl, instead of morphine, as an 
intrathecal adjuvant was fear of the risks of the side effects of intrathecal 
morphine, with specific reference to delayed respiratory depression.  The risk 
of developing this side-effect has however been demonstrated to be very low 
(0.26%) (Kato et al., 2008) and can be further reduced by selectively 
excluding patients who are at increased risk of developing post-operative 
respiratory complications (such as patients with obstructive sleep apnoea), 
and avoiding concomitant use of systemic opioids.  The intra-operative use of 
intrathecal fentanyl necessitates using additional analgesics for post-operative 
pain relief after surgery.  This practice can also increase the risk of respiratory 
depression.  Abboud et al (1988) demonstrated marked ventilatory depression 
in patients after administration of subcutaneous morphine for analgesia in 
elective caesarean section patients.  Therefore the use of intrathecal fentanyl 
in obstetric anaesthesia in South Africa will only serve to reduce the success 
of analgesic treatment without reducing the risk of respiratory depression, 
unless systemic opioids are completely eliminated from the treatment options 
for these patients. 
 
Despite current evidence of the lower analgesic effects of intrathecal fentanyl 
compared with morphine, the majority of respondents (654/933) to the 
national survey (chapter four) preferred fentanyl as an opioid additive for 
obstetric spinal anaesthesia.  Only 32/933 respondents used morphine as the 
intrathecal adjuvant.  This was in stark contrast to practices in the USA, where 
79% of anaesthetic doctors used intrathecal morphine for caesarean section 
anaesthesia (Tagaloa et al., 2009). 
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The clinical trial evaluating the analgesic effects of intrathecal morphine and 
fentanyl in caesarean section patients (chapters five and six) clearly 
demonstrated reduced post-operative analgesic requirements in patients who 
received intrathecal morphine compared to patients who received intrathecal 
fentanyl.  Furthermore, there were no incidences of respiratory depression in 
the entire study population, however this study was not powered to detect 
differences in the incidence of respiratory depression between the three 
treatment groups.  The results of this study were similar to other international 
studies evaluating the analgesic effects of intrathecal opioids (Cardoso et al., 
1998, Salmah and Choy, 2009, Palmer et al., 1999, Girgin et al., 2008).  
Intrathecal morphine provides good post-operative pain relief to patients after 
caesarean section surgery.  Furthermore, the results of this study confirmed 
that a low intrathecal morphine dose of 50μg has the same quality of 
analgesia as the 100μg intrathecal morphine dose.  Carvalho and Tenorio 
(2013) demonstrated similar results and in addition also concluded that this 
lower morphine dose is associated with a lower side effect profile. 
 
The combination of NSAIDs with intrathecal morphine improves the analgesic 
effects of the treatment and has opioid sparing effects (Cardoso et al., 1998).  
An NSAID suppository is a popular analgesic choice used by practitioners in 
South Africa.  In addition, IV paracetamol, despite concerns about the high 
cost of the drug by the South African experts, was used by 64% of South 
African anaesthetic service providers.  IV paracetamol also has good opioid 
sparing effects (Remy et al., 2005).  The combination of NSAIDs, paracetamol 
and intrathecal opioids satisfy the components of a multimodal analgesic 
regime and will ultimately lead to better patient analgesia with a lower side 
effect profile (Kehlet and Dahl, 1993). 
 
Many of the concerns from the South African anaesthesia experts around the 
use of long acting intrathecal opioids, related to the perceived poor post-
operative monitoring practices in the obstetric wards in South Africa.  The 
American Practice Guidelines (Horlocker et al., 2009) state that patients who 
receive neuraxial opioids should be monitored for up to 24 hours following 
intrathecal administration of hydrophilic opioids.  These sentiments were 
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echoed in the reference standards for South Africa.  However 58.3% of 
anaesthetic service providers in South Africa stated that the hospitals that 
they work in do not have protocols for monitoring patients who have received 
neuraxial opioids.  The reference standard for monitoring only required that at 
least one monitoring modality was used to monitor these patients.  
Respiratory rate monitoring and sedation score monitoring are low cost, 
simple and effective monitoring strategies that can easily be implemented in 
all obstetric units in South Africa.  The perceptions of poor post-operative 
monitoring practices can be overcome with simple interventions such as staff 
training programmes for the post-operative ward nurses.  The clinical trial that 
we conducted demonstrated that intrathecal morphine could be safely used in 
low doses in a public sector hospital where patients can be clinically 
monitored for respiratory depression. 
 
7.3 Limitations of the Study 
 
a. The development of the reference standard for obstetric anaesthesia 
practice was done by conducting eight individual interviews with 
representatives of the eight academic anaesthesiology departments in 
South Africa.  This process excluded any experts in obstetric anaesthesia 
from the private sectors and may also have excluded obstetric 
anaesthesia experts who work in the academic departments but were not 
included in the process by the head of the department.  Ideally the 
reference standard development process should be a two-phase process.  
The first phase is the identification phase, as conducted in this study.  The 
second phase should be a validation phase where a larger group of 
experts review and validate the items from the first phase.  This could not 
be done in my study because there are very few recognized obstetric 
anaesthesia experts in South Africa.  The heads of departments, as the 
developers of training standards for specialists were then accepted as 
appropriate surrogates for this process. 
b. The national survey only had 973 respondents, of which 933 were 
included in the data analysis.  There are approximately 1700 doctors on 
the South African Society of Anaesthesiologists (SASA) database.  This 
 248
implies the survey response rate is 57%.  However, in South Africa 
anaesthesia may be administered by specialist anaesthesiologists and 
also by general practitioners.  Not all these doctors may be affiliated to the 
SASA and therefore it is not possible to know how many doctors are 
actually providing anaesthetic services in South Africa.  The survey 
response rate may be lower than 58%. 
c. In the clinical trial, all clinicians involved in the study, and the patients, 
were blinded to the intervention drug used.  However, the doctor 
administering the anaesthetic was not blinded to the intervention, as 
he/she was required to mix up the opioid and local anaesthetic solution 
before administering it for the spinal anaesthetic.  This was done to ensure 
that the doctor had all the necessary information for the anaesthetic they 
were performing.  Also, due to study budget limitations, it was not possible 
to have a pharmacist available who could prepare the intrathecal drugs 
after randomization. 
d. Patient data collected in the clinical trial did not include height, and 
therefore the patients’ BMI’s could not be calculated.  In addition, history of 
previous caesarean section surgery was not documented. 
e. The clinical trial was not powered to detect differences in the side effects 
profile of each treatment group.  
f. The clinical trial did not evaluate patients pain beyond 24 hours after 
surgery 
 
7.4 Recommendations and future research agenda 
 
a. The reference standards for obstetric anaesthesia practices in South 
Africa need to be developed into a set of national guidelines for the 
management of obstetric anaesthesia in South Africa.  The results of this 
study will be used as a basis on which future South African guidelines will 
be developed.  We plan to develop these guidelines in conjunction with a 
wider panel of obstetric anaesthesia experts from both the public and 
private sectors. 
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b. A study evaluating the acceptance by nursing personnel of new monitoring 
protocols for patients who receive neuraxial opioids should be conducted 
in South Africa. 
c. Request the SASA to issue a statement warning anaesthetic service 
providers of the increased risk posed to patients by the use of Quincke 
spinal needles for spinal anaesthesia for caesarean sections. 
d. Based on the results of the clinical trial, the post-operative pain treatment 
protocols for caesarean section surgery must be updated in South Africa 
to include low dose intrathecal morphine in combination with NSAID 
suppositories and IV paracetamol. 
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APPENDIX C: Questions modified for Semi-structured Interview questionnaire 
 
The following questions were either added to or modified from the original 
questionnaire used by Tagaloa et al (2009) 
 
2. For a spinal anaesthetic, what would you consider the most 
appropriate needle to use? 
Quincke  
 Sprotte  
Whitacre  
Pencan  
Eldor  
       Other (Please Specify): 
_____________________________________  
3.    What needle gauge do you recommend? 
22G  
24G  
25G  
26G  
27G  
Other (Please Specify): ________________________________ 
 
4.  For a healthy, non-obese patient for a caesarean section, what 
would you recommend as the preffered choice of intrathecal local 
anaesthetic? 
 Bupivacaine 0.5% with Dextrose 
 Bupivacaine 0.5%  
 Lignocaine 2%  
 Ropivacaine 0.75%  
 Levobupivacaine 0.5%  
 Other (Please Specify): 
_____________________________________ 
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5. For a healthy, non-obese patient, what should be the  standard 
dose of the above mentioned intrathecal local anaesthetic?   
    ____________ mg   OR  ____________ ml 
 
6. For a healthy, non-obese patient, what other agents do you think 
should be routinely added to the intrathecal local anaesthetic 
mixture?     (mark all that apply) 
 No drugs routinely added 
  Fentanyl   Dose used  =  _____   μg 
 Morphine   Dose used  =        _____   μg 
 Sufentanil  Dose used  =        _____   μg 
   Other (Please Specify):   
  
7.  For EPIDURAL placement, what do you consider to be the best 
technique for loss of resistance? 
Air  
  Saline  
  Both  
 Other (Please Specify):  
_________________________________ 
 
11. For ELECTIVE caesarean delivery, what other agents should one 
routinely add to the epidural local anaesthetic?  (mark all that 
apply)  
No other agents added  
 Fentanyl  
 Sufentanil  
 Morphine  
 Sodium Bicarbonate 8.4%  
 Adrenaline  
Other (Please Specify):  
___________________________________ 
 
12. For elective caesarean delivery, should you give morphine via the 
epidural catheter for post-operative pain relief? 
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Yes  
   Please state the dose : ___________ mg    
 No  
 
13. In a labouring patient with an epidural in situ requiring an 
URGENT caesarean section, what should be the preferred method 
of anaesthesia? 
 (a) Top up the in-situ epidural 
 (b) Remove epidural and administer spinal anaesthesia  
 (c) General Anaesthesia  
 (d) Other (Please Specify): 
___________________________________ 
 
17. For an URGENT Caesarean section, would you routinely give 
morphine via the epidural catheter for post-operative pain relief? 
 Yes  
   Please state the dose : ___________ mg   
   No  
     
21. Should you routinely use an epidural catheter for postoperative 
analgesia after a caesarean section? 
Yes  
No  
 
27. If YES, what NSAIDs do you recommend?  
 Ibuprofen 
 Ketorolac 
 Diclofenac 
 Lornoxicam 
 Parecoxib 
 Other (Please Specify): 
______________________________________ 
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29. What is your preferred route of administration of NSAID’s after a 
caesarean section? 
 Oral 
 Intravenous 
 Rectal 
 Intramuscular 
Other (Please Specify):  ________________________________ 
 
30. Should we routinely prescribe intravenous Paracetamol for post-
operative analgesia? 
 Yes 
 No 
 
31. What other oral analgesics do you routinely prescribe after a 
caesarean delivery ?      (mark all that apply) 
 Paracetamol  
 Codeine   
 Oxycodone  
 Tramadol  
 Other (Please Specify): ________________________________ 
 
33. Do you have any other comments or questions which you think 
would be relevant to this discussion on the anaesthetic 
management of Obstetric Anaesthesia in South Africa? 
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1. What do you consider to be the preferred technique for healthy patients 
requiring elective Caesarean delivery? 
 
a.  Single shot spinal  
b.  Epidural  
c.  Combined spinal-epidural  
d.  General anaesthetic  
 
COMMENTS:  
________________________________________________________________________________
________________________________________________________________________________
_____________________________________________________________________________ 
 
2. For a SPINAL anaesthetic, what would you consider the most appropriate 
needle to use?  
a. Sprotte  
b.  Whitacre  
c.  Pencan  
d.  Eldor  
e.  Other (Please Specify): ____________  
 
3. What needle gauge do you recommend? 
a. 22G  
b.  24G  
c.  25G  
d.  26G  
e.  27G  
f.  Other (Please Specify): ________________ 
COMMENTS:  
________________________________________________________________________________
________________________________________________________________________________
_____________________________________________________________________________ 
 
 
 
APPENDIX D: Semi-structured Interview Questionnaire  
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4. For a healthy non-obese patient, what would you recommend as the 
preferred choice of intrathecal local anaesthetic? 
a.  Bupivacaine 0.5% with Dextrose 
 
b.  Plain Bupivacaine 0.5%  
 
c.  Plain Lignocaine 2%  
 
d.  Plain Ropivacaine 0.75%  
 
e.  Plain Levobupivacaine 0.5%  
 
f.  Other (Please Specify): _____________ 
 
5. For a healthy non-obese patient, what should be the standard dose of 
intrathecal local anaesthetic ( in mg)? _________________ 
COMMENTS:  
________________________________________________________________________________
________________________________________________________________________________
_____________________________________________________________________________ 
 
6. For a healthy non-obese patient, what other agents do you think should 
be routinely added to the intrathecal mixture? (mark all that apply) 
a.  No drugs routinely added 
b. Fentanyl  
DOSE USED =  ___   mcg   
c.  Morphine  
DOSE USED =     ___   mcg   
d.  Sufentanil 
DOSE USED =    ___   mcg   
e. Other (Please Specify):   
 
COMMENTS:  
________________________________________________________________________________
________________________________________________________________________________
_____________________________________________________________________________ 
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7. For EPIDURAL placement, what do you consider to be the best technique 
for loss of resistance? 
 
a.  Air  
 
b.  Saline  
 
c.  Both  
 
d.  Other (Please Specify): 
COMMENTS:  
________________________________________________________________________________
________________________________________________________________________________
_____________________________________________________________________________ 
 
8. Should EPIDURAL anaesthesia be used routinely for elective Caesarean 
delivery? 
 
a.  Yes  
 
b.  No 
COMMENTS:  
________________________________________________________________________________
________________________________________________________________________________
_____________________________________________________________________________ 
 
9. What would you recommend as the preferred choice of epidural local 
anaesthetic for this group of patients? 
a.  Lignocaine 2%  
 
b.  Bupivacaine 0.5%  
 
c.  Ropivacaine 0.75%  
 
d.  Levobupivacaine 0.5%  
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e.  Other (Please Specify): 
 
10. Please state the volume of local anaesthetic that should routinely be used 
(in ml) for these patients? ___________________ 
 
11. For elective Caesarean delivery, what other agents should one routinely 
add to the epidural local anaesthetic? (mark all that apply)  
 
a.  No other agents added  
 
b.  Fentanyl  
 
c.  Sufentanil  
 
d.  Morphine  
 
e.  Sodium Bicarbonate 8.4%  
 
f.  Adrenaline  
 
g. Other (Please Specify):   
 
12. For elective Caesarean delivery, should you give morphine via the 
epidural catheter for postoperative pain relief? 
 
a. Yes  
 If yes, please state the dose (in mg) ___________ 
 
b.  No 
COMMENTS:  
________________________________________________________________________________
______________________________________________________________________________ 
 
13. In a labouring patient with an epidural in situ requiring urgent Caesarean 
delivery, what should be the preferred method of anaesthesia? 
 
a.  Top up the in-situ epidural 
 
b.  Remove epidural and administer spinal anaesthetic  
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c.  General Anaesthesia  
 
d.  Other (Please Specify): ____________ 
 
14. What would you recommend as the preferred choice of epidural local 
anaesthetic in these patients? 
 
a.  Lignocaine 2%  
 
b.  Bupivacaine 0.5%  
 
c.  Ropivacaine 0.75%  
 
d.  Levobupivacaine 0.5%  
 
e.  Other (Please Specify): ____________ 
 
15. Please state the volume of local anaesthetic that should be routinely used 
(in ml) in these patients? ________________ 
 
  
16. For urgent Caesarean delivery, what other agents do you routinely add to 
your epidural local anaesthetic? 
 
a.  No agents added 
 
b.  Fentanyl  
 
c.  Sufentanil  
 
d.  Morphine  
 
e.  Sodium Bicarbonate 8.4%  
 
f.  Adrenaline  
 
g.  Other (Please Specify): ______________ 
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17. For urgent Caesarean delivery, would you routinely give morphine via the 
epidural catheter for postoperative pain relief? 
a.  Yes  
 If yes, please state the dose (in mg) __________ 
b.  No  
 
 
COMMENTS:  
________________________________________________________________________________
________________________________________________________________________________
_____________________________________________________________________________ 
 
18. Should all maternity units have a protocol for monitoring patients who 
receive neuraxial opioids? 
 
a.  Yes  
 
b.  No  
 
19. For how long should  patients be monitored for signs of respiratory 
depression after neuraxial opioid administration? 
a.  <6 hrs  
 
b.  6 - 12hrs  
 
c.  12hrs  
 
d.  24hrs  
 
e.  36hrs  
 
f.  48hrs  
 
g.  Other (Please Specify): _____________________ 
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20. How do you think healthy patients, who received neuraxial opioids for 
Caesarean delivery, should be routinely monitored to detect respiratory 
depression? (mark all that apply) 
a.  Respiratory rate  
b.  Sedation score  
c.  Pulse oximetry  
d. Other (Please Specify):   
COMMENTS:  
________________________________________________________________________________
________________________________________________________________________________
_____________________________________________________________________________ 
 
21. Should you routinely use the epidural catheter for postoperative 
analgesia after Caesarean Section surgery? 
a.  Yes  
 
b. No  
 
22. If yes, what method and agents do you recommend? 
 
a.  Patient Controlled Epidural Analgesia (PCEA)bolus administration 
only  
 
b.  PCEA with continuous infusion  
 
c.  Intermittent epidural boluses, local anaesthetic only  
 
d.  Intermittent epidural boluses, opioid only  
 
e.  Continuous infusion, local anaesthetic only  
 
f.  Continuous infusion, local anaesthetic plus opioid  
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g. Other (Please Specify):   
 
23. If no, please indicate why you would not use the catheter for 
postoperative analgesia ( mark all that apply) 
 
a.  Not standard protocol  
 
b.  No epidural pumps in postnatal wards  
 
c.  Inadequate monitoring in postnatal wards  
 
d.  Lack of nursing staff education in epidural care  
 
e.  Anaesthesia staff shortage  
 
f.  Nursing staff shortage  
 
g. Other (Please Specify):   
 
COMMENTS:  
________________________________________________________________________________
________________________________________________________________________________
_____________________________________________________________________________ 
 
24. Should you routinely prescribe an intravenous PCA following Caesarean 
delivery? 
a.  Yes  
b.  No  
 
 
25. If yes, what intravenous analgesic agent would you recommend? 
 
a.  Morphine  
b.  Fentanyl 
c.  Pethidine  
d.  Other (Please Specify): _______________ 
COMMENTS:  
_______________________________________________________________________________ 
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26. Should NSAID’s be routinely prescribed for postoperative analgesia? 
a.  Yes  
b.  No  
 
27. If yes, what NSAIDS do you recommend? 
a.  Ibuprofen  
b.  Ketorolac  
c.  Diclofenac  
d. Lornoxicam 
e. Parecoxib 
f.  Other (Please Specify):_________________________________ 
 
28. What dosing regimen would you recommend for  NSAID prescription? 
a.  PRN  
b.  Regular scheduled doses 'around the clock'  
c. Other (Please Specify):  _________________________________ 
 
29. What is your preferred route of administration of NSAID’s  
a. Oral 
b. Intravenous 
c. Rectal 
d. Intramuscular 
COMMENTS:  
________________________________________________________________________________
______________________________________________________________________________ 
 
30. Should we routinely prescribe intravenous Paracetamol for postoperative 
analgesia and why? 
a. YES 
b. NO 
COMMENTS:  
________________________________________________________________________________
________________________________________________________________________________
_____________________________________________________________________________ 
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31. What other oral analgesics do you routinely prescribe following 
Caesarean delivery (mark all that apply)? 
a.  Paracetamol  
b.  Codeine   
c.  Dextropropoxyfene  
d.  Tramadol  
e. Other (Please Specify):  _______________________________________ 
 
32. What dosing regimen do you use for these other oral agents? 
a.  PRN  
b. Regular scheduled doses 'around the clock'  
c. Other (Please Specify):   
 
COMMENTS:  
________________________________________________________________________________
________________________________________________________________________________
_____________________________________________________________________________ 
 
33. Do you have any other comments or questions which you think would be 
relevant to this discussion on the anaesthetic management of Obstetric 
Anaesthesia in South Africa? 
  
________________________________________________________________________________
________________________________________________________________________________
_____________________________________________________________________________ 
 
 
Thank you for your participation! 
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APPENDIX F: PARTICIPANT CONSENT FORM FOR RESEARCH 
STUDY 
 Study Number: 
Name of Interviewee:  ___________ 
Title of Project: A determination of what should be considered the Current GOLD 
standard practices for the management of Obstetric Anaesthesia and post-operative 
monitoring in South Africa 
Name of Researcher: Dr Sean Chetty 
   Please tick 
to confirm 
I confirm that I have read and understood the participant information 
sheet for the above study.  
 
I have had the opportunity to consider the information, ask questions 
and have had these answered satisfactorily.  
 
I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my legal 
rights being affected.  
 
 
 
  
I agree to take part in the above research study 
 
__________________________ 
Name of Patient  
______________ 
Date 
__________________________ 
Signature 
 
  
 
 
 
   
   
 
 
__________________________ 
Researcher 
 
 
______________ 
Date 
 
 
__________________________ 
Signature 
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Study Number:  ________________________ 
 
Name of Interviewee:  ________________________ 
Title of Project: A determination of what should be considered the Current GOLD 
standard practices for the management of Obstetric Anaesthesia and post-operative 
monitoring in South Africa 
Name of Researcher: Dr Sean Chetty 
I confirm that I have read and understood the participant information sheet for 
the above study.   
I agree that the structured interview with Sean Chetty can be electronically 
recorded in order to allow an accurate description of my responses.  I understand 
that these recordings will be destroyed after 5 years. 
 
I understand that my participation is voluntary and that I am free to withdraw at 
any time, without giving any reason, without my legal rights being affected.   
I agree to take part in the above research study 
 
 
 
__________________________ 
Name of Interviewee 
______________ 
Date 
__________________________ 
Signature 
 
 
 
__________________________ 
Researcher 
 
 
______________ 
   Date 
 
 
__________________________ 
            Signature 
 
 
  
  
  
 
 
APPENDIX G: PARTICIPANT CONSENT FORM FOR 
ELECTRONIC RECORDING OF INTERVIEW 
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The following questions were either added to or modified from the original 
questionnaire used by Tagaloa et al (2009):  
 
34. Which province do you work in? 
Gauteng 
 Western Cape 
 Eastern Cape 
 KwaZulu Natal 
 Mpumalanga 
 North West  
 Limpopo 
 Northern Cape 
 Free State 
 
35. Description of  your practice (Choose one of the following options): 
Private practice 
  Private practice with public sector sessions 
  Private practice with no public sector involvement   
Public sector  
   Medical officer with less than 5 years experience in anaesthesia 
   Medical officer with more than 5 years experience in 
anaesthesia 
  Registrar 
   Specialist with RWOPS 
   Specialist without RWOPS 
 
36. Highest  South African Anaesthetic Qualification: 
  MBChB / MBBCh  
  DA (SA) 
  FCA (SA) / FFA (SA) / MMed (Anaes)  
  International Fellowship in Obstetric Anaesthesia  
 
37. Approximately how many anaesthetics do you administer per month? 
     (Please indicate an average number and NOT a range) 
 Number: _________ 
Appendix I: Questions modified for Questionnaire 
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38. Approximately how many CAESAREAN SECTION anaesthetics do you 
administer per month?   (Please indicate an average number and NOT a range) 
Number: _________ 
 
9. When administering a SPINAL anaesthetic, which type of spinal needle 
do you prefer to use? 
Quincke  
 Sprotte  
Whitacre  
Pencan  
Eldor  
       I do not know the type of needle  
        I do not have a preference
  Other (Please Specify): _____________________________________  
10. When administering a SPINAL anaesthetic, which type of spinal needle 
do you routinely have to use? 
Quincke  
 Sprotte  
Whitacre  
Pencan  
Eldor  
Other (Please Specify): ___________________________________  
I do not know the type of needle  
I do not have a preference 
 
 
 
 
 
 
 
11. When administering a SPINAL anaesthetic, what needle gauge do you 
prefer to use? 
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22G  
24G  
25G  
26G  
27G  
Other (Please Specify): ________________________________ 
I do not know the guage of needle  
I do not have a preference 
 
12. When administering a SPINAL anaesthetic, what needle gauge do you 
routinely have to use? 
22G  
24G  
25G  
26G  
27G  
Other (Please Specify): ________________________________ 
I do not know the guage of needle  
I do not have a preference 
 
13. When administering a spinal anaesthetic for a healthy, non-obese 
patient for a caesarean section, what is your preferred choice of 
intrathecal local anaesthetic? 
 Bupivacaine 0.5% with Dextrose 
 Bupivacaine 0.5%  
 Lignocaine 2%  
 Ropivacaine 0.75%  
 Levobupivacaine 0.5%  
 Other (Please Specify): _____________________________________ 
 
 
14. For a healthy, non-obese patient, what is your standard dose of the 
above mentioned intrathecal local anaesthetic?   
    ____________ mg   OR  ____________ ml 
 287
 
15. For a healthy, non-obese patient, what other agents do you routinely 
add to your intrathecal local anaesthetic mixture?    
 (mark all that apply) 
 No drugs routinely added 
  Fentanyl   Dose used  =  _____   μg 
 Morphine   Dose used  =        _____   μg 
 Sufentanil  Dose used  =        _____   μg 
   Other (Please Specify):   
  Name of additive : ____________ Dose used  = _________ 
  Name of additive : ____________ Dose used  = _________ 
 
 
20. For ELECTIVE caesarean delivery, what other agents do you routinely 
add to your epidural local anaesthetic?   (mark all that apply)  
 No other agents added  
 Fentanyl  
 Sufentanil  
 Morphine  
 Sodium Bicarbonate 8.4%  
 Adrenaline  
 Other (Please Specify):  ___________________________________ 
 
21. For elective caesarean delivery, do you routinely give morphine via the 
epidural catheter for post-operative pain relief? 
Yes  
   (i)  Please state the dose : ___________ mg 
  (ii) When do you administer this medication? 
        BEFORE the baby is delivered   
        AFTER the baby is delivered  
 No  
 
22. In a labouring patient with an epidural in situ requiring an URGENT 
caesarean section, what is your preferred method of anaesthesia? 
 (a) Top up the in-situ epidural 
 (b) Remove epidural and administer spinal anaesthesia  
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 (c) General Anaesthesia  
 (d) Other (Please Specify): ___________________________________ 
 
26. For an URGENT Caesarean section, do you routinely give morphine via 
the epidural catheter for post-operative pain relief? 
 Yes  
   (i)  Please state the dose : ___________ mg 
  (ii) When do you administer this medication? 
        BEFORE the baby is delivered   
        AFTER the baby is delivered  
   No  
 
30. If you answered NO to QUESTION 27 , do you think it is necessary to 
monitor patients  who have been administered neuraxial opioids for 
respiratory depression? 
   YES    
   NO    
     
31. Following surgery for a caesarean section, who do you believe should 
be responsible for the management of the patients post-operative 
analgesia? 
   
      Obstetrician  
      Anaesthesiologist 
      Nurse 
      Other (Please specify): _____________________ 
 
32. In your practice, following surgery for a caesarean section the patient’s 
post-operative analgesia is prescribed by: 
   
      Obstetrician  
      Anaesthesiologist 
      Other (Please specify): ____________________ 
 
 
33. Do you routinely use an epidural catheter for postoperative analgesia 
after a caesarean section? 
Yes – Only if the patient has an epidural catheter pre-operatively 
Yes – I will insert an epidural catheter if the patient does not have one 
No  
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39. If you answered NO to QUESTION 38 , please skip the next three 
questions  (Q 39 - 41) , and go straight to QUESTION 42 
If you answered YES to QUESTION 38 , what NSAIDs do you routinely 
 prescribe?  
 Ibuprofen 
 Ketorolac 
 Diclofenac 
 Lornoxicam 
 Parecoxib 
 Other (Please Specify): ______________________________________ 
 
41. What is your preferred route of administration of NSAID’s after a 
caesarean section?
 Oral 
 Intravenous 
 Rectal 
 Intramuscular 
Other (Please Specify):  ___________________________________ 
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42. Do you routinely prescribe intravenous Paracetamol for post-operative 
analgesia? 
 Yes 
 No 
 
43. What other oral analgesics do you routinely prescribe after a caesarean 
delivery ?      (mark all that apply) 
 Paracetamol  
 Codeine   
 Oxycodone  
 Tramadol  
 Other (Please Specify): ________________________________ 
 
44. In your current practice of obstetric anaesthesia, do you think that your 
patients are     satisfied with their post-operative analgesia? 
 Yes 
 No 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 291
APPENDIX J: Survey of Obstetric Anaesthesia Practice for 
Caesarean Section 
Dear Colleague 
My name is Sean Chetty and I am currently conducting a survey on the 
current obstetric anaesthesia practices in South Africa.  This survey is 
being conducted as part of a PhD research project at the University of 
the Witwatersrand and has been approved by the Human Research 
Ethics Committee Medical (Approval no: M 140123). 
I would like to invite you, as a provider of anaesthetic services in South 
Africa, to participate in this research survey.  The results of this survey 
will provide valuable information to determine current obstetric 
anaesthesia practice in South Africa. The survey will take approximately 
3 - 5 minutes to complete. 
Your answers are confidential and data will be recorded anonymously.  
However, should you wish to receive the results of the survey, please 
indicate your e-mail address at the end of the survey and the results will 
be forwarded to you. 
All participants who complete the survey will be offered an opportunity to 
be entered into a lucky draw for a tablet computer.  Should you wish to 
be entered into the lucky draw for a tablet computer, you can enter your 
contact details at the end of the survey.  All entries will be detached from 
the survey responses to ensure anonymity of participants. 
Thank you in advance for your participation. 
Kind Regards 
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SURVEY 
PLEASE USE “X” IN THE CHECKBOX TO MARK YOUR ANSWERS TO THE QUESTIONS 
BELOW: 
1. Which province do you work in? 
  Gauteng 
 Western Cape 
 Eastern Cape 
 KwaZulu Natal 
 Mpumalanga 
 North West  
 Limpopo 
 Northern Cape 
 Free State 
 
2. Description of  your practice (Choose one of the following options): 
Private practice 
  Private practice with public sector sessions 
  Private practice with no public sector involvement   
Public sector  
   Medical officer with less than 5 years experience in anaesthesia 
   Medical officer with more than 5 years experience in anaesthesia 
  Registrar 
   Specialist with RWOPS 
   Specialist without RWOPS 
 
3. Highest  South African Anaesthetic Qualification: 
  MBChB / MBBCh  
  DA (SA) 
  FCA (SA) / FFA (SA) / MMed (Anaes)  
  International Fellowship in Obstetric Anaesthesia  
 
4. Approximately how many anaesthetics do you administer per month?  
     (Please indicate an average number and NOT a range) 
 Number: _________ 
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5. Approximately how many CAESAREAN SECTION anaesthetics do you 
administer per month?   (Please indicate an average number and NOT a range) 
Number: _________ 
6. What is YOUR extent of involvement in obstetric anaesthesia? 
  Daytime cover  
  On-call only  
  Daytime and on-call  
  Other (Please specify):  _________________________________________________ 
 
7.  On average, how often do you work in obstetric anaesthesia? 
  <1 day a week  
  1 - 2 days a week  
  > 2 days a week  
 
8. What is your preferred anaesthetic technique for healthy patients 
requiring an elective caesarean section? 
 Single shot spinal anaesthesia 
 Epidural anaesthesia 
 Combined spinal-epidural  
 General anaesthesia 
 
9. When administering a SPINAL anaesthetic, which type of spinal needle do 
you prefer to use? 
  Quincke  
 Sprotte  
  Whitacre  
  Pencan  
  Eldor  
         I do not know the type of needle  
            I do not have a preference
   Other (Please Specify): _______________________________________________  
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10. When administering a SPINAL anaesthetic, which type of spinal needle do 
you routinely have to use? 
  Quincke  
 Sprotte  
  Whitacre  
  Pencan  
  Eldor  
  Other (Please Specify): ______________________________________________  
  I do not know the type of needle  
  I do not have a preference 
 
11. When administering a SPINAL anaesthetic, what needle gauge do you 
prefer to use? 
  22G  
  24G  
  25G  
  26G  
  27G  
  Other (Please Specify): __________________________________________ 
  I do not know the guage of needle  
  I do not have a preference 
 
12. When administering a SPINAL anaesthetic, what needle gauge do you 
routinely have to use? 
  22G  
  24G  
  25G  
  26G  
  27G  
  Other (Please Specify): __________________________________________ 
  I do not know the guage of needle  
  I do not have a preference 
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13. When administering a spinal anaesthetic for a healthy, non-obese patient 
for a caesarean section, what is your preferred choice of intrathecal local 
anaesthetic? 
 Bupivacaine 0.5% with Dextrose 
 Bupivacaine 0.5%  
 Lignocaine 2%  
 Ropivacaine 0.75%  
 Levobupivacaine 0.5%  
 Other (Please Specify): _________________________________________________ 
 
14. For a healthy, non-obese patient, what is your standard dose of the above 
mentioned intrathecal local anaesthetic?   
    ____________ mg   OR  ____________ ml 
 
15. For a healthy, non-obese patient, what other agents do you routinely add to 
your intrathecal local anaesthetic mixture?     (mark all 
that apply) 
   No drugs routinely added 
    Fentanyl   Dose used  =  _____   μg 
   Morphine   Dose used  =       _____   μg 
   Sufentanil  Dose used  =       _____   μg 
   Other (Please Specify):   
   Name of additive : _______________ Dose used  = _________ 
   Name of additive : _______________ Dose used  = _________ 
 
16. In general, for an EPIDURAL placement, what is your preferred technique 
for loss of resistance? 
 
  Air  
 
  Saline  
 
  Both  
 
 Other (Please Specify):  ___________________________________________ 
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17. Do you routinely use EPIDURAL anaesthesia for ELECTIVE Caesarean 
sections? 
 Yes  
 No  
 
18. If you answered NO to QUESTION 17, please skip the next four questions (Q 
18 – 21), and go straight to QUESTION 22 
If you answered YES to QUESTION 17, what is your preferred choice of 
 epidural local anaesthetic? 
 Lignocaine 2%  
 Bupivacaine 0.5%  
 Ropivacaine 0.75%  
 Levobupivacaine 0.5%  
 Other (Please Specify):  _____________________________________________ 
 
19. Please state the volume of local anaesthetic that you routinely use (on 
average) in an standard sized pregnant patient: ______ml 
 
20. For ELECTIVE caesarean delivery, what other agents do you routinely add 
to your epidural local anaesthetic?      
 (mark all that apply)  
 
  No other agents added  
 Fentanyl  
 Sufentanil  
 Morphine  
 Sodium Bicarbonate 8.4%  
 Adrenaline  
  Other (Please Specify):  _______________________________________________ 
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21. For elective caesarean delivery, do you routinely give morphine via the 
epidural catheter for post-operative pain relief? 
  Yes  
   (i)  Please state the dose : ___________ mg 
  (ii) When do you administer this medication? 
        BEFORE the baby is delivered   
        AFTER the baby is delivered  
 No  
 
22. In a labouring patient with an epidural in situ requiring an URGENT 
caesarean section, what is your preferred method of anaesthesia? 
 (a) Top up the in-situ epidural 
 (b) Remove epidural and administer spinal anaesthesia  
 (c) General Anaesthesia  
 (d) Other (Please Specify): ______________________________________________ 
 
23. If you answered (b) (c) or (d)  in QUESTION 22 , please skip the next 4 
questions (Q 23 – 26) and go straight to question 27 
 If you answered (a) in QUESTION 22 ,   What is your preferred choice of 
 local anaesthetic for the epidural Top-up?  
 Lignocaine 2% 
 Bupivacaine 0.5%   
  Ropivacaine 0.75%  
  Levobupivacaine 0.5%  
  Other (Please Specify): _______________________________________________ 
 
24. Please state the average volume of local anaesthetic that you would 
routinely use in an average sized pregnant patient: ________ml 
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25. For an URGENT caesarean section, what other agents do you routinely add 
to your epidural local anaesthetic? 
 No agents added 
 Fentanyl  
 Sufentanil  
 Morphine  
 Sodium Bicarbonate 8.4%  
 Adrenaline  
  Other (Please Specify): _______________________________________________ 
 
26. For an URGENT Caesarean section, do you routinely give morphine via the 
epidural catheter for post-operative pain relief? 
   Yes  
   (i)  Please state the dose : ___________ mg 
  (ii) When do you administer this medication? 
        BEFORE the baby is delivered   
        AFTER the baby is delivered  
   No  
 
27. Do you or the hospital/s where you practice obstetric anaesthesia, have a 
protocol for monitoring patients who receive neuraxial opioids? 
    Yes  
    No   
  
28. If you answered YES to QUESTION 27 , how long are patients monitored for 
signs of respiratory depression after neuraxial opioid administration? 
 <6 hrs  
 6 – 12 hrs  
 Up to 12 hrs  
 24 hrs  
 Up to 36 hrs  
 Up to 48 hrs  
 Other (Please Specify): _________________________________________________ 
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29. If you answered YES to QUESTION 27 , how are healthy patients who 
receive neuraxial opioids for caesarean delivery routinely monitored to 
detect respiratory depression?        
  (mark all that apply) 
  Respiratory rate  
   Sedation score  
   Pulse oximetry 
   Other (Please Specify):  ______________________________________________ 
 
30. If you answered NO to QUESTION 27 , do you think it is necessary to 
monitor patients  who have been administered neuraxial opioids for 
respiratory depression? 
   YES    
   NO        
31. Following surgery for a caesarean section, who do you believe should be 
responsible for the management of the patients post-operative analgesia? 
   
      Obstetrician  
 
      Anaesthesiologist 
 
      Nurse 
 
      Other (Please specify): _________________________________ 
 
32. In your practice, following surgery for a caesarean section the patient’s 
post-operative analgesia is prescribed by: 
   
      Obstetrician  
 
      Anaesthesiologist 
 
      Other (Please specify): _________________________________ 
 
33. Do you routinely use an epidural catheter for postoperative analgesia after 
a caesarean section? 
  Yes – Only if the patient has an epidural catheter pre-operatively 
  Yes – I will insert an epidural catheter if the patient does not have one 
  No  
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34. If you answered YES to QUESTION 33 , which of the following is your 
preferred method of medication administration? 
  Patient Controlled Epidural Analgesia with bolus administration only  
 Patient Controlled Epidural Analgesia with continuous infusion  
 Intermittent epidural boluses, local anaesthetic only  
 Intermittent epidural boluses, opioid only  
 Continuous infusion, local anaesthetic only  
 Continuous infusion, local anaesthetic plus opioid  
  Other (Please Specify):  _____________________________________________ 
 
35. If you answered NO to QUESTION 33, please indicate why you do not use an 
epidural catheter for post-operative analgesia     ( 
mark all that apply) 
 No standard protocol  
 No epidural pumps in postnatal wards  
 Inadequate monitoring in postnatal wards  
 Lack of nursing staff education in epidural care  
 Anaesthesia staff shortage  
 Nursing staff shortage  
 Other (Please Specify): __________________________________________ 
 
36. Do you routinely prescribe an intravenous Patient Controlled Analgesic 
(PCA) pump  following a caesarean section? 
 Yes 
 No 
 
37. If you answered YES to QUESTION 36 , what intravenous analgesic agent do 
you routinely use in the PCA pump?
  Morphine  
 Fentanyl  
 Sufentanil 
 Pethidine  
  Other (Please Specify): _________________________________________________ 
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38. Do you routinely prescribe non-steroidal anti-inflammatory drugs 
(NSAIDs) for postoperative analgesia after a caesarean section?
 Yes   
 No 
39. If you answered NO to QUESTION 38 , please skip the next three questions  
(Q 39 - 41) , and go straight to QUESTION 42 
If you answered YES to QUESTION 38 , what NSAIDs do you routinely 
 prescribe?  
 Ibuprofen 
 Ketorolac 
 Diclofenac 
 Lornoxicam 
 Parecoxib 
 Other (Please Specify): ________________________________________________ 
 
40. What dosing regimen do you use for your NSAID prescription? 
 As required (PRN)  
  Regular scheduled doses 'around the clock'  
  Other (Please Specify):  _________________________________________________ 
41. What is your preferred route of administration of NSAID’s after a caesarean 
section?
 Oral 
 Intravenous 
 Rectal 
 Intramuscular 
  Other (Please Specify):  _________________________________________________ 
 
42. Do you routinely prescribe intravenous Paracetamol for post-operative 
analgesia? 
 Yes 
 No
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43. What other oral analgesics do you routinely prescribe after a 
caesarean delivery ?         
  (mark all that apply) 
 Paracetamol  
 Codeine   
 Oxycodone  
 Tramadol  
 Other (Please Specify): __________________________________________ 
44. What dosing regimen do you use for these other oral agents? 
 PRN  
 Regular scheduled doses 'around the clock'  
 Other (Please Specify):  ________________________________________________ 
45. In your current practice of obstetric anaesthesia, do you think that 
your patients are     satisfied with their post-operative analgesia ? 
 Yes 
 No 
 
Thank you for your participation! 
 
THIS SECTION WILL BE DETACHED FROM YOUR ANSWERS ABOVE 
Should you wish to be sent the results of this survey, please write your e-mail 
address here:  
  e-mail address:  _______________________________________ 
 
THIS SECTION WILL BE DETACHED FROM YOUR ANSWERS ABOVE 
Should you wish to be entered into a lucky draw for a tablet computer please 
enter your contact details here: 
  Name : ________________________________________ 
  e-mail address: __________________________________ 
  Contact Telephone Number: ________________________ 
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